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The corneal stroma is a transparent and avascular tissue constituting 90% of the cornea. The 
stroma comprises collagenous lamellae, oriented roughly orthogonally, and is populated by 
quiescent keratocytes. In vitro models of the stroma can be used for a variety of applications 
from drug toxicity to investigating the mechanisms of collagen fibril alignment. There are 
several drawbacks of current models: the orientation of collagen is not always considered; 
cell sheets are often manually stacked, a technically challenging and unreliable method; and 
cells typically require an extended culture period (several months) to create a construct that 
resembles the stroma. This project aimed to overcome these problems by providing cells 
with topographical cues to induce the deposition of an aligned matrix, with stratification and 
rotation of the deposited collagens. Macromolecular crowding (MMC) was incorporated into 
the model to accelerate collagen deposition. 
 The aim of this study was to develop an in vitro model that faithfully resembled the 
corneal stroma. Corneal stromal stem cells (hCSSCs), human corneal fibroblasts (hCFs) and 
human bone marrow mesenchymal stromal cells (hMSCs) were isolated, characterised and 
assessed for their ability to resemble keratocytes using immunocytochemistry. hCFs were 
readily expanded whilst hMSCs showed differentiation potential towards keratocyte lineage. 
hCSSCs could not be isolated and cultured in sufficient quantities, therefore, this cell type 
was not taken forward for subsequent use.  
 Two substrates, polytetrafluoroethylene nanofibres on glass and polycarbonate 
Transwell membranes, were investigated. hMSCs were cultured in control and differentiating 
media for 21 days. Differentiated hMSCs often formed cell pellets, regardless of the substrate 
or presence of topographical cues and lacked the expression of keratocyte markers. hCFs, 
cultured for up to 30 days, positioned themselves to align along the nanofibres and the 
orientation of deposited collagen was found to follow the direction of the cells. There was a 
shift in orientation as the cells stratified, resembling the lamellae of the stroma. hCFs 
cultured on the Transwell membranes stratified and appeared to deposit more collagen, 
although alignment was reduced.  
 MMC accelerates the deposition of extracellular matrix proteins such as collagen. To 
increase matrix deposition within the tissue engineered construct MMC was used. The use 
of carrageenan as a crowder accelerated the deposition of collagen, determined by ICC and 
the use of a collagen probe. However, the deposition of collagen was disrupted forming 
aggregates that showed little alignment. Crowding with a Ficoll cocktail appeared to increase 
the deposition of collagen without disrupting alignment but ultrastructural analysis 
suggested there was cellular uptake of Ficoll.  
 Collectively, these results suggest that culturing hCFs on aligned PTFE nanofibres is 
the most efficient method to mimic a lamella of the corneal stroma. Crowding with a Ficoll 
cocktail can enhance collagen deposition but the effects of the cellular uptake of Ficoll 
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Ms.  Mouse 
MW Molecular weight 
NBF Neutral buffered formalin 
NC Non-collagenous 
NEAA Non-essential amino acids 
NES Nestin 
NHS N-hydroxysuccinimide 
OCT Octamer-binding transcription factor  
ORO Oil red O 
PAX Paired box protein  
PBS Phosphate buffer solution 
PBST 0.1% Tween-20 in PBS 
PCPE Procollagen proteinase enhancer 
PCR Polymerase chain reaction 
PDGF Platelet-derived growth factor 
PEG Polyethylene glycol 
PGs Proteoglycans 
Pn Passage n (e.g. passage 3 (P3)) 
PSS Polysodium-4-styrene sulfonate 
PTFE-nf Polytetrafluoroethylene nanofibres 
PTGDS Prostaglandin D2 synthase 
PVP Polyvinylpyrrolidone 
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RNA Ribonucleic acid 
ROCK Rho-associated protein kinase 
ROI Region of interest 
RT-qPCR Reverse transcription quantitative real-time polymerase chain reaction  
SCM Stromal cell media (hMSCs) 
SLRPs Small leucine-rich proteoglycans 
SMA Smooth muscle actin 
SOX Sex determining region Y box 
SSEA Stage-specific embryonic antigen 
T25/T75/T175 Culture flasks with surface area of 25/75/175cm2 
TE Tris-ethylenediaminetetraacetic acid 
TEM Transmission electron microscopy 
TGF Transforming growth factor 
TIMP Tissue inhibitor of metalloproteinase 
TNF Tumour necrosis factor 
UV Ultraviolet 
VIM Vimentin 
VSI Vertical scanning interferometry 
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1.1 Overview  
The corneal stroma, a transparent tissue, makes up approximately 90% of the total cornea. 
It is composed primarily of heterotypic type I/V collagen fibrils that are restricted in diameter 
to maintain transparency of the tissue. Keratocytes are the quiescent cells that are 
responsible for maintaining the collagens and proteoglycans within the tissue. Keratocytes 
express corneal crystallins to reduce light scattering, allowing for light transmission onto the 
retina.  
 In accordance with the National Centre for the Replacement, Refinement & 
Reduction of Animals in Research, there is a need to reduce the use of animal models. One 
such alternative is the use of in vitro models and there is, therefore, a need for models of the 
corneal stroma. These models would enable the investigation of wound healing, collagen 
fibrillogenesis and pharmacological testing, all whilst reducing the number of animals used 
in research. Given the complex microarchitecture of the stroma, several challenges arise 
when trying to tissue engineer an in vitro model, such as selecting an appropriate cell type 
(as described in Chapter 2) and substrate (described in Chapter 3) that leads to the deposition 
of a uniform extracellular matrix (ECM), resembling that found in vivo.  
 Drawbacks of current in vitro models include the use of cell sheets cultured on tissue 
culture plastic which do not share the unique, organised collagen layers. Furthermore, the 
current models can take up to 9 weeks to create, risking the cells undergoing phenotypic 
drift and increasing the risk of contamination. Culturing cells on a substrate that provides 
topographical cues to induce the deposition of aligned collagen fibrils combined with a 
method of increasing ECM deposition, such as macromolecular crowding (Chapter 4), holds 
the potential to overcome these shortcomings. 
 
1.1.1 The basic structure and function of the human cornea 
The cornea is a transparent, avascular tissue which forms the outermost layer of the eye. Its 
key functions are to protect the eye, by acting as physical barrier; to transmit light by 
maintaining transparency; and to provide the majority of the refractive power necessary to 
focus light on to the retina (Meek and Knupp, 2015). Each of the cellular layers plays a unique 
role to maintain homeostasis within the tissue (Figure 1.1).  




Figure 1.1 Diagrammatic representation of the distinct layers within the cornea. 
 
 The tear film is the outermost layer of the ocular surface, providing a boundary 
between the epithelium and the environment. The tear film lubricates the surface of the eye 
whilst also protecting the eye from microbes via the secretion of defensins (Zhou et al., 2004; 
Pflugfelder and Stern, 2020). The epithelium is at the surface of the cornea and provides the 
majority of the refractive power at the air/tear interface whilst also providing a surface 
barrier that prevents the encroachment of pathogens (Eghrari et al., 2015). It is composed 
of 5-6 layers of stratified epithelial cells that turnover approximately every 7 days (Hanna et 
al., 1961). Tight junctions provide a continuous seal around the superficial cells that prevents 
the passage of molecules and pathogens between adjacent epithelial cells and into the 
stroma (Sugrue and Zieske, 1997; DelMonte and Kim, 2011). The cells in the basal layer of 
the epithelium are columnar in shape and are connected to the basement membrane, 
comprised of type VI collagen and laminin, via hemidesmosomes (Wijnholds, 2019). Beneath 
the basement membrane lies the Bowman’s layer, an acellular layer comprised of collagen 
types I, III, V and VII fibrils which are randomly arranged and have an average diameter of 
20-25 nm (Komai and Ushiki, 1991). The function of the Bowman’s layer is not completely 
understood but it has been hypothesised that it plays a role in facilitating stromal wound 
repair (Lagali et al., 2009).  
 Beneath the Bowman’s layer is the corneal stroma, the primary component of the 
cornea making up around 90% of the cornea with an average thickness of 461.8 – 465.4 µm 
(Reinstein et al., 2009). The stroma is composed of layers of aligned collagen fibrils (lamellae) 
which are oriented roughly orthogonally throughout (Radner et al., 1998; Chen et al., 2015). 
Interspersed between these lamellae are quiescent keratocytes, neural crest-derived 
mesenchymal cells with an almost dendritic morphology with lamellipodia that connect the 
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cells together (Fini, 1999; West-Mays and Dwivedi, 2006). The Descemet’s membrane resides 
below the stroma and is both collagenous and acellular (Eghrari et al., 2015). This membrane 
is the basement membrane of the corneal endothelium and contains both collagen types IV 
and VIII. There have also been reports of an acellular pre-Descemet’s layer termed Dua’s 
layer (Dua et al., 2013, 2014; Zaki et al., 2015; Dua and Said, 2016) however there is some 
controversy around this and the tissue identified may be a section of the stroma where the 
keratocytes are more widely spaced (Jester et al., 2013; McKee et al., 2014; Schlötzer-
Schrehardt et al., 2015).  
 The innermost layer of the cornea is the corneal endothelium, a monolayer of non-
replicative cells. Most of the nutrients required by the cornea are transported from the 
aqueous humour in the anterior chamber through the endothelium. The endothelium is also 
responsible for maintaining transparency by regulating the hydration of the cornea through 
a ‘leaky’ barrier and active sodium-potassium adenosine triphosphase pumps (Bonanno, 
2012). The endothelium pumps fluid out of the stroma, preventing swelling and haze whilst 
also ‘leaking’ to allow water and nutrients into the stroma (Hertsenberg and Funderburgh, 
2015). The loss of cells from the endothelium leads to swelling of the stroma which results 
in a loss of transparency (Meek et al., 2003).  
 
1.2 The corneal stroma 
The stroma, constituting a large proportion of the cornea, must provide mechanical support 
to protect the eye, whilst also remaining transparent so that light can be refracted on to the 
retina. Keratocytes, the main cell within the stroma, are responsible for synthesising the ECM 
whilst also expressing cytosolic corneal crystallins to reduce light scattering. The intricate 
microarchitecture of the stroma, with its lamellae of collagen, is responsible for both 
withstanding intraocular pressure and ensuring transparency.  
 
1.2.1 Collagens 
Collagens are triple helical proteins that are found in the ECM. They can be classified based 
on their structure and supramolecular assembly such as fibril-forming (e.g., type I), fibril-
associated collagens with interrupted triple helices (FACIT; e.g., type IX) and beaded-
filament-forming collagens (e.g., type VI) (Kadler et al., 2007). The polypeptide chains that 
form the triple helix are comprised of the sequence glycine-X-Y in which X and Y are often 
proline and hydroxyproline (Kadler et al., 1996). 
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Fibrillar collagens are the most abundant collagens in vertebrates and their 
formation has been extensively studied (Birk and Trelstad, 1986; Canty et al., 2004; Canty 
and Kadler, 2005; Kadler et al., 2008). The secretory pathway is where proteins are 
synthesised and carried to the cell surface membrane, via the ER and Golgi apparatus, to be 
secreted into the extracellular space, depicted in Figure 1.2. Following translation, 
procollagen chains in the endoplasmic reticulum (ER) undergo hydroxylation of proline and 
lysine (Harwood et al., 1975). Prolyl hydroxylase and lysyl hydroxylase, enzymes required to 
convert proline and lysine to hydroxyproline and hydroxylysine, both require ascorbic acid 
(vitamin C) as a cofactor to function (Gelse et al., 2003). In the absence of ascorbic acid, 
hydroxyproline is not usually formed, which is necessary for the formation of the triple helix 
and thus procollagen cannot easily leave the ER (Canty and Kadler, 2005). Similarly, 
hydroxylysine is required for the cross-linking of collagen fibres and so in the absence of 
ascorbic acid, collagen fibres are unstable (Eyre and Wu, 2005). Glycosylation, an additional 
post-translational modification, can also occur on lysine and hydroxylysine residues 
(Perdivara et al., 2013). Although the role of collagen glycosylation is not clearly defined, it 
is thought to play a role in fibrillogenesis, cross-linking and, collagen-cell interactions 
(Yamauchi and Sricholpech, 2012). Following post-translational modifications, triple helix 
nucleation occurs at the C-propeptides of procollagen chains and a procollagen triple helix is 
formed (Canty and Kadler, 2005). This is a precursor for collagen molecules in that it is 
flanked at either end by N- and C- propeptides. The procollagen is then transported to the 
plasma membrane, via the Golgi apparatus, in Golgi-to-plasma-membrane carriers (GPCs) 
and released from the cell. Here, procollagen is cleaved by C-proteinases (BMP-1/tolloid 
family) and N- proteinases (a disintegrin and metalloproteinase with thrombospondin 
motifs; ADAMTS 2, 3 and 14) to form tropocollagen, a collagen monomer (Kadler et al., 2007). 
Procollagen cleavage can be enhanced by proteins such as procollagen C-proteinase 
enhancer 1 protein (PCPE-1) and this conversion of procollagen to collagen has also been 
shown to occur intracellularly within GPCs prior to exocytosis (Canty et al., 2004; Steiglitz et 
al., 2006). In vivo fibril nucleation occurs in a crowded environment as collagen 
spontaneously self-assembles to form cross-striated fibrils which are stabilised through 
cross-linking, initiated by lysyl oxidase.  
 




Figure 1.2 A schematic of collagen biosynthesis. Following transcription and translation (1), procollagen undergoes hydroxylation and glycosylation in the ER 
(3). Nucleation of the triple helix occurs at the C-propeptide of procollagen chains to form procollagen which is then transported to the Golgi apparatus where 
lateral aggregation occurs (4 – 5). From here, procollagen is transported to the plasma membrane in GPCs and procollagen is cleaved by C- and N-proteinases 
to form tropocollagen (6 – 7) (collagen monomer) (Canty and Kadler, 2005). Blue pentagon represents hydroxylation of amino acids and orange star represents 
glycosylation.  
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 Within the stroma fibril-forming collagen types I and V form heterotypic fibrils where 
each fibril is 25 – 30 nm in diameter in the adult cornea (Craig and Parry, 1981; Birk et al., 
1988; Daxer et al., 1998). These fibrils are arranged in such a way that they have consistent 
interfibrillar spacing and form lamellae (layers of collagen fibrils) with each lamellae oriented 
roughly orthogonally to adjacent layers (Chen et al., 2015). The small fibril diameter, 
necessary for stroma transparency, is regulated by type V collagen which is also a nucleator 
of fibrillogenesis (Kadler et al., 2008). The diameter of fibrils has been linked to the number 
of nucleation sites, with an increase in nucleation sites resulting in a decrease in fibril 
diameter (Sun et al., 2011; Espana and Birk, 2020). In the stroma, collagen fibrils can form in 
the type V collagen knockout models but this is thought to be a result of the high 
concentration of type I collagen which can undergo self-assembly. These self-assembled 
fibrils, however, are large and irregular with decreased interfibrillar spacing, leading to 
corneal opacity (Sun et al., 2011). The expression of fibrillar type III collagen in the normal 
stroma is debated, with early reports suggesting it is expressed in the adult human stroma 
(Newsome et al., 1982), but later studies finding its expression in normal tissue is restricted 
to the limbus and sclera (White et al., 1997). Type III collagen is, however, deposited during 
corneal wound repair (Priyadarsini et al., 2016a; Lorenzo-Martín et al., 2019). 
 It should be noted that X-ray diffraction studies have revealed that collagen lamellae 
are not consistently orthogonal to their adjacent layers throughout the stroma 
(Aghamohammadzadeh et al., 2004; Abahussin et al., 2009). The orientation of collagen 
varies depending on the position (nasal-temporal and superior-inferior) as well as the 
location within the tissue (posterior, middle or anterior) (Figure 1.3 A and B, respectively), 
where collagen is roughly orthogonally arranged in the central cornea but more tangential 
at the periphery. This change in orientation can explain the differences in strength observed 
across the different regions of the cornea. Strip testing of the stroma has revealed that the 
stroma isolated in the inferior-superior direction has a greater strength than those isolated 
in the nasal-temporal direction and those isolated diagonally (Elsheikh et al., 2008). 
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Figure 1.3 Polar plot maps showing collagen fibril orientation. A: The preferred fibril 
direction, as determined by X-ray diffraction studies, across the entire cornea is shown 
overlaid onto an image of the human eye. As scattering increases at the periphery of the 
cornea, the plots became too large to fit onto the image and were, therefore, scaled down. 
The key represents the factor by which the polar plots were scaled down in order to fit them 
all on one figure. Figure in A is adapted from (Aghamohammadzadeh et al., 2004). B: Polar 
plots of the preferred fibril direction across the anterior, middle and posterior cornea are 
also shown. Again, the key represents the factor by which the polar plots were scaled down. 
Figure in B is adapted from (Abahussin et al., 2009). 
 
Another ubiquitously expressed collagen in the stroma is type VI collagen, a beaded-
filament-forming collagen that is thought to make up 17% of all collagens in the cornea (Table 
1.1) (Zimmermann et al., 1986; Michelacci, 2003). Beaded-filament collagen consists of a 
triple helical domain, flanked by large N- and C-terminal domains. Type VI collagen 
undergoes assembly intracellularly, beginning with the formation of a triple-helix monomer 
from three α chains, followed by dimer assembly, stabilised by disulphide bonds. These 
dimers then assemble to form a tetramer which is secreted extracellularly where they 
assemble, end-to-end, to form beaded microfilaments (Cescon et al., 2015). The 
microfilaments can also aggregate laterally, creating large banded structures, typically 
associated with pathological tissues (Knupp et al., 2002, 2006). Type VI collagen can bind to 
many other matrix proteins, such as type I collagen and proteoglycans. In fact, binding to the 
proteoglycan biglycan can induce a third supramolecular structure, the hexagonal lattice 
(Wiberg et al., 2002). The beaded microfilaments of type VI collagen are distributed 
throughout the stroma (Zimmermann et al., 1986; Cho et al., 1990). Given its ability to bind 
to many other matrix proteins, type VI collagen is thought to influence matrix integrity by 
binding to different levels within the stroma (Cescon et al., 2015; Chen et al., 2015).  
 FACIT collagens comprise non-collagenous domains interspersed amongst several 
triple helical domains (Ricard-Blum, 2011). Collagen types IX, XII and XIV are examples of 
FACIT collagens which do not form fibrils themselves but, instead, interact with collagen 
fibrils. Type IX collagen interacts with fibrillar type II collagen (Diab et al., 1996), whereas 
collagen types XII and XIV interact with type I collagen and can modulate tissue stiffness (M. 
Sun et al., 2020). The role of FACIT collagen types XII and XIV in the stroma are not fully 
understood. In an unwounded cornea, only weak expression of type XII collagen has been 
observed (Massoudi et al., 2012). A recent study by Sun et al. (2020) suggests that type XII 
collagen plays a role in maintaining the structure of the stroma (M. Sun et al., 2020). 
Although collagen type XII-null mouse corneas were transparent, the collagen fibrils were 
smaller in diameter and more densely packed with decreased interfibrillar spacing and 
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disrupted lamella organisation. Interestingly, type XII collagen is upregulated in corneal 
wounds, particularly in areas with an increased expression of α-smooth muscle actin (α-SMA) 
and may play a role in ECM remodelling (Massoudi et al., 2012). Type XIV collagen is present 
during early development but its expression is dramatically reduced in the adult avian cornea 
(Young et al., 2002). 
Collagen types VII, VIII and XIII may also play a role in the development of the stroma. 
Type VII collagen is an anchoring fibril that extends from the epithelium and bowman’s layer 
into the stroma, connecting the different structures. The anchoring fibrils are predominantly 
located in the basal lamina with few fibrils extending deep into the stroma (Gipson et al., 
1987). Network forming type VIII collagen is predominantly expressed in the Descemet’s 
membrane. A mouse knockout model of col8a1 revealed that the stroma was significantly 
thinner when compared to wild types, suggesting type VIII collagen plays a role in 
development (Hopfer et al., 2005). Although its role is unclear, transmembrane type XIII 
collagen has been found in the posterior of the stroma during corneal development but no 
corneal knockout has been studied (Sandberg-Lall et al., 2000). Type XIII collagen is also 
expressed by myofibroblasts in corneal wounds, suggesting that it may play a role in wound 
healing (Määttä et al., 2006).  
 
Table 1.1 Collagens within the corneal stroma and their relative abundance in the entire 
cornea. 
Collagen type Classification  Distribution 
% of total 
collagens 
I Fibrillar  Ubiquitous 75 
III Fibrillar Wound healing  
V Fibrillar Ubiquitous 2 
VI Beaded-filament  Ubiquitous 17 
XII FACIT Weak expression in adults, 
upregulated in wounds 
 
XIV FACIT Expressed during development, 
reduced in adults 
 
Table adapted from (Michelacci, 2003). 
 
 The rate of collagen turnover in the corneal stroma is unclear. It has previously been 
reported to be in the range of 2 – 7 years but there is little evidence to support this estimation 
(Paik et al., 2018). Pulse-chase experiments, using radiolabelled proline, performed on a calf 
corneal stroma indicated that the turnover time for type I collagen was 36 hours (10 and 6 
hours for type V and VI collagens respectively) (Kern et al., 1991). A radiolabelled rabbit 
cornea (using radiolabelled glycine) implanted into an unlabelled host cornea persisted up 
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to 17 months, the length of the study (Smelser et al., 1965). However, it should be noted that 
a corneal graft may not behave the same way as an intact cornea. Collagens can be degraded 
by matrix metalloproteinases (MMPs) and cathepsins and both have been observed in 
pathological corneas (Brookes et al., 2003). Cathepsins are lysosomal enzymes that can 
cleave collagen molecules (Turk et al., 2012). MMPs are a group of proteinases responsible 
for degrading the ECM and its subsequent remodelling (Löffek et al., 2011). Tissue inhibitors 
of matrix metalloproteinases (TIMPs) and other non-specific inhibitors, such as the fragment 
from the proteolytic conversion of PCPE-1, can inhibit MMPs (Mott et al., 2000). Fibrillar 
collagens, such as those found in the corneal stroma, are mostly cleaved by a group of MMPS 
called collagenases (MMP-1, -8 and -13) and the gelatinase MMP-2 (Löffek et al., 2011). The 
expression of MMP-2, -3, -9 and proMMP-13 have all been shown to be upregulated in 
diseased and injured corneas (Mulholland et al., 2005; Predović et al., 2008). 
 
1.2.2 Corneal transparency 
The organisation of collagen plays a key role in maintaining corneal transparency. Initial 
models suggested that the stroma is transparent as a result of its constituents all having the 
same refractive index, however this was disproved and replaced with a model by Maurice, 
called Lattice Theory (Maurice, 1957). This theory proposes that the small, uniform diameter 
of collagen fibrils, with consistent interfibrillar spacing results in the lateral scattering of light. 
Secondary radiation of light travelling in the non-forward direction destructively interferes 
with other back-scattered light, maintaining transparency whilst the light travelling forward 
propagates through the cornea. Later theories, based on observations from transmission 
electron micrographs, suggested the lattice structure is not necessary throughout the entire 
stroma, but that short-range order is sufficient (Hart and Farrell, 1969). This was further 
supported by Benedek who proposed that the cornea will be transparent so long as the 
spacing between the collagen fibrils is smaller than half the wavelength of light (Benedek, 
1971). More recently, Doutch et al. outlined the crucial parameters thought to affect corneal 
transparency and these are: the number of collagen fibrils; collagen fibril diameter; the order 
in interfibrillar spacing; differences in refractive index between fibrils and interfibrillar 
substances; and the thickness of the stroma (Doutch et al., 2008). Models of collagen 
organisation have revealed that increasing collagen fibril diameter can result in the back-
scattering of light (Meek and Knupp, 2015). Furthermore, increasing interfibrillar spacing, 
such as that observed in corneal swelling, can also result in the backwards scattering of light. 
The corneal endothelium regulates the hydration of the cornea through a leaky barrier. If the 
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endothelium becomes damaged, such as in Fuchs’ endothelial dystrophy, the stroma can 
swell and increase interfibrillar spacing. The backward scattering of light reduces the 
intensity of light travelling in the forward direction thus impairing corneal transparency. 
 
1.2.3 Proteoglycans within the stroma 
Proteoglycans (PGs) consist of glycosaminoglycan (GAG) side chains attached to a core 
protein. There are four main proteoglycans found within the corneal stroma and these are 
members of the small leucine-rich proteoglycans (SLRPs). These can be further classified 
based on the sulphate chains they contain with decorin containing chondroitin/dermatan 
sulphate side chains whereas lumican, keratocan and mimecan all comprise keratan sulphate 
side chains and are referred to as keratan sulphate proteoglycans (KSPGs) (Funderburgh et 
al., 1998; Iozzo, 1999; Dunlevy et al., 2000; Michelacci, 2003). Biglycan, a proteoglycan with 
a dermatan sulphate side chain, has been detected at low levels in the human corneal stroma 
and is observed at increased levels in pathologic corneas (Funderburgh et al., 1998).  
 
1.2.3.1 Decorin  
Decorin is expressed across the stroma, typically decorating collagen fibrils and its crystal 
structure can be seen in Figure 1.4 (Kimura et al., 1995). Decorin-null mice present with 
lateral fusion of collagen fibrils in both the skin and tail tendon but not in the corneal stroma 
(Danielson et al., 1997; Zhang et al., 2009). In the stroma there are not many distinguishable 
features when comparing the ultrastructure of corneal collagen fibrils of decorin-null mice 
to wild-types, with only the occasional fibril found to have a larger diameter (Zhang et al., 
2009). However, the expression of biglycan has been shown to be upregulated when decorin 
is knocked out. In a decorin-/biglycan-null mouse severe disruptions to the ultrastructure are 
observed in the posterior stroma, with lateral fusion of fibrils that also have a large diameter 
(Zhang et al., 2009). Interestingly, this phenotype is not observed in early stages of mouse 
corneal development suggesting that both decorin and biglycan play roles in regulating 
mature fibril formation at later stages of development.  
 




Figure 1.4 Rope diagram of a glycosylated model of decorin. Decorin is composed of two 
horseshoe-shaped monomers depicted here in green and red. The N-termini have been 
extended by a few residues to show directionality (grey; top of image). Glycosylation occurs 
in the C-terminal half of the protein; oligosaccharide chains are modelled (grey; bottom of 
image). Other SLRPs have a similar structure. Figure adapted from (Scott et al., 2004).  
 
1.2.3.2 Lumican 
Lumican plays a role in regulating collagen fibrillogenesis and its presence is necessary for 
the formation of thin collagen fibrils found within the stroma. Lumican is homogenously 
expressed in the developing murine cornea but in adult mice greater expression is observed 
in the posterior stroma (Chakravarti et al., 2006; Chen et al., 2014). In vitro assays have 
shown that the addition of lumican to acetic acid-extracted collagen significantly decreases 
the diameter of collagen fibrils formed when compared to fibrils formed in the absence of 
PGs (Rada et al., 1993). The regulatory role of lumican has been further investigated in vivo 
in mice. Lumican knockout mice displayed collagen fibrils with a larger diameter than those 
observed in wild type mice and lateral fibril fusion was also observed (Chakravarti et al., 
1998, 2000). These effects are more pronounced in the posterior stroma and it has been 
suggested that lumican is necessary for maintaining hydration (Chakravarti et al., 2000). 
Phenotypic manifestations of lumican-null mice include corneal hazing and a thin stroma. 
Interestingly, the overexpression of lumican has no observable effect on collagen 
arrangement or corneal transparency (Carlson et al., 2005). However, it has been shown that 
lumican regulates keratocan expression with an increase in lumican resulting in an increase 
in keratocan (Carlson et al., 2005). Although not considered a major PG in the stroma, the 
expression of fibromodulin, a KSPG expressed during development and wound healing, has 
been shown to increase in lumican knockout models (Chen et al., 2010). 
  
1.2.3.3 Keratocan 
Keratocan is a KSPG found throughout the corneal stroma (Liu et al., 2003). It has been 
reported that knocking out the gene encoding keratocan in mice does not affect corneal 
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transparency but results in abnormal interfibrillar spacing of collagen fibrils within the 
stroma (Kao and Liu, 2003). Similarly, keratocan-null mice exhibited larger collagen fibril 
diameters but a thinner stroma suggesting that keratocan plays a role in maintaining corneal 
shape (Liu et al., 2003). This is further supported by pathologies observed in human corneas. 
Cornea plana, a condition where the cornea is flattened, can be caused by mutations in the 
gene encoding keratocan (KERA), which are likely to cause a loss of function of keratocan 
(Pellegata et al., 2000). Interestingly, an increase in keratocan expression has been observed 
in patients with keratoconus, a condition in which the stroma thins and the cornea protrudes 
(Wentz-Hunter et al., 2001). Corneal thinning is a phenotype in both conditions, suggesting 
that an optimal level of keratocan expression is required for normal corneal thickness. 
Histopathology of keratoconic corneas shows a decrease in the number of collagen lamellae 
and irregular arrangements of collagen fibrils (Rabinowitz, 1998). Keratocan is, therefore, 
likely to play an important role in regulating matrix assembly.  
 
1.2.3.4 Mimecan 
Mimecan, also referred to as osteoglycin, is another KSPG detected in the cornea although 
its exact function in the stroma is unknown. Mouse knockout models have revealed that 
mimecan may play a role in regulating fibril diameter although these corneas remained 
transparent (Tasheva et al., 2002). Together, these SLRPs are essential for regulating collagen 
fibril assembly, restricting lateral fibril growth and maintaining corneal shape.  
 
1.2.4 Cells within the corneal stroma 
1.2.4.1 Keratocytes 
The predominant cell type in the stroma is the keratocyte. These quiescent cells have a 
dendritic-like morphology with interconnecting lamellipodia and are fundamental to the 
maintenance of the ECM, synthesising collagens and proteoglycans. Furthermore, these cells 
express corneal crystallins which reduce light scattering and corneal opacities. 
 Keratocytes have a small cell body with numerous process and cortical filamentous-
actin (F-actin) bordering the cells, revealed by phalloidin staining (Jester et al., 1994; 
Funderburgh et al., 2003). This morphology limits the surface area exposed to light and may 
contribute to their reduced light scattering. In vivo confocal microscopy of the stroma has 
revealed that the main source of light scattering is from keratocyte nuclei, and not the cell 
body itself (Møller-Pedersen, 2004). The refractive index of the large number of organelles 
and macromolecules within a cell is unknown but, it is thought that these would scatter light 
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(Jester, 2008). As the cell body is not the predominant source of light scattering in 
keratocytes, Jester et al. hypothesised that fluctuations in the refractive index of the 
cytoplasm are reduced by corneal crystallins (Jester et al., 1999). 
The cell body of keratocytes can vary in size from 200 – 600 nm which, according to 
the aforementioned models of corneal transparency, should result in light backscattering 
(Jester, 2008). It has been proposed that corneal crystallins, such as aldehyde dehydrogenase 
(ALDH) and transketolase (TKT), create short range order within keratocytes thus minimising 
fluctuations of the refractive index both within the cell and also between the cell and the 
collagenous matrix (Jester et al., 1999). ALDH3A1 is the most common corneal crystallin in 
mammals and a knockout mouse model revealed that keratocytes scattered more light than 
wild type controls (Jester, 2008; Chen et al., 2017). Both ALDH1A1 and ALDH3A1 indirectly 
protect against ultraviolet (UV) light via the generation of nicotinamide adenine dinucleotide 
phosphate. ALDH3A1 has also been shown to protect against UV-induced apoptosis and has 
an antioxidant function in stromal cells in vitro (Lassen et al., 2006; Estey et al., 2007). 
To characterise keratocytes, particularly in vitro, phenotypic markers have been 
identified, the most common of which are: keratocan (KERA), lumican (LUM), aldehyde 
dehydrogenase 1A1 and aldehyde dehydrogenase 3A1 (ALDH1A1 and ALDH3A1), where the 
associated gene is written in parentheses (Carlson et al., 2005; Pei et al., 2006; Yam et al., 
2020). Other proteins used to identify keratocytes are prostaglandin D2 synthase (PTGDS), 
an enzyme thought to behave as a proteoglycan in the stroma (Berryhill et al., 2001; Du et 
al., 2007), and carbohydrate sulfotransferase 6 (CHST6), an enzyme that transfers sulphate 
residues to keratan sulphate proteoglycans (Wu et al., 2013). CD34, a cell surface sialomucin, 
is thought to play a role in anchoring keratocytes between collagen lamellae and has also 
been considered a phenotypic marker for keratocytes (Joseph et al., 2003; Perrella et al., 
2007; Sidney et al., 2014). Aquaporin 1 (AQP1), a protein that transports water across the 
cell, is also highly expressed by keratocytes although its exact role in the stroma remains 
unclear (Ruiz-Ederra and Verkman, 2009). Finally, keratocytes do not express Thy-1/CD90 
(THY-1) nor α-smooth muscle actin (α-SMA) (ACTA2), which are associated with corneal 
fibroblasts and myofibroblasts (Pei et al., 2004).  
 
1.2.4.2 Activated keratocytes, fibroblasts and myofibroblasts  
Many studies have investigated the change in keratocyte phenotype observed when the 
cornea is wounded (Jester et al., 1995; Fini, 1999; Mohan et al., 2003; Torricelli et al., 2013). 
Here, the focus is on cells that are likely to have originated from the keratocyte, however 
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other cells, such as those derived from bone marrow, are also involved in the response to 
injury. Within minutes of wounding, keratocytes adjacent to the site of injury undergo 
apoptosis (Wilson et al., 1996). Keratocytes from elsewhere in the stroma transition into an 
activated phenotype, where their morphology changes from the typical dendritic shape to a 
larger, more fusiform shape, resembling fibroblasts (Fini and Stramer, 2005; Hassell and Birk, 
2010). These fibroblasts proliferate and migrate to the edge of the wound where they then 
begin to synthesise and deposit new matrix (Figure 1.5) (Mohan et al., 2003). The haze 
associated with early wound repair is likely due to the presence of these fibroblasts, which 
have a decreased expression of corneal crystallins (Pei et al., 2006). A proportion of these 
cells then differentiate into myofibroblasts. Several different phenotypes have been 
observed at different timepoints during corneal wound healing, from those that express just 
vimentin to those that express vimentin, α-SMA, and desmin, suggesting ordered 
differentiation in response to wounding (Powell et al., 1999; Chaurasia et al., 2009; Torricelli 
et al., 2016). During normal wound healing, myofibroblasts secrete collagen, hyaluronic acid 
and proteoglycans. These proteoglycans, however, tend to be those with 
chondroitin/dermatan sulphate side chains and there is a reduction in KSPGs compared to 
those secreted by keratocytes (Funderburgh et al., 2003). There is also an increase in the 
expression of type III collagen in both fibroblasts and myofibroblasts (Funderburgh et al., 
2003; Galiacy et al., 2011). Consequently, the matrix deposited is often disorganised, with 
large collagen fibrils, and is not transparent. Myofibroblasts then either transition into 
wound fibroblasts or undergo apoptosis. Wound fibroblasts secrete collagenases, MMPs and 
TIMPs which remodel the matrix and the cells start to re-stratify (Lim et al., 2003). Normal 
wound healing requires re-epithelialisation and the secretion of the epithelial basement 
membrane. If this does not occur, epithelial cells continue to release growth factors (e.g. 
platelet-derived growth factor, PDGF and transforming growth factor, TGFβ) and cytokines 
(e.g. interleukin-1 and tumour necrosis factor alpha) which subsequently enter the stroma 
(Wilson et al., 2001, 2003). These chemicals continue to signal the recruitment of 
myofibroblasts to the wound site and either prevent the apoptosis or the transition of cells 
to wound fibroblasts which results in the continuous formation of disorganised ECM (Wilson, 
2020). It is worth mentioning that upon wounding, cells derived from the bone marrow 
migrate into the stroma. The labelling of bone marrow cells with green fluorescent protein 
revealed that once in the cornea, these cells can also differentiate into myofibroblasts 
(Barbosa et al., 2010). More research is required to explore the complex interactions 
between each of the cells involved (epithelial cells, keratocytes, fibroblasts, myofibroblasts, 
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bone marrow-derived cells), growth factors, cytokines and exactly how the matrix is 
remodelled to avoid corneal haze. 
 Keratocytes extracted from the cornea and subsequently cultured in serum-
containing media also exhibit a morphology change to a fusiform conformation 
(Funderburgh et al., 2003). Treatment with serum results in a phenotypic switch from 
keratocytes to corneal fibroblasts, characterised by a change in F-actin distribution, a 
decrease in the expression of KSPGs and an increase in the expression of Thy-1 (Beales et al., 
1999; Pei et al., 2004).  
 
 
Figure 1.5 Diagrammatic representation of corneal wound healing. 1) Corneal wound 
occurs, resulting in the loss of the epithelial basement membrane; 2) cytokines and growth 
factors are secreted by epithelial cells and keratocytes and can also enter the cornea from 
tears; 3) following keratocyte apoptosis at the site of injury, peripheral/distal keratocytes 
become activated and transition to fibroblasts; 4) Growth factors, including TGFβ, result in 
the transition of fibroblast to myofibroblast; 5) under physiological conditions, following the 
deposition and remodelling of the ECM, myofibroblasts undergo apoptosis; 6) in pathological 
conditions, myofibroblasts continue to be exposed to growth factors and cytokines resulting 
in the continued deposition of an irregular matrix; 7) the irregular matrix ultimately results 
in corneal haze and opacity. Image from (Chaurasia et al., 2015).  
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1.2.4.3 Corneal stromal stem cells 
Residing within the anterior stroma, at the periphery of the cornea and in close proximity to 
the limbal epithelial stem cell niche, are multipotent cells that are categorised as stem cells 
(Figure 1.6). These multipotent cells were coined corneal stromal stem cells (CSSCs) by 
Funderburgh’s group but have also been referred to as limbal mesenchymal stromal cells 
(Bray et al., 2014; Shaharuddin et al., 2016). Funderburgh’s group were amongst the first to 
identify this population of cells that exhibited characteristics of mesenchymal stromal cells 
(MSCs) as characterised by the International Society for Cellular Therapies (ISCT) (Du et al., 
2005; Funderburgh et al., 2005; Dominici et al., 2006). Unlike keratocytes, CSSCs express 
PAX6, a protein that’s ocular expression is limited to progenitor cells, the retina and the 
corneal epithelium (Funderburgh et al., 2005; Polisetty et al., 2008). CSSCs possess the 
potential to differentiate down neurogenic, osteogenic, chondrogenic and adipogenic 
lineages, alongside their ability to differentiate into keratocytes (Dravida et al., 2005; Du et 
al., 2005). The potential use of CSSCs clinically has also been investigated. The application of 
CSSCs to a mouse wound model has been shown to prevent corneal scarring by significantly 
reducing the expression of type III collagen and reducing neovascularisation (Basu et al., 
2014). These results are likely amplified as a result of the immunosuppressive nature of 
CSSCs, which not only suppress T-cell proliferation but also stimulate the growth of epithelial 
cells, which in turn would result in the apoptosis of corneal myofibroblasts (Bray et al., 2014). 
These cells typically express markers of pluripotent cells, such as stage-specific embryonic 
antigen 4 (SSEA4) and octamer-binding transcription factor 4 (OCT4); markers associated 
with mesenchymal stromal cells, for example adenosine triphosphate (ATP)-binding cassette 
super-family G member 2 (ABCG2); markers of neural progenitor cells, such as nestin (NES); 
and markers for ocular precursors such as paired box protein Pax-6 (PAX6) (Dravida et al., 








Figure 1.6 Location of CSSCs in the limbus. The section shows the corneal limbus where 
limbal epithelial stem cells (light blue) are localised. Unlike the central cornea, the limbal 
stroma is vascularised and contains melanocytes (black) and keratocytes (blue). CSSCs 
(green) are located subjacent to the basement membrane near limbal epithelial stem cells. 
Image from (Pinnamaneni and Funderburgh, 2012). 
  
 Interestingly, keratocytes isolated from corneoscleral rims have shown the ability to 
transition to a MSC phenotype (Branch et al., 2012). As cells were expanded, the expression 
of CD34 decreased with passaging, until it was negligible at passage 3 (P3). The authors then 
showed that at P3 these cells met the minimal criteria set by the ISCT to define multipotent 
MSCs, including trilineage differentiation (Dominici et al., 2006). Moreover, these cells could 
then be differentiated back into keratocytes, however they still expressed surface markers 
associated with MSCs (Sidney and Hopkinson, 2018). These data are further supported by an 
earlier study which found that cells isolated from limbal biopsies expressed the same surface 
markers as bone marrow-derived MSCs at P2 (Polisetty et al., 2008). Whilst these cells did 
not express PAX6, they showed osteogenic and adipogenic differentiation potential and did 
not express markers associated with limbal epithelial cells. 
 
1.2.5 Corneal stroma assembly during development 
Whilst the adult cornea contains resident stem cells and a continuous renewal of the corneal 
epithelium, most of the stroma formation occurs during development. Much of the research 
on embryonic stroma development has been carried out on chick corneas. Although this is 
similar to the events that occur in humans, it differs in that a distinct primary stroma is first 
formed, an event not present in human stroma development (Espana and Birk, 2020). During 
development keratoblasts, cells derived from the neural crest and the precursor to 
keratocytes, begin to synthesise a hyaluronic acid-rich ECM with few collagen fibrils (Hassell 
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and Birk, 2010). These cells then differentiate to form keratocytes, which replace the 
hyaluronic acid-rich ECM with collagen fibrils (Chen et al., 2015). Keratocytes extend several 
processes that have two major axes which are almost perpendicular to one another. Collagen 
is secreted between these processes from fibripositors and fibrillogenesis occurs before the 
keratocyte processes then retract and bundles of fibrils are formed (Birk and Trelstad, 1984; 
Feneck et al., 2019; Young et al., 2019). This process continues allowing bundles of fibrils to 
continue to form, resulting in lamellae. Simultaneously, the formation of fibril bundles also 
occurs at the keratocyte processes oriented at approximately 90°, creating orthogonally 
arranged fibrils (Birk and Trelstad, 1984). En face serial bock face scanning electron 
micrographs have revealed that from as early as day 12 in the embryonic chick, an orthogonal 
template is formed by keratocyte processes (Young et al., 2014). A recent study of mouse 
corneal development did not show any evidence of fibripositors (Feneck et al., 2019). This 
suggests that collagen alignment in mouse (and perhaps mammal) cornea differs to that 
described in avian models where, as opposed to fibripositors, keratocyte projections align 
the collagen fibrils. Proteoglycans and FACITs are thought to interact with collagen fibrils to 
regulate fibril diameter, interfibrillar spacing and lamellae formation (Chen et al., 2015).  
 
1.3 Tissue engineering of the corneal stroma 
The act of replacing damaged tissue has been around for centuries, from wooden toes to 
clay ocular prostheses (Thurston, 2007; Sajjad, 2012). As technology has advanced there has 
been a shift in the major role of these replacements where value is now placed on 
maintaining the tissues’ function. 
 There are several design requirements that must be met when creating a tissue 
replacement, and whilst these often vary depending on the tissue, one key requirement must 
be met – tissue replacements must be biocompatible. Cytotoxicity must be avoided and 
unwanted immune responses circumvented. The design requirements of the tissue 
replacement must be identified and every effort should be made to ensure that each of these 
is met whilst maintaining biocompatibility. The key design requirements for a replacement 
of the corneal stroma are that it: maintains structural integrity (is mechanically strong); is 
transparent; does not unintentionally degrade; provides the appropriate shape for light 
refraction; and has good handleability (Brunette et al., 2017). When creating an in vitro 
model of the stroma, the design requirements shift and focus less on the handleability and 
the mechanical properties of the construct. The primary focus of an in vitro model is to 
recapitulate the native tissues composition and structure. In the case of the corneal stroma 
Chapter 1 Tissue engineering of the corneal stroma 
21 
 
this refers to the organisation of collagen fibrils and keratocytes throughout. A model of the 
stroma can reduce the use of animals models whilst still allowing for investigative studies, 
such as the study of MMP expression during wound healing (Couture et al., 2016).  
 
1.3.1 Design criteria and applications of a corneal model 
In vitro models of the cornea can be used for a multitude of applications, some of which may 
result in a reduction of the number of animal models used. The success of a stroma model is 
dependent on the intended use and the associated design criteria. With the minimum design 
criteria changing with application (as highlighted in Table 1.2), there may not be a “one size 
fits all” model and, in fact, several versions may be required. Certain applications, for 
example drug testing, may only require the corneal epithelium whilst others, such as 
investigating collagen fibrillogenesis, requires corneal keratoblasts and/or fibroblasts. 
 MatTek is a biotechnology company that produces in vitro models of a variety of 
different tissues. Aware of the fact that different applications require different attributes, 
MatTek has developed two models of the cornea, EpiCorneal™ and EpiOcular™ which are 
commercially available. EpiOcular™ is a standard Organisation for Economic Co-operation 
and Development model for eye irritation tests. However, the EpiOcular™ model is 
composed of normal human epidermal keratinocytes that have been derived from neonatal-
foreskin and stratified to mimic the corneal epithelium. Not only are these cells not derived 
from ocular tissue, and may therefore react differently to the corneal epithelium but the 
stroma, the major component of the cornea, is ignored. The EpiCorneal™ model is composed 
of normal corneal epithelial cells with applications including corneal drug delivery, corneal 
wound healing and dry eye disease (Kaluzhny et al., 2016, 2018). However, as with 
EpiOcular™, this model lacks the stroma – a key component in corneal wound healing, as 
aforementioned (1.2.4.2). To improve on commercial products, such as those supplied by 
MatTek, the corneal stroma should be incorporated into the model. This would allow for 
further research into corneal wound healing as well as the communication between 
keratocytes/fibroblasts and epithelial cells under a variety of conditions (i.e. possible 










Table 1.2 Minimal design criteria for the different applications of a corneal model. 
Application Design criteria Comparison to OECD model 
(EpiOcular™) 
Drug testing*  5-6 layers of epithelial cells plus 
target layer 
Thickness: variable (50 – 200 
µm) 
Consists only of 5-8 layers of 
epithelial cell 




5 – 6 layers of epithelial cells 
plus keratocytes and/or 
fibroblasts 
Organised collagenous layer 
composed of heterotypic type 
I/V collagen fibrils 
Thickness: variable (50 – 200 
µm) 
Consists of 5-8 layers of epithelial 
cells cultured in media 
supplemented with growth factors 
Collagen 
fibrillogenesis* 
Collagen-producing cells (e.g. 
keratoblasts or fibroblasts) 
Extracellular matrix consisting 
of at least collagen types I, V 
and VI 
Thickness: variable (10 – 200 
µm) 






Provides necessary refractive 
power 
Unsuitable for this purpose 
*These models may also replace animal models.  
 
1.3.2 Acellular biomaterials  
There is currently a global shortage in donor corneal tissue, with just one cornea available 
for every 70 patients that require a transplant (Gain et al., 2016). The use of acellular 
biomaterials has been explored as an alternative to an allogenic stroma graft. Given that 
collagen is the primary component of the corneal stroma, most research has focused on 
using this protein to create a biocompatible structure. Recombinant human collagen (RHC) 
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types I and III, produced in yeast, have been cast into curved moulds to form hydrogels via 
cross-linking with 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide and N-
hydroxysuccinimide (NHS) (Liu et al., 2008). Hydrogels made from RHC type III (RHCIII) were 
more transparent, likely as a result of the collagen fibrils having a smaller diameter than RHC 
type I. RHCIII also had better mechanical properties and was able to absorb more UV light, 
essential properties of the stroma that protect the posterior parts of the eye. More recently, 
RHCIII has been combined with a polymer, 2-methacryloyloxyethyl phosphorylcholine, to 
reduce neovascularisation post-implant (Buznyk et al., 2015). Whilst these implants have 
been trialled clinically, with some promising results, they are not yet available for commercial 
use (Islam et al., 2018). Furthermore, their composition and disorganised structure does not 
recapitulate the corneal stroma (Hayes et al., 2015). 
 
1.3.3 Top-down approaches to engineering the stroma 
A top-down approach to engineering the corneal stroma involves culturing stromal cells on 
a three-dimensional scaffold, which is often primed with either chemical or mechanical cues 
to encourage cells to deposit their own ECM. As the scaffold often forms part of this 
structure, their applications tend to be limited to graft-alternatives and for this reason, they 
will only be briefly introduced. 
  
1.3.3.1 Collagen scaffolds 
Collagen has been used in other constructs as a scaffold for corneal cells. Type I collagen gels 
have been created with orthogonal layers of fibrils, achieved by placing a collagen solution 
onto a magnetic bore, increasing the temperature to induce fibrillogenesis and then rotating 
the gel by 90° before adding more collagen solution (Torbet et al., 2007). These collagen gels 
supported corneal fibroblast growth but lacked transparency, which was subsequently 
improved by the addition of proteoglycans to the gels, reducing the diameter of the collagen 
fibrils (Torbet et al., 2007). The corneal fibroblasts in this model successfully synthesised and 
deposited their own collagen fibrils, with smaller diameters than the surrounding collagen 
gel (Builles et al., 2010). Acellular collagen gels have been implanted in to rabbit models, 
however, of the five grafts implanted, only one was retained with the failed grafts exhibiting 
signs of poor wound healing and neo-vascularisation (Builles et al., 2010).  
 Plastic compressed collagens, via the Real Architecture for 3D Tissues process, have 
been used as an alternative to typical collagen gels, given their improved mechanical 
properties (Jones et al., 2011). Whilst the primary aim of these constructs is to support limbal 
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epithelial cells and act as a cell carrier, with data showing they supporting epithelial cell 
growth (Levis et al., 2010), the technique has recently been modified for a stromal 
application (Mukhey et al., 2017). Here, collagen gels were cast into a mould prior to plastic 
compression which resulted in the parallel alignment of collagen fibrils and the cells cultured 
within. This tissue equivalent may be a feasible alternative to partial thickness stromal grafts 
although further work is required to investigate the transparency of the constructs. 
 
1.3.3.2 Silk scaffolds 
Silk fibroin is a naturally occurring polymer with excellent mechanical properties and can be 
reconstituted to create a number of different scaffolds, from fibres and films to sponges and 
gels (Altman et al., 2003). Of particular interest within the field of corneal tissue engineering 
is the processing of silk to create films, which are transparent and thus incredibly useful. Silk 
has been cast onto patterned surfaces to create films with grooves that provide 
topographical cues. Stromal cells have been shown to align along the grooves and deposit an 
aligned matrix (Zhang et al., 2016). Zhang et al. also cast a collagen hydrogel on top of corneal 
cells, cultured in 2% serum, to create a 3D environment which models the stroma (Zhang et 
al., 2016). Equibiaxial strain was incorporated into the system to create a biomimetic model. 
The 3D environment and the incorporation of mechanical strain significantly upregulated the 
expression of lumican and keratocan. A similar 3D model, with silk films surrounded by a 
collagen hydrogel, has also been peripherally capped with silk sponges (Wang et al., 2017). 
The sponges were used to support the growth of dorsal root ganglion cells to model corneal 
innervation in a construct that comprised both hCSSCs and epithelial cells. 
 
1.3.3.3 3D bioprinting  
An emerging area within tissue engineering is the use of bioinks and 3D printing. Extrusion-
based (Isaacson et al., 2018; Kim et al., 2019; Kilic Bektas and Hasirci, 2020), laser-assisted 
(Sorkio et al., 2018), and drop-on-demand (Duarte Campos et al., 2019) bioprinting have all 
been used to print hydrogels for corneal stroma tissue engineering.  
 In extrusion-based bioprinting, loaded biomaterials are forced out of a nozzle in a 
continuous stream (Zhang et al., 2019). A proof-of-concept study used extrusion-based 
bioprinting to successfully print a collagen-alginate bioink containing stromal cells (Isaacson 
et al., 2018). Despite the printed structures unravelling during culturing, keratocytes were 
shown to still be viable at day 7, however their phenotype was not analysed. Extrusion-based 
printing of methacrylated gelatin had a more stable structure and hCFs were shown to be 
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viable up to day 21 but were rounded in shape (Kilic Bektas and Hasirci, 2020). Decellularised 
bovine cornea has also been used as a bioink with extrusion-based bioprinting to print a 
hydrogel encapsulating human turbinate-derived MSCs which were then differentiated into 
keratocytes (Kim et al., 2019). By day 28, cells showed positive expression for KERA, ALDH 
with little ACTA2 expression and collagen was deposited, detected by a hydroxyproline assay. 
Implantation into rabbit models revealed that the printed hydrogels were more transparent 
than the pipetted (non-printed) control after 28 days with no evidence of degradation.  
In laser-assisted bioprinting, the bioink sits atop a donor slide, onto which a laser is 
fired. This results in the evaporation of the donor slide, releasing a droplet of the bioink 
which falls onto the receiving substrate (Li et al., 2016). Laser-assisted bioprinting of adipose-
derived MSCs encapsulated in human type I collagen has been used to successfully print 
viable human cells (Sorkio et al., 2018). Despite being printed in the same orientation, the 
cells were seen to rotate across the printed layers, creating a structure that somewhat 
resembles the corneal stroma. The printed structure was incorporated in to a porcine cornea 
organ culture model and cultured for 7 days. Immunohistochemical staining revealed that 
the cells migrated and infiltrated into the porcine model. 
 Inkjet bioprinting is a technique where droplets of a bioink are dispensed in a 
predetermined pattern (Rider et al., 2018). Drop-on-demand bioprinting is a type of inkjet 
printing that has been used by Duarte Campos et al. to create a dome-shaped stroma 
substitute, encapsulating keratocytes in bovine type I collagen blended with agarose (Duarte 
Campos et al., 2019). Although the mechanical properties were considerably poorer than the 
native tissue, the keratocytes were cultured in 0.5% FBS and appeared to maintain their 
phenotype.  
 At present, bioprinted structures are focusing on an alternative to allogeneic corneal 
grafts with the primary focus being on transparency, tissue integration and mechanical 
properties. Although these stroma equivalents may be used in the future to alleviate the 
demand for corneal grafts, the use of a matrix-derived protein as a bioink restricts their use 
to just that and not as a model which can be used to investigate corneal wound healing, 
collagen fibrillogenesis and cell stratification. 
 
1.3.4 A bottom-up approach using corneal keratocytes and fibroblasts  
A bottom-up approach to engineering the corneal stroma has involved culturing corneal 
keratocytes/fibroblasts to produce a tissue construct that recapitulates the nano-structure 
of the stroma. Early attempts at creating an in vitro model focused on culturing sheets of 
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dermal and corneal fibroblasts in culture flasks (Carrier et al., 2008). One dermal and one 
corneal fibroblast sheet, plus their associated ECM, could then be stacked on top of one 
another to create a thick, fibrous construct. Dermal fibroblasts were incorporated into the 
model as they reportedly supported the stratification of corneal epithelial cells more than 
the use of corneal fibroblasts alone. Corneal epithelial cells were cultured on the surface at 
the air-liquid interface and the construct could also support the adherence of corneal 
endothelial cells, which appeared to reduce swelling of the stroma-equivalent (Proulx et al., 
2010). The model has since been improved, by replacing the dermal fibroblasts with a second 
sheet of corneal fibroblasts, and it has been used to study MMP expression during wound 
healing, however, the orientation of collagen has not been investigated (Couture et al., 
2016). As the fibroblasts used in this model are cultured in flasks, without the provision of 
topographical cues, it is likely that they will be oriented randomly across the cell sheet with 
little organisation. The formation of roughly orthogonal lamellae within the stroma relates 
to its function and is key to ensuring the tissue can withstand intraocular pressure, therefore 
the orientation of collagen is an important requirement of recapitulating the stroma.  
 
1.3.4.1 Transwell membrane as a substrate for hCF cornea model 
Human corneal fibroblasts (hCFs) supplemented with ascorbic acid and foetal bovine serum 
(FBS) have been shown to deposit orthogonal layers of collagen when cultured on a 
polycarbonate Transwell membrane (Guo et al., 2007) (Figure 1.7). Transmission electron 
microscopy (TEM) revealed that the collagen fibrils within the lamellae-like matrix had an 
average fibril diameter of 38.1 nm, larger than that found in the stroma (25 – 30 nm). 
Different iterations of this model have been investigated, from changing the initial seeding 
density to supplementing culture media with growth factors. It has also been used to model 
pathologic conditions such as fibrosis and keratoconus (Karamichos et al., 2010, 2012). In 
these models, hCFs consistently deposited collagen types I, V and VI. However, the 
expression of type III collagen and α-SMA has varied (Guo et al., 2007; Karamichos et al., 
2010, 2012; Lee et al., 2018). The cell sheets varied in thickness, between 20 and 40 µm and 
are commonly referred to as 2.5D cultures. In an effort to create a more 3D model, these cell 
sheets have been stacked to create a construct greater than 300 µm (D. Karamichos et al., 
2014; Priyadarsini et al., 2017a). Furthermore, the Transwell model has recently been 
modified to incorporate additional cell types such as a neuroblastoma cell lines to investigate 
the interaction between the corneal stroma and nerve cells in the diabetic cornea 
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(Priyadarsini et al., 2017b). The Transwell membrane shows great promise as a substrate for 
an in vitro model, supporting the deposition of an ECM that resembles the native stroma.  
 
 
Figure 1.7 TEM of hCFs cultured on Transwell membrane for 4 weeks. A: Low magnification 
image of the hCFs that had been cultured on the Transwell membrane which is also in view. 
A change in the collagen fibril orientation is observed (black arrows). B: As the magnification 
is increased the change in organisation of the collagen fibrils becomes more apparent (black 
arrows). C: A high magnification image shows the orthogonally arranged collagen fibrils. 
Scale bars are A and B: 2 µm and C: 1 µm. Figure from (Guo et al., 2007). 
 
1.3.4.2 The influence of contact guidance and topographical cues on corneal stromal cells 
Cells are known to react and respond to the underlying topography of the substrate on which 
they are cultured via contact guidance (Tamiello et al., 2016). Contact guidance has been 
shown to affect cell morphology, orientation and migration in a number of different cell 
types from fibroblasts (Vrana et al., 2008) and endothelial cells (Dreier et al., 2013a) to 
neuronal cells (Lizarraga‐Valderrama et al., 2019) and osteoblasts (Refaaq et al., 2020). The 
process of cell alignment, depicted in Figure 1.8 A, begins shortly after cells adhere to the 
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substrate, where the cell undergoes spreading before responding to the cues and orienting 
itself along the direction of the grooves. There are several theories that suggest how contact 
guidance occurs, and these have been thoroughly reviewed (Tamiello et al., 2016). The first 
is the mechanical restriction theory whereby the distance between the anisotropic features, 
such as nanofibres, is the primary factor for cell alignment (Figure 1.8 B) (Dunn and Heath, 
1976). If the groove width is so great that cellular processes and filopodia cannot bridge 
across, the cells become polarised and align parallel to the grooves. Actin filaments and focal 
adhesions (multi-protein complexes, directly connected to actin filaments and components 
of the ECM) also align in a parallel direction. The second theory suggests that focal adhesion 
formation and maturation, and subsequently cell alignment, only occurs if the width of the 
feature is greater than 2 µm – the size of a focal adhesion (Figure 1.8 C) (Ohara and Buck, 
1979). By aligning in the direction of the anisotropic features, there is a greater length of 
substrate available for the formation of focal adhesions. An alternative theory is that cells 
react to substrate discontinuities, such as an edge, by forming focal adhesions (Figure 1.8 D) 
(Curtis and Clark, 1990). Increasing the height of the anisotropic features results in the cells 
being more exposed to discontinuities and they consequently align in the direction of the 
features (Tamiello et al., 2016). No consensus has yet been reached on precisely how contact 
guidance occurs, and any of these hypotheses may explain the alignment of corneal stromal 
cells when cultured on anisotropic substrates.  
 
 




Figure 1.8 A schematic representation of cellular orientation in response to aligned, linear 
topographical features. A: Cell orientation response, from adhesion to alignment on a 
substrate with aligned topographical cues. The parameters characterising microgrooved 
substrates are indicated (groove width, ridge width and groove height). B-D: Conditions in 
which cell alignment are thought to occur are indicated. B: If the groove width is so great 
that cell processes cannot bridge across it, the cells become polarised and align parallel to 
the grooves. C: The width of the ridge can influence focal adhesion and, consequently, cell 
orientation. D: Sufficiently high grooves are thought to result in the formation of focal 
adhesions along the groove edge, as the cells respond to substrate inconsistency. Image from 
(Tamiello et al., 2016). 
 
 The orientation of corneal stromal cells has been shown to improve the transparency 
of tissue engineered stroma constructs and can prevent the transdifferentiation of hCFs to 
myofibroblasts (Vrana et al., 2008; Myrna et al., 2012). Furthermore, the use of 
topographical cues to align cells can induce the secretion of a more organised matrix. Micro-
structured substrates, such as those with grooves, have been shown to support hCF 
proliferation and alignment (Guillemette et al., 2009). In fact, hCFs stratified and formed a 
second layer which rotated by approximately 50°, whilst still remaining aligned (Figure 1.9). 
TEM showed organised matrix deposited by hCFs when cultured on the substrates with 
topographical cues, particularly when compared to the flat controls. Furthermore, when 
these sheets of cells were stacked on top of one another, the constructs cultured on micro-
structured substrates macroscopically appeared to be more transparent than the controls.  
 




Figure 1.9 Immunofluorescence staining of actin filaments of hCFs cultured on a substrate 
with topographical cues. A-C: hCFs cultured on the control substrate are randomly oriented 
at time points day 3, 9 and 13. D-F: When cultured on a substrate with topographical cues, 
hCFs align in the direction of cues, evident by day 3. As time progresses the hCFs continue to 
follow the topographical cues (long white arrows) but are also observed stratifying and 
rotating (white arrow heads). S: As the hCFs stratify and form a second layer they rotate by 
53.07°. Figure adapted from (Guillemette et al., 2009). 
 
 Electrospinning is a method of extruding fibres, with diameters in the nano- to micro- 
range, from a polymer solution. This method, which can produce both aligned and randomly 
oriented fibres, has been used to create substrates for corneal stromal cells. A variety of 
polymers have been trialled, from poly lactic acid to collagens, which have all supported 
corneal cell growth (Wray and Orwin, 2009; Wilson et al., 2012; Yan et al., 2012; Fernández-
Pérez et al., 2020a). The alignment of these electrospun fibres not only resulted in the 
alignment of stromal cells but also influenced cell phenotype. Corneal fibroblasts isolated 
from rabbits and cultured on aligned electrospun type I collagen fibres had a reduced 
expressed of α-SMA compared to those cultured on randomly oriented fibres (Wray and 
Orwin, 2009). Moreover, aligned rabbit corneal fibroblasts scattered less light than those 
cultured on randomly oriented fibres and those cultured in a collagen gel (Phu et al., 2011). 
Surprisingly, cells cultured on orthogonally aligned electrospun scaffolds had a significant 
reduction in ALDH3A1 expression compared to those cultured on randomly oriented fibres 
(Fernández-Pérez et al., 2020a). A reduction in ALDH3A1, a corneal crystallin, could result in 
an increase in light scattering and reduction in transparency, although this was not 
measured. To create a construct resembling the corneal stroma, Wilson et al. incorporated 
layers of electrospun poly (L, D lactic acid) fibres and a type I collagen hydrogel (Wilson et 
al., 2012). Human corneal stromal cells were seeded onto the orthogonally arranged 
electrospun fibres prior to the addition of a collagen solution, which was added to provide 
support to the fibre layers. The incorporation of fibres within the hydrogel significantly 
reduced the gene expression of THY-1 and ACTA2, markers typically used to characterise 
fibroblasts and myofibroblasts (Pei et al., 2004). Whilst this substrate can support the growth 
of stromal cells; the ultrastructure of the collagenous matrix is unlikely to resemble the 
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native stroma. Poly lactic acid is a biodegradable polymer and this construct may be better 
suited as a graft-alternative. 
An alternative method of producing substrates with topographical cues is the use of 
friction transfer. Friction transfer of polymers has been shown to produce nanofibres when 
the polymer is rubbed against a smooth, flat surface (Myshkin et al., 2005; Kearns et al., 
2010). Polytetrafluoroethylene (PTFE) is the polymer most commonly associated with 
friction transfer where either a thin film or a series of nanofibres is created (Beamson et al., 
1996). Several different parameters can influence how PTFE is transferred, including: the 
temperature of both the substrate (where the fibres are deposited) and the PTFE blade; the 
speed at which the polymer slides across the substrate; and the pressure exerted on the 
substrate (Beamson et al., 1996; Kearns et al., 2010). Kearns et al. identified that increasing 
the substrate temperature to 250°C caused the PTFE fibres produced to have minimal 
spacing between them and covered more of the substrate when compared to lower 
temperatures (200 – 225°C), which tended to produce surfaces with large uncoated areas 
(Kearns et al., 2010). The research to date has allowed for the creation of nanofibres of a 
non-uniform diameter and spacing. In general, the fibres have a nanoscale diameter with 
fibres ranging from 100 – 800 nm and spacing between the fibres ranging from 0.5 – 10 µm 
(Kearns et al., 2010, 2013). The culturing of human gingival fibroblasts on PTFE nanofibres 
(PTFE-nf) resulted in the alignment of cells (Kearns et al., 2010). Similarly, murine fibroblasts 
cultured on PTFE-nf deposited aligned collagen (Schofield et al., 2011).  
PTFE-nf have also been used in corneal stroma tissue engineering. Gouveia et al. 
cultured corneal fibroblasts on PTFE-nf alone and PTFE-nf coated with a peptide amphiphile 
in serum-free media (to reverse the phenotype back to a keratocyte-like cell) for 21 days 
(Gouveia et al., 2013; Foster et al., 2015). Although the addition of a peptide amphiphile 
coating (which can be enzymatically degraded to release a cell sheet) created irregular 
topography, hCFs still successfully aligned on both substrates. The provision of topographical 
cues provided by the PTFE-nf was found to be important not only for reversing the phenotype 
of hCFs to keratocyte-like cells, but also for the deposition of aligned collagen which 
increased the stiffness of the tissue construct (Gouveia et al., 2017a). PTFE-nf support the 
alignment of cells and the deposited matrix, showing potential as a substrate for creating an 
equivalent of a stroma lamella. 
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1.3.4.3 The influence of substrate stiffness on corneal stromal cells 
Substrate stiffness can also influence cell behaviour and phenotype (Wells, 2008). The 
reported stiffness of the stroma is 33 kPa (Last et al., 2012). A recent study compared the 
cellular response of corneal stromal cells cultured on tissue culture plastic (106 kPa) to those 
cultured on Softwell plates which are coated with a polyacrylamide hydrogel to give 
substrates with a stiffness of 1 kPa and 25 kPa (Chen et al., 2020). Culturing stromal cells (in 
2% FBS) on the substrate with a stiffness that more closely resembles the cornea resulted in 
an increase in the gene expression of ALDH1A1, ALDH3A1, CD34 and LUM (the gene coding 
for lumican) when compared to tissue culture plastic (106 kPa). An increase in these genes 
suggests that stromal cells cultured on more compliant substrates can revert back to a more 
keratocyte-like phenotype. The expression of corneal crystallins could reduce light scattering 
if employed in a tissue engineered stroma equivalent. This is further supported by Dreier et 
al. who reported that hCFs cultured on tissue culture plastic also exhibited increased 
expression of α-SMA when induced with TGF-β1, compared to more compliant substrates 
(Dreier et al., 2013b). Stiffness, along with topographical cues, can modulate cell phenotype 
and may be an important factor to consider when creating a tissue engineered equivalent of 
the stroma.  
In summary, culturing corneal stromal cells on substrates with topographical cues 
shows a lot of potential for the creation of a construct that resembles one or two lamellae 
within the stroma. One drawback of the above-mentioned studies is their use of corneal 
fibroblasts as opposed to keratocytes. Whilst some research suggests that this phenotype 
can be reversed, and fibroblasts can de-differentiate, an alternative strategy is to use 
multipotent cells that can be differentiated into keratocytes. 
 
1.3.5 A bottom-up approach using stem and mesenchymal stromal cells  
Fibroblasts can secrete a matrix that is typically associated with a wound environment, such 
as type III collagen (Funderburgh et al., 2003). Stem cells, which can be differentiated into 
keratocytes, have been incorporated into in vitro models because the ECM they secrete is 
more likely to accurately resemble that found within the stroma. Multipotent cells can be 
isolated from a variety of tissues and many have been used in an effort to obtain keratocytes, 
including cells derived from adipose tissue (Du et al., 2010), bone marrow (Dos Santos et al., 
2019), umbilical cord (Dos Santos et al., 2019), dental pulp (Syed-Picard et al., 2015), 
periodontal ligament (Yam et al., 2018) and the cornea itself (Du et al., 2005; Wu et al., 2013). 
A table summarising the most commonly used cell sources can be found in Table 1.3. 




1.3.5.1 The influence of topographical cues on stem/progenitor cells 
As with hCFs, electrospun substrates have also been used to culture CSSCs. Aligned 
poly(ester urethane) urea fibres resulted in the deposition of an aligned matrix composed of 
collagen types I, V and VI (Wu et al., 2012). They also supported the differentiation of CSSCs 
into keratocytes to a greater extent than those that were randomly oriented, characterised 
by the increased gene expression of KERA, CHST6 and ALDH (Wu et al., 2012). The addition 
of fibroblast growth factor-2 (FGF-2) and TGF-β3 to keratocyte differentiating medium (KDM) 
further improved matrix deposition and resulted in the formation of a thick, multi-layered 
construct with orthogonal collagen fibrils (Wu et al., 2013). When directly compared to hCFs 
in the same medium, CSSCs deposited more collagen whilst expressing significantly less α-
SMA (Wu et al., 2014a). Furthermore, the constructs created by CSSCs were not only thicker 
than the hCF constructs but the cells also deposited orthogonal layers of collagen (Figure 
1.10). Similar results have also been shown when hCFs and CSSCs were cultured for up to 9 
weeks on films of silk that had previously been cast on a patterned surface to form grooves 
(Wu et al., 2014b). CSSCs cultured on the silk films produced a construct much thicker than 
hCFs, with orthogonal layers of collagen (Wu et al., 2014b). As with electrospun fibres, these 
films have also been stacked to create constructs that somewhat mimic the stroma with an 
increased expression of keratocyte markers such as keratocan, lumican and ALDH3A1 (Ghezzi 
et al., 2017). Polydimethylsiloxane cast onto a patterned surface has also supported the 
formation of a CSSCs cell sheet, after culture in KDM, composed of aligned collagen that 
could be peeled off the substrate (Syed-Picard et al., 2016). 5 weeks post-implant into a 
mouse model, light scattering from the cell sheets was similar to control corneas suggesting 
that the sheets had become transparent. Dental pulp stem cells cultured in KDM exhibited 
upregulation of keratocyte markers such as KERA, ALDH3A1 and CHST6 (Syed-Picard et al., 
2015). When cultured on aligned electrospun nanofibres for 4 weeks, the dental pulp cells 
aligned with the orientation of collagen shifting by approximately 80° throughout the 30 µm 












Figure 1.10 A comparison between constructs generated by hCSSCs and hCFs cultured on 
electrospun poly(ester urethane) urea for up to 9 weeks. A-B: The ECM secreted by hCSSCs 
is demonstrably thicker than that secreted by hCFs. C-D: The ultrastructure of the matrix, 
evaluated by TEM, shows that hCSSCs secreted collagen in tightly packed, orthogonal layers. 
 
1.3.5.2 Transwell membrane as a substrate for stem cell-based cornea model 
Stem cells isolated from the cornea have also been cultured on polycarbonate Transwell 
membranes, similar to the model described by Guo et al. (Guo et al., 2007; Dimitrios 
Karamichos et al., 2014). Interestingly, in this model the hCF-generated construct was 
greater in thickness than that generated by CSSCs. The cells aligned and, upon the 
supplementation with TGF-β3, formed orthogonal layers of collagen, whereas the collagen 
secreted by CSSCs was more randomly oriented. The polycarbonate Transwell membranes 
were found to have parallel features along the surface of the membrane (Figure 1.11) 
(Dimitrios Karamichos et al., 2014). These features had an average spacing of 218 nm and 
likely acted as topographical cues for the cells, resulting in cell alignment. They may also 
explain the orthogonal lamellae formed in the hCF Transwell models described by Guo et al. 
(Guo et al., 2007). In the Transwell model, the gene expression of KERA and CHST6, genes 
associated with a keratocyte phenotype, increased after hCFs were cultured in the Transwell 
model for 4 weeks (Dimitrios Karamichos et al., 2014). Mesenchymal stromal cells isolated 
from umbilical cords have also been incorporated into the Transwell model (Karamichos et 
al., 2011). The addition of TGF-β1 to culture media increased the diameter of deposited 
collagen fibrils, from 28 nm to 32 nm, whilst also disrupting the orthogonal arrangement of 
the matrix. Furthermore, the supplementation of TGF-β1 resulted in a decrease in the 
expression of keratocan, but type V collagen expression was upregulated. A reduction of 
hCSSCs hCFs 
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keratocan could be indicative of cells transitioning to a more fibroblast-like phenotype and 
may explain the increased collagen fibril diameter. An increase in type V collagen suggests 
that the umbilical cord cells can synthesise a matrix that somewhat resembles the stroma. 
Whilst these results show potential, the expression of fibroblast and myofibroblast markers 
was not investigated and it is, therefore, unclear just how well MSCs derived from umbilical 
cords can differentiate into keratocytes. A more recent study directly compared the 
differentiation capacity toward keratocyte lineage of multipotent cells from adipose tissue, 
bone marrow, umbilical cord, and CSSCs (Dos Santos et al., 2019). Here, umbilical cord cells 
did not show an increase in the expression of genes KERA nor CHST6 and the authors 




Figure 1.11 Topographical cues present on the surface of polycarbonate Transwell 
membranes. A: Scanning electron micrograph (SEM) at 5000X shows the 0.45 µm pores. B: 
At 20,000X faint lines can be seen across the surface of the membrane. Reported scale bars 
are A: 10 µm and B: 1 µm. Figure adapted from (Dimitrios Karamichos et al., 2014). 
 
1.3.5.3 Induced pluripotent stem cells 
Although not directly used to create a construct that mimics the corneal stroma, another 
source of cells used to differentiate down a keratocyte lineage is induced pluripotent stem 
cells (iPSCs). In one study, iPSCs were first differentiated into neural crest cells before 
pelleting and culturing in KDM for 21 days (Naylor et al., 2016). The pelleted cells expressed 
keratocan, however, when directly compared to isolated keratocytes, the gene expression 
of markers such as ALDH3A1 and CHST6 was significantly lower. Corneal organoids, produced 
from iPSCs after neural crest induction, also expressed keratocan alongside lumican and 
collagen types I and V (Foster et al., 2017). TEM analysis revealed collagen accumulation 
similar to that seen in the developing cornea, suggesting that perhaps iPSC-derive cornea 
organoids could be used to model corneal stroma development.  
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Table 1.3 Potential cell sources for corneal stroma tissue engineering. 
Cell type Advantages Limitations 
Keratocytes Native cell type 
Tissue readily available 
Deposits collagen similar to that in 
vivo 
 
Difficult to expand in culture 
Cells readily transition into 
fibroblasts and/or myofibroblasts, 
although can reportedly be 
dedifferentiated (Foster et al., 




Tissue readily available 
Cells easily isolated and expanded 
Commonly used to model the 
stroma 
 
Deposits collagen similar to that 





Tissue readily available 
Can be differentiated into 




MSCs Available from multiple source 
tissues 
Can be differentiated into 
keratocytes (Du et al., 2010; Dos 
Santos et al., 2019) 
 
Differentiation potential towards 
keratocyte lineage not as great as 
CSSCs (Dos Santos et al., 2019) 
Cost 
 
iPSCs Available from multiple source 
tissue 
Can be differentiated into 
keratocytes 
Requires two differentiation steps 
(Naylor et al., 2016) 
Cost 
 
 Whilst there has been great progress in creating constructs and scaffolds as an 
alternative to allogeneic grafts, there are still several challenges that must be overcome to 
create an in vitro model that recapitulates the corneal stroma. To date, one of the biggest 
drawbacks is the time it takes for cells to deposit an organised matrix. Cells have been 
cultured for up to 3 months in an effort to create a structure resembling just several lamellae 
of the stroma; reducing this time could allow for high-throughput models to be created. 
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1.4 Macromolecular crowding 
Typical two-dimensional (2D) cell culture removes cells far from their typical 
microenvironment, where they are usually surrounded by ECM, other cell types, and 
chemical cues such as cytokines, hormones and growth factors (Barthes et al., 2014). Most 
cells within the body are not surrounded by large volumes of aqueous media, with the 
approximated concentration of macromolecules in tissues ranging from 50 – 400 mg/ml 
(Minton, 2001). In contrast, typical cell culture media has macromolecule concentrations of 
as little as 1 mg/ml (Ellis, 2001). This can be slightly increased with the addition of serum 
which contains 80 mg/ml of protein however, as serum is commonly used at 10% (v/v), this 
only equates to 8 mg/ml (Lareu et al., 2007a). In an effort to place cells in an environment 
that somewhat resembles the in vivo microenvironment, macromolecular crowding (MMC) 
has been employed. The addition of inert macromolecules to aqueous cell culture media can 
effectively crowd the media and this has been shown to have a number of advantages from 
upregulating the expression of certain genes, such as COL1A1, to increasing the processing 
of procollagen to collagen (Bateman et al., 1986; Kumar et al., 2015b).  
 The addition of macromolecules to media results in the exclusion of volume, 
restricting the area that other macromolecules, such as proteins, can occupy. The fraction of 
volume occupied (fractional volume occupancy; FVO) can be approximated by assuming the 
macromolecule is a hard sphere; with a well-defined molecular weight; is neutrally charged; 
and that there is only a single macromolecule present (Hall and Minton, 2003; Chen et al., 
2011). The calculations used to estimate the FVO are found in Table 1.4 (Chen et al., 2011). 
The total excluded volume that a molecule of interest will experience is greater than just the 
FVO, as depicted in Figure 1.12, as a result of the unavailable space between macromolecules 
(Chen et al., 2011). This effect can be enhanced further by the use of charged 
macromolecules, which will repel from one another creating an even larger excluded 
volume. Given that most proteins at physiological pH are negatively charged, the excluded 
volume effect will be greater when a negatively charged crowder is used, with 
macromolecules and proteins repelling one another (Harve et al., 2006).  
 Upon the addition of macromolecules to an aqueous media, cells are immersed in 
an environment that more accurately captures their surroundings in situ. Crowding increases 
the apparent concentration of molecules of interest by reducing the available space (Figure 
1.13). This ultimately increases thermodynamic activity (effective concentration of a species 
in a mixture) and is, therefore, different to simply reducing the volume of media added to 
cultured cells, which does not increase collagen deposition (Peng and Raghunath, 2010). 
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MMC is thought to increase the deposition of ECM via the following mechanisms: 1) 
increasing the relative density of both procollagen and proteinases (Satyam et al., 2014) 2) 
increasing the proteolytic conversion of PCPE-1 to its active form, enhancing procollagen C-
proteinase (Kessler and Adar, 1989; Takahara et al., 1994; Lareu et al., 2007b); 3) proteolytic 
conversion of PCPE-1 also produces a small fragment that can inhibit MMP-2, reducing 
collagen degradation and remodelling (Mott et al., 2000); 4) increasing lysyl oxidase activity, 
which increases collagen crosslinking (C. Chen et al., 2009; Peng and Raghunath, 2010).  
 The ideal crowder is one that does not self-aggregate and is biologically inert, only 
exerting steric repulsion on the molecules of interest within the culture media. At 80 mg/ml 
albumin, the main protein in serum, has been estimated to wield an FVO of 18% in vivo (Chen 
et al., 2011). Albumin itself has been used as a crowder in cell-free in vitro collagen 
fibrillogenesis but aggregates of type I collagen were formed (Zeiger et al., 2012). It would, 
therefore, be logical to identify and use a crowder that exerted a similar FVO in culture media 
to mimic the crowded conditions found in vivo. A recent study by Gaspar et al. suggests that, 
along with negative charge, the polydispersity (distribution of particle sizes) of a crowder can 
enhance matrix deposition (Gaspar et al., 2019a). Polydispersity can be achieved either by 
using a single inherently polydisperse molecule, such as carrageenan, in a mono-crowded 
system or by combining two crowders of different molecular weights, otherwise known as 
mixed-MMC.  
 




𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑟𝑜𝑤𝑑𝑒𝑟 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 =
4
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𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠 𝑖𝑛 𝑋 𝑚𝑔 =
(𝑋 × 10−3) × (6.022 × 1023)
𝑀𝑊




𝐹𝑉𝑂 (%) =  
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑟𝑜𝑤𝑑𝑒𝑟 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠 𝑖𝑛 𝑋 𝑚𝑔
× 100 (Eq. 1.4.3) 
Where r, hydrodynamic radius; X, mass of crowder added per ml; 6.022 x 1023 Avogadro number; MW, 
molecular weight of crowder used; FVO, fractional volume occupancy. Equations described by (Chen 
et al., 2011). 
 
 




Figure 1.12 A simplified model of MMC and the excluded volume effect. In this model, the 
molecule of interest (blue) encounters a volume (pink box). The macromolecular crowders 
(yellow) occupy a given volume, termed the fractional volume occupancy (FVO). This, 
combined with the additional unavailable space, between the macromolecules, is the 
excluded volume. The unavailable volume is challenging to calculate due to the number of 
factors in play, such as electrostatic repulsion. Image adapted from (Chen et al., 2011). 
 
 
Figure 1.13 A schematic representation of the effects of MMC in cell culture media. In 
normal culture media collagen deposition is slow and procollagen often dissolves before it 
can be processed into collagen (left). In crowded media (right), volume is occupied by 
macromolecules which has been suggested to increase the relative density of both 
procollagen and proteinases, thus accelerating collagen deposition. Image adapted from 
(Satyam et al., 2014).  
 
1.4.1 Mono-Macromolecular Crowding 
Crowding with a single macromolecule has been referred to as mono-MMC, and this can be 
with either a neutrally charged or a negatively charged crowder. Relatively neutral crowders, 
such as polyethylene glycol (PEG) (Bateman et al., 1986; Gonzalez-Molina et al., 2019), 
polyvinylpyrrolidone (PVP) (Bateman et al., 1986; Rashid et al., 2014), Ficoll (Lareu et al., 
2007b) and dextran (Bateman et al., 1986; Lareu et al., 2007a) have previously been added 
to cell cultures in an attempt to increase the deposition of the ECM, with varying success. 
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Negatively charged crowders such as dextran sulphate (Bateman and Golub, 1990; Lareu et 
al., 2007a; Kumar et al., 2015b), polysodium-4-styrene sulfonate (PSS) (Lareu et al., 2007b), 
hyaluronic acid (Shendi et al., 2019) and carrageenan (Satyam et al., 2014; Kumar et al., 
2015b; Gaspar et al., 2019b) have all been used to enhance matrix deposition in vitro. 
 
1.4.1.1 Neutral crowders 
PEG was one of the first crowders to be added to cell culture media and it has been shown 
that crowding with PEG results in the complete processing of collagen, secreted by dermal 
fibroblasts, into cell layers by 24 hours (Bateman et al., 1986). This is in contrast to control 
samples where procollagen and partially processed procollagen were secreted in culture 
media. Similar results have also been observed with the addition of PVP as a crowder 
(Bateman et al., 1986). This was supported by Rashid et al. who found that MMC with PVP 
increased the deposition of type I collagen in cell layers in both dermal fibroblasts and in 
mesenchymal stromal cells (Rashid et al., 2014). More recently, PEG has been added to the 
culture medium of a cancer cell line to mimic the tumour microenvironment (Gonzalez-
Molina et al., 2019). MMC with PEG increased the deposition of collagens and caused cell 
elongation, resulting in some cell alignment.  
 Ficoll is a neutral polysaccharide that has been used in Ficoll-Paque for the isolation 
of mononuclear cells from blood samples via a density gradient. The 70 kDa version of Ficoll 
was unable to accelerate the rate of type I collagen deposition in lung fibroblasts (Lareu et 
al., 2007b). Similar results have been shown with dermal fibroblasts where type I collagen 
deposition was not increased but, interestingly, type III collagen was (Gaspar et al., 2019a). 
Increasing the molecular weight of Ficoll does not appear to improve the crowding effect and 
the use of Ficoll 400 kDa also failed to enhance type I collagen deposition after 48 hours 
(Lareu et al., 2007b). Similar to the low molecular weight version of the polymer, type III 
collagen deposition increased after 14 days in dermal fibroblast cultures crowded with Ficoll 
400 kDa, but this appeared to be less than that observed when crowded with Ficoll 70 kDa 
(Gaspar et al., 2019a). 
 Another neutrally charged polymer that has been used as a macromolecular crowder 
is dextran. Dermal fibroblasts crowded with dextran (40 kDa) induced the processing of 
procollagens secreted by dermal fibroblasts and the incorporation of processed collagen in 
the cell layer (Bateman et al., 1986). Interestingly, Lareu et al. found that crowding with 
dextran (670 kDa) did not increase the incorporation of processed collagen into the cell layer 
but, the negatively charged dextran sulphate (500 kDa) did (Lareu et al., 2007a).  
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1.4.1.2 Negatively charged crowders 
Negatively charged crowders have been shown to further increase the crowding effect, and 
thus increase the deposition of ECM, compared to neutral molecules of a similar size (Lareu 
et al., 2007a; Gaspar et al., 2019a). Crowding with dextran sulphate (500 kDa) can increase 
the proportion of secreted collagen incorporated into the cell layer compared to the media 
(Bateman and Golub, 1990; Lareu et al., 2007a; Gaspar et al., 2019a). Lareu et al. have also 
shown that whilst crowding with dextran sulphate did not increase the amount of 
procollagen C-proteinase present, it did increase the presence of the active form of PCPE-1, 
which is known to enhance procollagen cleavage (Steiglitz et al., 2006; Lareu et al., 2007b). 
Additionally, the authors note that the PCPE-1 C-terminus can inhibit MMP2 activity, further 
contributing to the increased amount of collagen in the cell layer by limiting degradation 
(Mott et al., 2000). The addition of dextran sulphate has also been shown to upregulate the 
expression of COL1A1 and COL5A1 in corneal fibroblasts, with a corresponding increase of 
collagen deposition in the cell layer observed (Kumar et al., 2015b). However, the expression 
of ACTA2, the gene coding for α-SMA and a marker for myofibroblasts, was also increased. 
This suggested that the addition of dextran sulphate may result in myofibroblast 
transdifferentiation although this was not seen at the protein level with 
immunocytochemistry. Negative effects, such as cell death, have been reported when 
dextran sulphate was added to bone marrow-derived MSC cultures (Prewitz et al., 2015). 
Similarly, PSS (200 kDa) was incompatible with MSCs despite enhancing collagen deposition 
into the cell layer of lung fibroblasts (Lareu et al., 2007b; Prewitz et al., 2015).  
 Carrageenans are a natural mucopolysaccharide derived from red seaweed and are 
commonly used as a gelling agent in the food industry. They can be distinguished by the 
number of sulphate groups (one, two or three) per disaccharide unit and are denoted by the 
prefixes κ-, ι-, and λ- respectively (Carneiro-Da-Cunha et al., 2011). Given its inherent 
polydispersity, carrageenan has been regularly used to increase collagen deposition in 
cultures of bone marrow-derived MSCs (Cigognini et al., 2016), corneal fibroblasts (Kumar et 
al., 2015b), dermal fibroblasts (Satyam et al., 2016) and tenocytes (Tsiapalis et al., 2020). In 
contrast to dextran sulphate, crowding corneal fibroblasts with carrageenan did not cause a 
change in gene expression in either COL1A1, COL5A1 or ACTA2 (Kumar et al., 2015b). This 
suggests that carrageenan could be used to accelerate the formation of a corneal stroma 
model. 
 




The combination of a larger and a smaller macromolecule within medium can increase 
polydispersity, a factor shown to improve the effects of crowding (Gaspar et al., 2019a). This 
further increases the excluded volume effect, with the smaller crowder occupying additional 
space including in between the larger molecules. An example of such a combination is a Ficoll 
cocktail, often containing 37.5 mg/ml Ficoll 70 kDa and 25 mg/ml Ficoll 400 kDa. The Ficoll 
cocktail has successfully increased the deposition of type I collagen by fibroblasts, unlike each 
of the Ficoll solutions alone (Satyam et al., 2020). Similarly, the Ficoll cocktail increased 
collagen deposition in bone marrow-derived MSCs (Zeiger et al., 2012), dermal fibroblasts 
(Graham et al., 2019) and corneal fibroblasts (Kumar et al., 2015a). Similar to carrageenan, 
crowding with a Ficoll cocktail did not upregulate the hCF gene expression of COL1A1, 
COL5A1 or ACTA2. Dextran sulphate cocktails have also been used, either combining 
different dextran sulphates of various molecular weights (Gaspar et al., 2019a), or by adding 
dextran sulphate to a Ficoll cocktail (Prewitz et al., 2015). Dextran sulphate cocktails (10, 100 
and 500 kDa) increased the deposition of type I collagen by dermal fibroblasts (Gaspar et al., 
2019a). Crowding bone marrow-derived MSCs with a dextran sulphate (10 kDa) and Ficoll 
cocktail (70 and 400 kDa) increased type IV collagen deposition in the absence of ascorbic 
acid (Prewitz et al., 2015). Interestingly, when the culture media were supplemented with 
ascorbic acid collagen deposition was not increased but thicker fibrils were formed.  
 
1.4.3 MMC and tissue engineering of the corneal stroma 
A bottom-up approach to the engineering of the corneal stroma aims to create a 
microarchitecture that resembles the native stroma. This usually involves starting with 
relevant cells, such as keratocytes or stem cells, and culturing them in media supplemented 
with ascorbic acid to stimulate collagen deposition. Work by Proulx et al. (2010) has shown 
that after approximately 30 days in culture, supplemented with ascorbic acid, fibroblasts can 
produce sheets that can be peeled off and superimposed to create an engineered stroma 
construct (Proulx et al., 2010). Similarly, work by Wu et al. (2014) has shown that the culture 
of corneal fibroblasts on patterned silk for 9 weeks can create a construct that is 
approximately 30 µm thick (Wu et al., 2014b). Extensive culture periods can cause problems 
such as phenotypic drift whilst also increasing the risk of contamination. One of the main 
drawbacks of the self-assembly method, therefore, is the long culture period required to 
create a tissue construct. 
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 Macromolecular crowding can accelerate the rate of collagen deposition and thus 
reduce the necessary culture period to create a tissue engineered stroma equivalent. 
Research by Kumar et al. has shown that mixed-MMC with a neutrally charged Ficoll cocktail 
can increase the deposition of type I collagen from as early as 2 days (Kumar et al., 2015a). 
Immunocytochemistry (ICC) revealed an increase in the deposition of collagen types I, III, IV, 
V and VI and fibronectin but no change in gene expression was observed. The use of a 
thermal-responsive polymer allowed the detachment of cell sheets after 6 days and no 
differences were observed in the transparency of the cell sheets produced under crowded 
conditions when compared to a PBS buffer. The sheets transmitted > 90% of light across a 
range of wavelengths (380 – 780 nm). This is greater than the native cornea which typically 
allows < 60% transmittance at wavelengths shorter than 400 nm, increasing to around 90% 
transmittance at 700 nm (Fernández-Pérez et al., 2020b). Kumar et al. also trialled the use of 
negatively charged crowders, carrageenan and dextran sulphate, to enhance collagen 
deposition (Kumar et al., 2015b). Whilst both crowders were shown to increase the same 
ECM proteins via ICC, only dextran sulphate appeared to increase the gene expression of 
COL1A1, COL5A1, CD34 and ACTA2. CD34 is considered a phenotypic marker for keratocytes 
and its positive expression is indicative of corneal stromal cells maintaining a keratocyte-like 
phenotype (Sidney et al., 2014). Conversely, ACTA2, the gene encoding for α-SMA, is a 
phenotypic marker for myofibroblasts typically observed in corneal wounds. However, 
immunocytochemistry did not reveal an increase in the expression of the protein α-SMA 
(Kumar et al., 2015b). As with the mixed-MMC, no differences were observed in the 
transparency of the cell sheets crowded with carrageenan. In a more recent study, 
carrageenan was used as a crowder in corneal fibroblast cultures for up to 14 days at varying 
oxygen and serum concentrations (Kumar et al., 2018). Culturing hCFs at 2% oxygen and 0.5% 
serum resulted in the greatest deposition of collagen types I, V and VI and fibronectin, 
although transparency was not assessed. Whilst the authors do not analyse collagen 
alignment, construct thickness and cell orientation, there is an apparent increase in the rate 
that the ECM is deposited. The crowded culture periods are much shorter than those 
typically used with the self-assembly approach of recapitulating the stroma. It is therefore 
possible that, by extending the culture period, a tissue engineered equivalent of the full 
corneal stroma can be created. As corneal stromal cells are particularly susceptible to 
phenotypic drift, care should be taken to ensure the cells do not transition into 
myofibroblasts. 
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 MMC has also been used with in vitro collagen fibrillogenesis to create aligned fibrils 
which can form multiple layers, resembling the structure of tissues such as the corneal 
stroma (Saeidi et al., 2012b). Young et al. recently presented a model suggesting that 
collagen organisation can occur in a cell-free system and may be influenced by proteoglycans 
(Young et al., 2019). Manipulating crowding conditions can tune collagen matrices, produced 
by in vitro fibrillogenesis, to create a 3D matrix with narrow collagen fibrils that are more 
resistant to degradation which, in turn, can affect cell morphology (Ranamukhaarachchi et 
al., 2019). To further optimise this system, exogenous proteoglycans could be added to the 
collagen solution which may improve fibril diameter and organisation.  
 
1.5 Summary 
The corneal stroma is a complex structure, with collagen fibrils arranged in such a way that 
they do not scatter light. Keratocytes, the main cell within the stroma, express corneal 
crystallins, allowing their cytoplasm to match the refractive index of the surrounding matrix, 
further reducing light scatter. For these reasons, tissue engineering of the cornea poses 
several challenges including: identifying an appropriate cell type; selecting an appropriate 
substrate which will result in the alignment of cells and thus the deposited matrix; and 
accelerating the rate of collagen deposition for the creation of a high throughput model.  
 There are several cell types that can be implemented into a corneal stroma model, 
such as cells isolated from the cornea, MSCs and iPSCs. A high throughput model requires 
cells that are easy to obtain. The Department of Eye and Vision Science regularly receives 
donated corneoscleral rims after the central tissue has been removed for transplantation 
and MSCs are frequently purchased for use in the adjacent Department of Musculoskeletal 
and Ageing Science. A search of relevant literature yielded only a handful of articles where 
iPSCs have been differentiated into keratocytes (Joseph et al., 2016; Naylor et al., 2016; 
Foster et al., 2017). In contrast, CSSCs are cornea-derived cells that have been reported by 
several different groups and are frequently used in stroma tissue engineering (Wu et al., 
2014b; Syed-Picard et al., 2016; Ghezzi et al., 2017). In Chapter 2 hCFS, hCSSCs and bone 
marrow-derived MSCs were chosen based on the ease of obtaining tissue and their reported 
abilities to deposit a matrix resembling the stroma. hCFs are easy to obtain from 
corneoscleral rims, easy to expand and are frequently used in corneal tissue engineering. 
CSSCs can also be obtained from corneoscleral rings, excess tissue after a corneal graft, and 
can be differentiated into keratocytes. MSCs, such as those derived from adipose tissue have 
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also been shown to have the potential to differentiate into keratocytes and deposit an 
aligned matrix.  
 To support the deposition of an organised matrix, substrates for a stromal model 
should provide cues to ensure that cells can secrete collagen fibrils in such a way that it 
resembles the microarchitecture of the stroma. Both PTFE-nf and Transwell membranes 
show potential as substrates, with hCFs reportedly depositing organised collagen on both. 
Furthermore, the Transwell membrane is a commonly used substrate in corneal tissue 
engineering showing the deposition of lamellar-like collagen and will act as a comparator in 
Chapter 3 (Guo et al., 2007; Priyadarsini et al., 2017a; Brown et al., 2021). 
 Carrageenan is a negatively charged macromolecule that can exert a large excluded 
volume effect and has been shown to increase collagen deposition without inducing the 
expression of ACTA2, suggesting it could play a useful role in accelerating the formation of a 
corneal stroma tissue construct. The deposition of collagen by corneal fibroblasts has also 
been increased when crowding with a Ficoll cocktail, composed of relatively neutral 
macromolecules. Hence, carrageenan and a Ficoll cocktail are good candidates to take 
forward and their impact on collagen deposition will be assessed in Chapter 4. 
 
1.6 Hypothesis 
This study will address the hypothesis that progenitor cells and/or cells residing in the limbal 
stroma can be influenced by nanotopography to deposit an organised matrix resembling the 
microarchitecture of the corneal stroma. It is further hypothesised that macromolecular 
crowding will increase matrix deposition without disrupting the organisation of the matrix. 
 
1.7 Aims 
1. To isolate and characterise hCFs and hCSSCs from corneoscleral rings, and MSCs from 
bone marrow; including analysis of stem and MSC marker expression. Further, to 
identify at least one cell type to carry forward for the creation of an in vitro stroma 
model. 
2. To compare two substrates, one with nanofibres and a polycarbonate Transwell 
model; including analysis of cell alignment, collagen deposition and, where 
applicable, successful differentiation into keratocytes. Further, to identify the 
optimal method to create a stroma model. 
3. To compare two macromolecular crowders, carrageenan and a Ficoll cocktail; 
including the analysis of collagen deposition via immunocytochemistry. Further, to 
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Chapter 2. Cell isolation and characterisation




To establish an in vitro model of the corneal stroma, suitable cell types must first be selected. 
Current cell culture models typically use corneal fibroblasts (hCFs) isolated from a corneo-
scleral rim. This chapter focuses on isolating and characterising cells that have the potential 
to create a stromal equivalent. hCFs, corneal stromal stem cells (hCSSCs) and bone marrow-
derived mesenchymal stromal cells (hMSCs) were expanded and the cell phenotype, stability 
and protein expression were analysed.  
 
2.2 Aims and Objectives  
The aim of this chapter was to isolate and characterise suitable cell sources for the 
development of an in vitro corneal stroma model.  
 
The objectives of this chapter were: 
1. To isolate and expand hCFs and hCSSCs 
2. To characterise hCFs, hCSSCs and hMSCs 
3. To determine which of these cell types can be used to represent keratocytes  
  




Sigma/Merck (Germany): Amphotericin B solution (A2942); β-glycerophosphate (G9422); 
Bovine serum albumin (BSA; A2153); Collagenase type-L (C8176); Dexamethasone (D4902); 
Fibronectin (F4759); Goat serum (G9023); Greiner culture flasks 75 cm2 (T75; C7231) and 175 
cm2 (T175; C7356); Greiner CELLSTAR 96 well plates (M9936); 3-Isobutyl-1-methylxanthine 
(IBMX; I5879); Indomethacin (I7378); Insulin (I9278); L-Ascorbic acid 2-phosphate 
sesquimagnesium salt (A2P; A8960); Millicell EZ SLIDE 8-well glass, sterile (PEZGS0816); 10% 
neutral buffered formalin solution (NBF; HT501128); Papain from papaya latex (P3125); 
Penicillin-Streptomycin (P4333); Triton-X (23,472-9); Trypsin-EDTA (T4174); MCDB-201 
(M6770); Tween-20 (P1379) 
Thermo Fisher (USA): Advanced Dulbecco’s Modified Eagle Medium (DMEM) (12491); 
AlbuMAX I (11020-021); DMEM GlutaMAX (61965); DMEM/F-12 (31331); DMEM low 
glucose, no phenol (118800-28); DMEM low glucose (21885); 4’,6-Diamidino-2-Phenylindole, 
dilactate (DAPI; D3571); Epidermal Growth Factor (EGF; PHG0311); Gentamicin (15750-060); 
Insulin, Transferrin, Selenium (ITS; A8960); Minimum essential medium (MEM) Non-Essential 
Amino Acids Solution (11140035); Mr Frosty™ Freezing Container (5100-0001); Nunc™ Cell 
Culture Treated Flasks 25 cm2 (T25; 136196); Oxoid™ Phosphate Buffered Saline Tablets (PBS; 
BR0014G); Quant-iT™ PicoGreen™ dsDNA Assay Kit (P7589); TRI Reagent solution (AM9738); 
TrypLE express (12604-013) 
Corning (USA): Costar® 6-well/24-well/48-well TC-treated Well Plates (3516/3524/3548) 
Promega (USA): M-MLV Reverse Transcriptase (M1701); Nuclease free water (P1195); 
Polymerase chain reaction (PCR) nucleotide mix (C1145); Random primers (C1181); RNasin 
Ribonuclease Inhibitors (N2615) 
LabTech (England): Heat Inactivated Foetal Bovine Serum (batches 013BS145 and 70428) 
Eurogentec (Belgium): Takyon Rox SYBR MastrMix dTTP Blue (UF-RSMT-B0710) 
R&D Systems (USA): Human Mesenchymal Stem Cell Verification Kit (FMC020); Platelet-
Derived Growth Factor (PDGF; 520-BB-050) 
Enzo Life Sciences (USA): FNC coat (AES-0407-L050)  
BD Biosciences (USA): BD CompBeads Anti-Mouse Ig, κ/Negative Control Compensation 
Particles Set (552843) 
Smith Scientific (England): Academy 22 x 50 mm coverslip (NPS16/2250) 
Lonza (Switzerland): Human bone marrow aspirate (1M-105); Human bone marrow 
mononuclear cells (19TL071807) 
Agilent (USA): Dako fluorescent mounting medium (S3023) 




2.4.1 Isolation of human corneal fibroblasts 
Human corneoscleral rims (Figure 2.1) were obtained either from the Royal Liverpool 
University Hospital, after a corneal button had been removed for transplantation, or from 
the Venice eye bank (Fondazione Banca Degli Occhi Del Veneto Onlus). The use of human 
tissue was approved by a Research Ethics Committee (16/EM/0090). The rims were washed 
thrice in DMEM GlutaMAX with high glucose, the epithelium gently scraped off and excess 
sclera was trimmed. The remaining cornea was dissected into small chunks and digested 
overnight at 37°C in 1 mg/ml collagenase type L. The resulting cell suspension was 
centrifuged at 160 x g for 5 minutes and the supernatant discarded. The hCFs were 
resuspended in hCF growth medium (Table 2.1) and plated in T75 culture flasks. These freshly 
isolated cells were at passage 0 (P0) and were cultured at 37°C, 5% CO2 and 20% O2 for 21 
days or until confluent. If large epithelial colonies were observed, cells were treated with 1X 
trypsin-EDTA for 4 to 5 min, leaving behind the epithelial cells, and re-plated in a new T75 
culture flask (P1). If no epithelial colonies were present, hCFs were passaged directly into a 
T175 flask (P1). From P2 all hCFs were passaged in T175 culture flasks. For freezing, 1 x 106 
cells were resuspended in hCF freezing medium (Table 2.1) in a cryovial that was transferred 
to -80°C in a ‘Mr Frosty’. The Mr Frosty contained isopropanol for a freezing rate of -1°C/min. 
Cells were transferred to vapour phase nitrogen for long term storage. 
 
 
Figure 2.1 Human corneoscleral rim indicating the main regions: sclera, limbus and cornea. 
 
Chapter 2 Methods 
51 
 
2.4.2 Isolation of human corneal stromal stem cells  
2.4.2.1 Method 1 
Human corneal rims were washed thrice in hCSSC wash medium (Table 2.1), the epithelium 
and endothelium scraped off and the superficial limbus was dissected out. The limbal stroma 
was dissected further and digested in 0.5 mg/ml collagenase-L overnight at 37°C. The 
resulting cell suspension of hCSSCs was centrifuged at 360 x g for 5 min. Cells were 
resuspended in CSSC growth medium (Table 2.1), plated into a T25 culture flask coated with 
FNC and cultured until small polygonal cell colonies were visible. Cells were then passaged 
using TrypLE Express and again when at 70-80% confluent.  
 
2.4.2.2 Method 2 
Cells were isolated as described above however, after a visit to The University of Pittsburgh 
to learn the technique first-hand, a few alterations to the protocol were made. A narrower 
section of the limbus was taken to reduce corneal/scleral fibroblast contamination (Figure 
2.2). After overnight digestion, the cell suspension was pipetted up and down to break up 
any larger pieces of tissue and, if required, incubated again for an additional 1 hour at 37°C. 
The suspension was then passed through a 70 µm cell strainer, centrifuged, and plated into 
an FNC coated T25 flask. Cells were cultured until colonies were visible and then passaged 
using TrypLE Express at room temperature. After the first passage, cells were seeded at 300-
500 cells/cm2 to prevent differentiation. When cells reached approximately 103 cells/cm2 
they were passaged again.  
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Table 2.1 Media and supplements used for each of the different cell types. 
Cell type Application Basal media Supplements 
hCFs Wash DMEM high glucose GlutaMAX None. 
Growth DMEM high glucose GlutaMAX 10% foetal bovine serum (FBS), 100 U/ml penicillin, 100 μg/ml 
streptomycin and 2.5 µg/ml amphotericin B. 
Freezing DMEM high glucose GlutaMAX 20% FBS and 10% dimethyl sulfoxide (DMSO). 
hCSSCs Wash Equal volumes of DMEM GlutaMAX and 
DMEM/F-12 
100 U/ml penicillin, 100 µg/ml streptomycin and 50 µg/ml 
gentamicin. 
Growth 300 ml DMEM low glucose GlutaMAX and 
200 ml MCDB-201  
2% FBS, 1 mg/ml AlbuMaxI, 0.12 mM L-ascorbic acid 2-
phosphate sesquimagnesium salt hydrate (A2P), 1 μg/ml 
insulin, 0.55 μg/ml transferrin, 670 ng/ml (ITS), 10 ng/ml 
platelet-derived growth factor (PDGF), 10 ng/ml epidermal 
growth factor (EGF), 10 nM dexamethasone, 100 U/ml 
penicillin, 100 μg/ml streptomycin and 50 μg/ml gentamicin 
Freezing DMEM/F-12 20% FBS and 10% DMSO. 
Mononuclear cells 
(hMNCs) 
Growth DMEM low glucose, no phenol Up to passage 3: 
10% FBS, 1% L-glutamine, 1 mM A2P, 100 U/ml penicillin, 100 
μg/ml streptomycin and 2.5 µg/ml amphotericin B. 
hMSCs Growth DMEM low glucose, no phenol 0-14 days: 
DMEM low glucose, 5% FBS, 1% GlutaMAX, 1% MEM non-
essential amino acids (NEAA), 100 U/ml penicillin, 100 μg/ml 
streptomycin and 2.5 µg/ml amphotericin B. 
 
Day 15 onwards: 
As above but increased FBS to 20%. 
Freezing DMEM low glucose, no phenol 20% FBS and 10% DMSO. 




Figure 2.2 A diagram to highlight the differences between the methods used to isolate 
hCSSCs. The sections outlined in blue (left) show where the tissue was taken from in method 
1. A smaller section was isolated in method 2, as outlined in red. 
 
2.4.3 Expanding human bone marrow derived mesenchymal stromal cells 
Adherent human mesenchymal stromal cells (hMSCs) were recovered from human bone 
marrow aspirate from 2 different donors (donors 1 and 2) following an established protocol 
(Rotherham et al., 2018). Briefly, T175 flasks were coated with 10 ng/ml fibronectin solution 
in PBS for 1 h at room temperature. hMSC growth medium was added to each flask before 
aspirating 1 x 105 cells/cm2 (Table 2.1). After a 7-day incubation period (37°C, 5% CO2 and 
20% O2) a 50% media change was performed. After a further 7 days a complete media change 
was executed and MSC colonies were visible. Cells were passaged when they reached 70-
80% confluency and switched to complete media with 10% FBS. Human mononuclear cells 
(hMNCs) were purchased from Lonza and seeded at 12.5 x 106 cells per T75 flask (donor 3) in 
hMNC growth medium (Table 2.1). Cells were allowed to attach for 5 days (37°C, 5% CO2 and 
5% O2) before a complete media change was performed. After P3, cells were transferred to 
37°C, 5% CO2 and 20% O2 and cultured in hMSC growth medium as above. These cells are 









2.4.4.1 Validating primary antibodies 
A human cornea, purchased from the Liverpool Research Eye Bank, was washed thrice in 
DMEM high glucose and the epithelium and endothelium were scraped off. The stroma was 
then minced and digested in 1 mg/ml collagenase-L overnight at 37°C. The resulting cell 
suspension was strained through a 70 µm cell strainer and centrifuged at 360 x g for 5 min. 
Cells were resuspended in phosphate buffer solution (PBS) at a concentration of 1.5 x 105 
cells/ml. 200 µl of the cell suspension was added to a cytospin funnel chamber and 
centrifuged in a Shandon Cytospin 3 at 800 rpm for 5 min onto Shandon cytoslides. The cells 
were allowed to air dry at room temperature before fixing in 10% neutral buffered formalin 
(NBF) for 10 min. Rapid Romanovsky staining was used to confirm the presence of cells, 
which consists of 30 s in methanol, 20 s in eosin red and 20 s in methylene blue (Figure 2.3).  
Freshly isolated corneal stromal cells (keratocytes) on cytoslides were permeabilised 
with 0.5% Triton-X in PBS prior to blocking with 10% goat serum in 1% bovine serum albumin 
(BSA). Primary antibodies (Table 2.2) were diluted in BSA and added to cells overnight at 4°C. 
Unbound primary antibody was removed with two washes in 0.1% Tween-20 in PBS (PBST) 
at room temperature. Secondary antibodies (Table 2.3) were diluted to 5 µg/ml and added 
to cells for 1 hour at 37°C in the dark. Where possible, conjugated phalloidin (Table 2.3) was 
added in conjunction with the secondary antibodies to label F-actin. Two PBST washes 
removed unbound secondary antibody prior to the addition of 364 nM 4',6-Diamidino-2-
Phenylindole (DAPI) to label the nucleus which was incubated at room temperature for 15 
min in the dark. A final wash with PBS followed by distilled water was performed and the 
slides were mounted using Dako, a hardset fluorescent mounting medium, and a 22 x 22 mm 
coverslip. The mounting medium was left to set for 40 min and the slides stored in 4°C until 
imaged on the Zeiss confocal laser scanning microscope 800 (LSM). Images were analysed 
using Zen Lite (v 3.1 blue edition; Zeiss) and Fiji (ImageJ v 1.52p) (Schindelin et al., 2012). 
Results shown in Appendix A. 




Figure 2.3 Rapid Romanovsky staining shows the presence of corneal stromal cells 
(keratocytes) after cytospinning. Eosin red stains the cytoplasm and methylene blue stains 
the nucleus. Scale bar represents 100 µm.  
 
2.4.4.2 Characterisation of cells 
For the characterisation of all cell types, 700 cells/cm2 were seeded into an EZ 8-well glass 
slide and cultured for up to 1 week. The cells were then stained for phenotype-specific 
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Table 2.2 Primary antibodies used for ICC characterisation of hCFs, hMSCs and CSSCs. 





Poly Keratocan (KERA) Rabbit Sigma 
HPA039321 
1.50 
Mono Lumican (LUM) Rabbit Abcam 
ab168348 
3.23 





Mono Hematopoietic progenitor cell 













Poly Collagen I (Col I) Rabbit Abcam 
ab34710 
2.00 
Mono Collagen III (Col III) Mouse ThermoFisher 
MA1-22147 
4.00 
Poly Collagen V (Col V) Rabbit Abcam 
ab7046 
4.20 









Mono Thy-1 (CD90) Mouse Abcam 
ab23894 
10.00 
Mono 5′-nucleotidase (CD73) Rabbit Abcam 
Ab133582 
20.00 
Mono ATP-binding cassette super-




Mono Stage-specific embryonic 
antigen 4 (SSEA4) 
Mouse R&D Systems 
MAB1435 
10.00 
Mono Octamer-binding transcription 
factor 4A (OCT4A) 
Mouse R&D Systems 
MAB17591 
10.00 








Chapter 2 Methods 
57 
 
Table 2.3 Secondary antibodies and phalloidin used in ICC. 




Goat anti-mouse IgG 488 Invitrogen A-11029 4 
Goat anti-rabbit IgG 488 Invitrogen A-11008 4 
Goat anti-mouse IgG 594 Invitrogen A-11005 4 
Goat anti-rabbit IgG 594 Invitrogen A-11012 4 
Goat anti-mouse IgG 647 Invitrogen A-21235 4 
Goat anti-rabbit IgG 647 Invitrogen A-21244 4 
 
Conjugated Phalloidin Supplier/ Catalogue number Concentration 
Alexa Fluor™ 488 Phalloidin Invitrogen A22287 3 U 
Alexa Fluor™ 647 Phalloidin Invitrogen A12379 7.5 U 
 
2.4.5 Optimising RNA extraction from tissue 
2.4.5.1 Homogenising tissue 
Corneal buttons from porcine eyes, purchased from Morphets abattoir (Widnes, UK), were 
minced and added to a microcentrifuge tube along with a stainless-steel bead. The 
microcentrifuge was then placed into a homogeniser and homogenised in bursts of 20 s. TRI 
reagent was added to the tube and stored at -80°C until the ribonucleic acid (RNA) was 
extracted. RNA was purified using Zymo’s Direct-zol RNA MiniPrep Plus kit, as per the 
manufacturer’s instructions.  
 
2.4.5.2 Dismembrating tissue 
Porcine corneal buttons were minced and snap frozen in liquid nitrogen in a dismembrator 
chamber. The chamber was then placed into the Mikro-dismembrator U at 2000 rpm for 30 
s. The tissue was scraped out and placed into a microcentrifuge tube before TRI reagent was 
added. Samples were stored at -80°C and RNA was purified using Zymo’s Direct-zol RNA 
MiniPrep Plus kit.  
 
2.4.5.3 Collagenase digesting tissue 
Porcine corneal buttons were minced and digested in 2 mg/ml collagenase-L overnight at 
37°C. The cell suspension was strained through a 70 µm cell strainer, centrifuged at 360 x g 
for 5 min, washed with PBS and then stored in TRI reagent at -80°C. RNA was purified using 
Zymo’s Direct-zol RNA MiniPrep Plus kit. The collagenase digest was deemed to be the best 
method (Figure 2.4) and was used to extract RNA from human corneas from this point 
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onwards but the concentration was decreased to 1 mg/ml for human corneas as RNA 
extraction was unsuccessful with 2 mg/ml.  
 
Figure 2.4 RNA yields using different extraction methods. RNA was purified from cell lysates 
using Zymo’s Direct-zol kit following the above extraction methods. Collagenase digest yields 
the highest concentration of RNA and was selected going forward.  
 
2.4.6 RNA extraction from cultured cells 
Cells cultured in a 6-well plate were rinsed twice with distilled PBS before adding 500 µl TRI 
reagent to each well. The well was then scraped and the solution transferred to a 
microcentrifuge tube and stored at -80°C. 
Cells cultured in a T75 flask were trypsinised using 1X trypsin for 4 min at 37°C. The 
cell suspension was centrifuged at 360 x g for 5 min, the pellet washed twice in distilled PBS 
and 350 µl TRI reagent was added to the tube. RNA was purified using Qiagen’s RNeasy Plus 
Micro Kit. The quality and quantity of RNA was examined using the NanoDrop 2000.  
 
2.4.7 Reverse Transcription and RT-qPCR 
Complementary DNA (cDNA) was produced from RNA in a 25 µl reaction. 500 µg/ml random 
primers (1 µl) was added to RNA in a total volume of 12.4 µl and heated to 70°C for 5 min in 
a Bio-Rad Thermal Cycler T100. M-MLV buffer (5 µl), 8 U/µl M-MLV (1 µl) reverse 
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(0.6 µl) was added to each PCR tube, mixed and incubated at 37°C for 60 min. The reaction 
was inactivated by heating to 93°C for 5 min.  
 Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) 
was performed using Takyon Rox SYBR MastrMix dTTP Blue and 10 ng of cDNA was amplified 
in a 25 µl reaction in a LightCycler 480 (Roche). Following Takyon activation at 95°C for 3 min, 
40 PCR cycles were completed consisting of 10 s denaturation at 95°C followed by 45 s at 
60°C. Relative gene expression was calculated according to the efficiency corrected ΔCT 
method (Svec et al., 2015).  
Primers were either designed using Primer-BLAST (NCBI), found in the literature or 
purchased from Qiagen (see Table 2.4). Both the designed primers and those found in 
literature were subjected to a BLAST search to check primer specificity. The designed primers 
were also quality tested using NetPrimer (Premier Biosoft). The efficiency of GAPDH, 
ALDH3A1, AQP1, KERA and PTGDS primers were tested on the collagenase-digested corneal 
stroma. Where primer efficiencies were not measured, 100% efficiency was assumed. 
GAPDH was selected as the best housekeeping gene following efficiency testing and GeNorm 
analysis (Appendix B) (Vandesompele et al., 2002).  
 
Table 2.4 Forward and reverse primer sequences. 
Gene Forward Reverse Source 
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC (McDermott 
et al., 2016) 
ALDH3A1 CATTGGCACCTGGAACTACC GGCTTGAGGACCACTGAGTT (Du et al., 
2007) 
AQP1 CCACTGGATTTTCTGGGTG CCAGACCCCTTCTATTTGGGC Designed 
KERA CCTGGAAGGCAAGGTGCTA AGTAGGAAAACTGGGTGGGC Designed 
PTGDS CCTGCCCCAAACCGATAAT CAGAGACATCCAGAGCGTGG Designed 
ABCG2 ACGAACGGATTAACAGGGTCA CTCCAGACACACCACGGAT (Liang et al., 
2017) 
NES Hs_NES_2_SG QuantiTect Primer Assay Qiagen 
NOTCH1 Hs_NOTCH1_2_SG QuantiTect Primer Assay Qiagen 
 
2.4.8 Growth curves 
2.4.8.1 Growth curve of hCFs 
To determine the growth rate of hCFs, growth curves were set up for 21 days. hCFs were 
seeded in to a 48-well plate at a density of 5 x 103 cells/cm2. A cell standard curve was created 
by seeding 1 x 103 – 1 x 105 cells directly into tubes and centrifuging at 360 x g for 5 min to 
remove excess media. The cell pellets were then lysed with 200 µl of lysis buffer (1X Tris-
EDTA (TE) + 1% Triton-X). At days 1, 3, 5, 7, 14 and 21 cells were rinsed with PBS and lysis 
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buffer (200 µl) was added to each well. The wells were scraped before transferring the cell 
lysate to microcentrifuge tubes and storing at -80°C.  
The quantification of DNA, assessed using a PicoGreen assay, was used as an 
estimate of cell number. Cell lysates were thawed to room temperature and the 200X 
PicoGreen solution was diluted to a working solution in 1X TE buffer. Cell lysate (50 µl) and 
PicoGreen (50 µl) were added to a black 96-well plate and incubated at room temperature 
for 5 – 10 min in the dark. The plate was then read on a FLUO star OPTIMA plate reader at 
excitation/emission of 490/525 nm. Cell number was calculated using the cell standards 
(Figure 2.5).  
 
 
Figure 2.5 Representative standard curve to determine hCF cell number from relative 
fluorescence units (RFU). The cells were analysed in triplicate to account for any pipetting 
error when seeding the cells. 
 
2.4.8.2 Growth curve of hMSCs 
To determine the growth rate of hMSCs cells were set up as described in 2.4.8.1 however a 
few alterations were made. hMSCs were seeded in to a 24-well plate at a density of 5 x 103 
cells/cm2 and lysed with 500 µl of lysis buffer at each time point.  
Room temperature cell lysates (100 µl) were added to a black 96-well plate along 
with working PicoGreen solution (100 µl). The plates were analysed as described above with 
the optimal gain for each plate used. To correct for the variation in gain, a subset of samples 
from day 7 were read at gains from 1000-2000. A standard curve was generated and the 
equation of the curve was used to correct for variations in the optimal gain used and allow 
for comparisons between plates (Figure 2.6).  
 

















y = 0.2570x + 662.7
R2 = 0.9764




Figure 2.6 Representative gain curve for correcting PicoGreen data. DNA samples were read 
at each gain to create a standard curve. Experimental samples were then read at their 
optimal gain and corrected for using the above equation.  
 
2.4.9 Flow Cytometry  
The International Society for Cellular Therapies (ISCT) defined cell surface markers that an 
MSC population must express in addition to markers that they must lack (≤ 2% positive) 
(Dominici et al., 2006). To verify that the hMSCs expressed the necessary cell surface 
antigens, flow cytometry using R&D Systems Human Mesenchymal Stem Cell Verification kit 
was performed on donor 1 at passages 1 and 4 and donor 3 at P4. Briefly, cells were 
trypsinised, counted and washed in staining buffer (2 ml). The cells were resuspended at 1 x 
105 cells/ml in staining buffer with 1% FBS. The cell suspension (100 µl) was added to a 
microcentrifuge tube and each positive antibody (10 µl) and the negative marker cocktail (10 
µl) was added to the cell suspension, mixed, and incubated for 40 min at room temperature 
in the dark. Excess antibody was removed by centrifuging the cell suspension and washing 
the resultant pellet in staining buffer. The final cell pellet was resuspended in 500 µl PBS and 
the samples were analysed on the BD FACS Canto II. Cells in the absence of an antibody were 
used as negative controls. Data of donor 2 at passage 1 (P1) and P3 were provided by Adam 
Janvier and the data for donor 3 P1 were provided by Daniel Green. 
Owing to the fact that multiple fluorochromes were used in a singular sample, flow 
cytometric compensation was performed to remove any spillover fluorescence from one 
channel to another. To do this, one drop of CompBeads was added to a microcentrifuge tube 
along with 10 µl of one antibody. The bead suspension was then treated the same as the 
cells and each of the samples were read separately.  
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 Data obtained were analysed on a dotplot and histogram using FlowJo™ (v 10.6.1). 
Dead cells were excluded by plotting the area for side scatter against the area for forward 
scatter (FSC) and doublets were excluded by plotting the height against the width of the FSC. 
To identify the positive dataset, histograms of the stained sample and the unstained control 
were plotted. Gating was performed to eliminate the effects of autofluorescence of the cells 
and any overlap was manually deconvoluted as shown in Figure 2.7.




Figure 2.7 An example to show the method used to analyse flow cytometry data. A: Histograms of both the stained sample (red) and unstained control 
(blue) were plotted to identify where the overlap, if any, began. B: This gating was then applied to both the stained sample and C: the unstained control. 
Manual deconvolution was used to identify the true positive dataset: the number of unstained cells that were autofluorescent was subtracted from the 
number of positive cells in the stained sample to obtain the true positive dataset.  
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2.4.10 Trilineage differentiation of hMSCs 
The ISCT defines MSCs as cells with the potential to differentiate to osteoblasts, adipocytes 
and chondroblasts (Dominici et al., 2006). Studies were, therefore, conducted to verify the 
trilineage differentiation potential of the hMSCs.  
 
2.4.10.1 Osteogenic induction and characterisation 
hMSCs at P4-5 were seeded into a 6-well plate at 3 x 103 cells/cm2 and cultured in growth 
hMSC medium overnight. After 24 hours, the medium was switched and cells were cultured 
for 21 days in osteogenic medium (DMEM low glucose, 10% FBS, 100 nM dexamethasone, 
10 mM β-glycerophosphate and 50 µM A2P). Control cells were cultured in growth medium. 
After culturing, cells were washed twice with PBS prior to fixation with 10% NBF for 30 min. 
Cells were then washed with PBS followed by the addition of 0.5% Alizarin red for 45 min in 
the dark. Alizarin red stains calcified matrix and is used to confirm in vitro bone formation 
(Javidan and Schilling, 2004). To remove any unbound stain, cells were washed 4 times with 
distilled water prior to imaging.  
 
2.4.10.2 Adipogenic induction and characterisation 
hMSCs at P4-5 were seeded into a 6-well plate at 1 x 104 cells/cm2 in growth medium 
overnight before commencing adipogenic induction with DMEM low-glucose supplemented 
with 10% FBS, 1 µM dexamethasone, 100 µM indomethacin, 10 µg/ml insulin and 500 µM 3-
isobutyl-1-methylxanthine for 21 days. Control cells were cultured at the same seeding 
density in growth DMEM. To assess adipogenic differentiation, Oil Red O staining was used. 
Oil Red O stains neutral triglycerides and lipids (Koopman et al., 2001). Cells were rinsed 3 
times with PBS prior to fixation in 10% NBF for 30 min. Cells were then washed with PBS 
before incubation in 60% isopropanol for 5 min at room temperature. The isopropanol was 
then removed, cells rinsed once more, before the addition of 1% Oil Red O for 15 min at 
room temperature. To remove any unbound stain, cells were washed 4 times with distilled 
water prior to imaging. 
 
2.4.10.3 Chondrogenic induction and characterisation 
Cell pellets containing either 5 x 105 (high density) or 2.85 x 105 (low density) were cultured 
in screw-cap microcentrifuge tubes for 21 days in chondrogenic medium (DMEM low 
glucose, 100 nM dexamethasone, 10 ng/ml TGF-β3, 1X ITS and 86.34 µM A2P). Control cells 
were also cultured in high- and low-density cell pellets in growth DMEM.  
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High density cell pellets were washed with PBS prior to fixation in 10% NBF for 1 
hour. The pellets were then paraffin embedded (Appendix C) and 4 µm sections were 
mounted onto microscope slides. Samples were rehydrated in sequential 2 x 5 min xylene, 
100% ethanol for 5 min, 90% ethanol for 5 min, 70% ethanol for 5 min followed by a wash in 
water. 1% Alcian blue was added to the sample for 30 min at room temperature before 
dehydrating the sample in increasing concentrations of ethanol for 30 s followed by xylene 
washes. Alcian blue stains the proteoglycans of the extracellular matrix associated with 
chondrocytes (Javidan and Schilling, 2004). Slides were then mounted and imaged.  
Low density cell pellets were washed with PBS and transferred to clean 
microcentrifuge tubes. The pellets were then digested in 500 µl 10 U/ml papain solution for 
4 h at 60°C and stored at 4°C overnight before analysis. Equal volumes of the digested 
material and dimethyl methylene blue (DMMB) were added to a 96-well plate and the 
absorbance read immediately at 570 nm. The glycosaminoglycan (GAG) content was 
calculated from a standard curve produced using chondroitin sulphate standards (Figure 2.8).  
 
 
Figure 2.8 Representative standard curve produced using chondroitin sulphate standards. 
The standard curve enabled quantification of sulphated GAG in the cell pellets. 
 
2.4.11 Keratocyte differentiation of hMSCs 
To determine the differentiation potential of hMSCs into keratocytes 5000 cells/cm2 were 
seeded into a Millicell EZ 8-well glass slide and cultured in growth medium overnight at 37°C, 
5% CO2, 20% O2. The following day, the media of 4 wells was switched to keratocyte 
differentiating medium (KDM) for 21 days (Table 2.5). Control cells were cultured in stromal 
cell medium (SCM) (Table 2.5). 
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Cells were rinsed with PBS and fixed in 10% NBF for 15 min before being processed 
and stained as described in 2.4.4.1. hMSCs were stained with anti-keratocan and anti-
lumican antibodies and co-stained with phalloidin and DAPI.  
 
Table 2.5 Media and supplements used to treat hMSCs. 







10% FBS, 1% GlutaMAX, 1% NEAA, 
1 mM A2P, 100 U/ml penicillin, 
100 μg/ml streptomycin and 2.5 








1 mM A2P, 10 ng/ml basic 
fibroblast growth factor (FGF-2) 
and 0.1 ng/ml transforming 
growth factor, beta 3 (TGF-β3). 
 
2.4.12 Statistical analysis 
Statistical analysis was performed using GraphPad Prism software (v 9.0.0). Where n > 2, data 
were reported as mean ± 1 standard deviation (SD). A significance level of p < 0.05 was set 
for all experiments. Data were analysed for significance using paired t-tests. To ensure data 
were normally distributed a Shapiro-Wilk test was performed. Statistical analysis was not 
performed on RT-qPCR data (Figure 2.20) or flow cytometry data (Figure 2.23) due to the low 


















2.5.1 hCF characterisation 
2.5.1.1 hCFs maintain their morphology through passaging 
hCFs were cultured in vitro up to P5 and used in experiments at this passage. Phase contrast 
images of isolated hCFs showed that the cells maintained their spindle-shaped morphology 
across passages (Figure 2.9).  
 
 
Figure 2.9 Representative phase contrast images of hCFs at different passages. hCFs 
maintain their spindle-shaped morphology with passaging as shown in the micrographs. n = 
4. Scale bar represents 200 µm. 
 
2.5.1.2 hCFs expand and proliferate with minimal donor variation 
hCFs at P5 proliferated and increased in cell number up to day 7 where a slight decrease was 
observed in two of the donors (Figure 2.10). Between days 14 and 21 cell number declined, 
as expected in in vitro culture. 




Figure 2.10 Growth curve of hCFs at P5. hCFs were seeded at 5 x 103 cells/cm2 and cultured 
for up to 21 days prior to PicoGreen analysis. n = 3 and a logistic growth curve was applied. 
R2 = 0.90. All cells increased in number up to day 14 before plateauing.  
 
2.5.1.3 hCFs do not appear to express all of the typical keratocyte-associated markers 
Immunocytochemistry (ICC) of hCFs at P5 was used to further characterise the cells and 
assess if the fibroblasts retained any features typically associated with keratocytes (Figure 
2.11). In this study, hCFs expressed cell surface marker CD34 and lumican (LUM) – markers 
commonly used to confirm keratocyte phenotype in cell culture (Dunlevy et al., 2000; Wu et 
al., 2013; Sidney et al., 2014). In contrast, there was little expression of keratocan (KERA), 
aldehyde dehydrogenase 3A1 (ALDH3A1), and collagen types V and VI (Col V and Col VI) 
which are also used as markers to identify keratocytes (Carlson et al., 2005; Pei et al., 2006; 
Wu et al., 2014a). In addition, CD73 was expressed but CD90 expression was not seen. There 
was diffuse staining of α-SMA, but no evidence of the stress fibres associated with 
myofibroblasts. Vimentin (VIM) and F-actin were stained to visualise the cytoskeleton and 
revealed stress fibres traversing the cell. 
 




















Figure 2.11 ICC characterisation of hCFs at P3. Representative images of single or double 
immunofluorescent staining used to characterise hCFs. Cellular expression of keratocyte 
markers: ALDH3A1 (green), keratocan (magenta), type I collagen (magenta), type V collagen 
(magenta) type VI collagen (magenta), CD34 (magenta) and lumican (magenta) are shown. 
Expression of fibroblast and myofibroblast markers: type III collagen (green), α-SMA (green), 
CD90 (green), CD73 (magenta) were also assessed. Vimentin (magenta) and F-actin (yellow) 
were stained to analyse the arrangement of the cytoskeleton. n = 1. Scale bars represent 100 
µm. 




Figure 2.12 IgG negative controls for rabbit and mouse primary antibodies. n = 1 biological 
replicate. Scale bar represents 100 µm.  
 
2.5.2 CSSC characterisation 
2.5.2.1 Morphology of CSSCs varies depending on the method of isolation used 
Phase contrast images of CSSCs isolated using two slightly different methods showed 
variation between passages. Small, polygonal shaped cells can be seen in cultures isolated 
using both method 1 (Figure 2.13 A) and 2 (Figure 2.13 B), however, this was always a 
heterogeneous population with several fibroblastic cells present too.  
The cells expanded using the first methodology seemed to undergo phenotypic drift 
and transdifferentiate into fibroblast and myofibroblast-like cells after the first passage. This 
is indicated by the presence of cells with a large, flat cell body. Conversely, the cells that were 
passaged at a seeding density of 400 cells/cm2, as in method 2, appeared to maintain their 
morphology at P1 although a heterogeneous population was still observed.  




Figure 2.13 Phase contrast images of CSSCs using two different methods. Images show 
small, polygonal shaped cells that resemble the morphology of CSSCs at P0. A: Using method 
1 these cells began to transdifferentiate into a more fibroblast-like cell by P1. B: In contrast, 
more of the cells isolated using method 2 maintain their polygonal shape. n = 7 for method 
1; n = 9 for method 2. Scale bars represent 100 µm. 
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2.5.2.2 ICC characterisation of CSSCs is inconclusive 
To further characterise the cells isolated using the two different methods, 
immunocytochemistry was performed. Initially, only the expression of MSC markers CD90 
and CD73 were assessed (Figure 2.14). The cells expressed CD73 with mixed positive and 
negative expression of CD90. Co-staining with DAPI allows us to see the nucleus which also 
suggests there was a heterogeneous population of smaller and larger cells. Interestingly, the 
cells isolated using the second method did not appear to express CD73 and had low 
expression of CD90 (Figure 2.15). A more in-depth characterisation was performed on 
hCSSCs isolated using method 2, based on the fact that this is the published method and the 
cells had the desired polygonal morphology. 
OCT-4A, a transcription factor associated with stem cells, was observed in donors 1 
and 5 (Figure 2.16) (Sidney et al., 2015). Similarly, punctate staining of PAX6, a progenitor 
marker of corneal stromal cells, was observed in the nucleus of cells isolated from these 
same donors, however no expression was seen in donor 3 (Figure 2.17) (Funderburgh et al., 
2005; Sidney et al., 2015). Both donors 1 and 5 also expressed ABCG2, a progenitor cell 
marker, across the cell membrane but it was not observed in isolates from the donor 3 
(Figure 2.17) (Basu et al., 2014). Phalloidin staining of F-actin showed the cytoskeletal 
differences amongst cells isolated from the same donor. Donor 1 consisted of cells of a 
similar size whereas donors 3 and 5 both contained a heterogeneous population of cells with 
mixed sizes.  
To further characterise the cells, the expression of typical keratocyte and 
fibroblast/myofibroblast markers was explored (Figure 2.18). Cells from all 3 donors 
expressed α-SMA, although stress fibres were absent, and cells isolated from donors 1 and 5 
appeared to express CD34. All donors exhibited negative expression of keratocan but donor 
5 did express the corneal crystallin ALDH3A1. IgG controls showed non-specific staining 
(Figure 2.19).  




Figure 2.14 ICC characterisation of Method 1-isolated CSSCs. Cells were stained with 
antibodies for two cell surface markers commonly associated with multipotent cells, CD73 
(magenta) and CD90 (green). Cells were co-stained with DAPI (blue) and merged images are 
also shown. n = 1 biological replicate. Scale bars represent 100 µm. 
 
 
Figure 2.15 ICC of stem cell markers on CSSCs isolated using Method 2. Cells isolated from 
3 different donors were stained with multipotent cell markers, CD73 (magenta) and CD90 
(green) and representative images are shown. All cells were co-stained with phalloidin 
(yellow) and DAPI (blue) with the merged images also shown. Scale bars represent 100 µm.  
 




Figure 2.16 ICC of pluripotent cell markers on CSSCs isolated using Method 2. Cells isolated 
from 3 different donors were stained with SOX2 (magenta) and OCT-4A (green) and 
representative images are shown. All cells were co-stained with phalloidin (yellow) and DAPI 
(blue) with the merged images also shown. Scale bars represent 100 µm. 




Figure 2.17 ICC of pluripotent and progenitor cell markers on CSSCs isolated using method 
2. Cells isolated from 3 different donors were stained with PAX6 (magenta), ABCG2 (green) 
or SSEA-4 (green). All cells were co-stained with phalloidin (yellow) and DAPI (blue) with the 
merged images also shown. Scale bars represent 100 µm. 
  




Figure 2.18 ICC of keratocyte/fibroblast markers on CSSCs isolated using Method 2. Cells 
were stained for negative markers of CSSCs and positive markers for keratocytes or 
fibroblasts: keratocan (magenta), ALDH3A1 (green), cD34 (magenta), α-SMA (green). All cells 
were co-stained with phalloidin (yellow) and DAPI (blue) with the merged images also shown. 








Figure 2.19 IgG negative controls for rabbit and mouse primary antibodies. Cells were co-
stained with phalloidin (yellow) and DAPI (blue) with the merged images also shown. Scale 
bar represents 100 µm. 
 
2.5.2.3 CSSCs isolated using method 2 vary in stem cell marker expression 
The gene expression of stem cell and keratocyte markers was assessed using RT-qPCR (Figure 
2.20). CSSCs are known to express progenitor markers NES, ABCG2 and NOTCH1 and have 
low expression of keratocyte markers KERA, ALDH3A1, PTGDS and AQP1 (Funderburgh et al., 
2005, 2016; Du et al., 2007; Basu et al., 2014; Dos Santos et al., 2019). The data highlight the 
donor-to-donor variation found when attempting to isolate CSSCs. NES, NOTCH1, ABCG2 and 
AQP1 were expressed at similarly low levels by donors 1 and 5. However, stark differences 
were observed in the expression levels of PTGDS and ALDH3A1. Interestingly, the passaging 
of donor 5 seemed to alter the expression levels of each of the genes. Between P4 and P5 
there was a decrease in the expression of NES, NOTCH1, ABCG2 and AQP1 which was then 
partially recovered by P6. Similarly, there was a decrease in PTGDS and ALDH3A1 however 
this was consistent with passaging and does not recover.  
Donors 2, 3 and 4 exhibited similar expression of NES, NOTCH1 and ABCG2 – genes 
associated with stem cells. These same donors also had similar expression of keratocyte 
markers: KERA and AQP1. Differences were observed between the two different populations 
derived from donor 2 at P4. The cells isolated from the first parent flask (P4a) had greater 
expression of NES, NOTCH1, KERA and AQP1 when compared to its sister flask (P4b).




Figure 2.20 Gene expression analysis of stem cell and keratocyte markers in isolated CSSCs. Values are shown on a logarithmic scale and normalised to 
GAPDH. Passages of cell cultures isolated from the same donor but different parent flasks are distinguished by the letters ‘a’ and ‘b’ following passage number. 
n = 1 for all samples. 
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2.5.3 hMSC characterisation 
2.5.3.1 hMSCs can maintain their morphology through passaging 
hMSCs were cultured in vitro up to passage 4 (P4). At P1, donor 1 exhibited the typical MSC 
morphology with a population of spindle-shaped cells (Figure 2.21 A). With passaging, these 
cells became a more heterogeneous population with fewer spindle-shaped cells and a 
greater number of cells with a flattened, irregular geometry which were also larger in size. 
Donors 2 and 3 retained a spindle-shaped morphology throughout passaging (Figure 2.21 B 
and C). 




Figure 2.21 Phase contrast images of hMSCs through passages. A: Morphological changes 
of donor 1 through passaging. B: Morphology of cells isolated from donor 2. C: Spindle-
shaped morphology of cells isolated from donor 3. Scale bar represents 200 µm. 
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2.5.3.2 Growth rate of hMSCs is consistent between donors 
hMSCs at P5 showed an increase in cell number up to day 21 (Figure 2.22). All 3 donors 
followed the initial trend of the typical sigmoid growth curve for cultured cells and 
proliferated as expected. 
 
 
Figure 2.22 Growth curve of hMSCs at P5. hMSCs were seeded at 5 x 103 cells/cm2 and 
cultured for up to 21 days prior to PicoGreen analysis. n = 3 and a logistic growth curve was 
applied. R2 = 0.91. All cells continued to increase in cell number up to day 21.  
 
2.5.3.3 A change in phenotype occurs after in vitro culture 
Flow cytometry was used to assess the expression of typical MSC markers, with the data from 
donor 2 at both P1 and P3 and the data from donor 3 at P1 being provided by colleagues. 
The expression of CD73 decreased in all donors after passaging (Figure 2.23). Conversely, 
CD90 expression increased in donor 1 following passaging but was consistent between 
passages in donors 2 and 3. CD105 expression decreased after passaging in donors 1 and 3 
(43.7% to 26.8% and 95.9% to 86.9% respectively) but increased in donor 2 from 61.2% to 
85.2%.  
The percentage of cells that express all 3 positive MSC markers decreased with 
passaging in both donors 1 and 3 (Table 2.6). Donor 2, however, showed an increase in the 
number of cells that expressed the positive markers after in vitro culture (66.2% at P1 to 
88.7% at P3). In contrast, after passaging donors 1 and 2 showed a decrease in the expression 
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of the negative markers whereas the expression of these markers increased in donor 3 from 
2.3% to 99.4%. 
 




Figure 2.23 Flow cytometric analysis of MSC markers expressed by hMSCs at early and late 
passages. The blue peaks represent the control unstained samples and the red peaks 
represent samples in the presence of each antibody. Results are shown as percentage of 
positive cells after the subtraction of control fluorescence. 
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Table 2.6 Summary of flow cytometric analysis of hMSCs. 
 
Passage 
% of cells expressing 
all positive markers* 
% of positive cells that 
express negative markers† 
Donor 1 
Early 64.0 82.9 
Later 4.4 0.9 
Donor 2 
Early 66.2 33.8 
Later 88.7 13.5 
Donor 3 
Early 96.4 2.3 
Later 94.8 99.9 
* Percentage of cells that express CD90, CD73 and CD105. † Percentage of those cells that also express 
the markers in the negative marker cocktail (CD45, CD34, CD11b, CD79A, HLA-DR). 
 
2.5.3.4 hMSCs are capable of trilineage differentiation 
The ability to differentiate hMSCs into different cell lineages was assessed using histology 
and a glycosaminoglycans (GAGs) assay. Oil Red O stains neutral triglycerides and lipids red 
which can be seen in all 3 donors, suggesting successful adipogenic differentiation (Figure 
2.24). Alizarin Red stains calcium deposits red which can be seen in donors 2 and 3 after 
osteogenic induction. Donors 2 and 3 also successfully differentiated into chondrocytes and 
GAGs have been stained blue in the chondrogenic pellets. A low cell number from donor 1 
prevented osteo- and chondrogenic inductions for histological analysis. GAG content was 
also analysed using the DMMB assay. Donor 1 showed a high GAG content prior to 
chondrogenic induction which did not increase with chondrogenic differentiation (Figure 
2.25). Conversely, both donors 2 and 3 showed an increase in the mean total GAG content 
after chondrogenic induction (from 2.20 µg to 6.55 µg and 2.59 µg to 4.10 µg respectively) 
as anticipated. 




Figure 2.24 Histological analysis of trilineage differentiation potential of hMSCs. Representative images are shown for each donor before (negative) and 
after (positive) adipogenic, osteogenic and chondrogenic differentiation. hMSCs subjected to adipogenic induction stained positively with Oil Red O to show 
lipid formation. A low cell number from donor 1 prevented osteo- and chondrogenic inductions for histological analysis. Cells subjected to osteogenic 
induction stained positively with Alizarin red to highlight calcium deposits. Cell pellets subjected to chondrogenic differentiation were stained with Alcian 
blue which labelled GAGs. Scale bars represent 100 µm.





Figure 2.25 Total glycosaminoglycan (GAG) content without (negative) and with (positive) 
chondrogenic induction. n = 2 technical repeats for donor 1 and n = 3 technical repeats for 
donors 2 and 3; bar represents the mean. Multiple paired t-tests were performed. p values 
reported are: a = 0.00125 and b = 0.00862.  
 
2.5.3.5 hMSCs have the potential to differentiate into keratocyte-like cells 
ICC was used to assess the ability of hMSCs to differentiate into keratocyte-like cells. 
Qualitatively, the cells cultured in keratocyte differentiating medium (KDM) appeared to 
have an increased expression of keratocan, a proteoglycan found in the corneal stroma, 
when compared to cells cultured in standard medium (SCM) (Figure 2.26). Interestingly, cells 
cultured in both KDM and SCM expressed lumican.  
 The phalloidin staining of F-actin revealed that the differentiated hMSCs had a 
different morphology to the control hMSCs with a smaller, more spindle-shaped cell body. A 
cell sphere was also present in one of the wells cultured in KDM.  
 


























Figure 2.26 Representative images show ICC of differentiated hMSCs. hMSCs were seeded into 8-well chamber slides and cultured in either stromal cell 
medium (SCM) or keratocyte differentiating medium (KDM) for 21 days. Cells were stained for keratocyte markers keratocan (magenta) and lumican 
(magenta) with the IgG negative controls also shown. Nuclei are co-stained with DAPI (blue) and F-actin stained with phalloidin (yellow) with the merged 
image also shown. n = 1 biological replicate. Scale bars represent 100 µm. 
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2.6 Discussion  
The aim of this chapter was to characterise different cell types in order to identify a suitable 
cell source to use in an in vitro corneal stroma model. hCFs were easily isolated and 
expanded, unlike hCSSCs. A heterogeneous population of cells were obtained when trying to 
isolate hCSSCs, which readily transitioned into cells resembling fibroblasts, suggesting 
phenotypic drift had occurred. hMSCs did not meet all of the criteria set out by the ISCT but 
two donors exhibited trilineage differentiation potential. Expression of keratocan and 
lumican, after keratocyte lineage induction, suggests that hMSCs can be differentiated into 
keratocytes. 
 
2.6.1 Characterisation of hCFs 
The nomenclature for cells isolated from the corneal stroma varies in the literature and is 
often dependent on the conditions used to culture these cells (Beales et al., 1999; 
Funderburgh et al., 2003; Pei et al., 2004; Musselmann et al., 2005). It is widely accepted 
that corneal stromal cells cultured in ≥ 10% FBS transdifferentiate from a keratocyte 
phenotype to a fibroblast- or myofibroblast-like cell (Fini, 1999; Funderburgh et al., 2001; 
Berryhill et al., 2002; Pei et al., 2006; Foster et al., 2015). However, culturing stromal cells in 
the absence of FBS results in slower cell growth (Beales et al., 1999; Lynch et al., 2016). In 
this study, human corneal stromal cells that had been cultured in 10% FBS were 
characterised and so these are referred to as human corneal fibroblasts (hCFs).  
The phase contrast images revealed that culturing stromal cells in growth medium 
resulted in the cells exhibiting a spindle shaped morphology from as early as P0. This 
morphology is associated with the transdifferentiation from a keratocyte – which is typically 
dendritic with multiple processes – to a fibroblast phenotype (Jester et al., 1999; 
Funderburgh et al., 2003; Jester, 2008). To further evaluate this change in phenotype, ICC 
was used to assess the expression and distribution of proteins. F-actin in keratocytes is 
restricted to the cortical region of the cell, whereas the F-actin staining in this study revealed 
stress fibres traversing the cell (Jester et al., 1994; Funderburgh et al., 2003; Ruberti and 
Zieske, 2008). This phenomenon has previously been reported and the change in phenotype, 
from keratocyte to fibroblast, has been associated with the development of actin stress 
fibres (Foster et al., 2015; Yam et al., 2015).  
The induction of CD90 and decreased expression of both ALDH3A1 and keratocan 
has also been reported when keratocytes activate and transition into fibroblasts (Pei et al., 
2004, 2006; Ren et al., 2008; Hassell and Birk, 2010). The lack of keratocan and ALDH3A1 
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expression supports the evidence that the cells had become activated and transitioned into 
fibroblasts during culturing however, this is contradicted by the low expression of CD90 seen 
with ICC. The present study also found positive expression of lumican which is associated 
with keratocytes and typically downregulated, but still expressed, in hCFs (Funderburgh et 
al., 2001; Yam et al., 2015). Similarly, the hCFs exhibited weak punctate expression of CD34, 
a phenotype that is reportedly lost during keratocyte activation (Espana et al., 2004; Sidney 
et al., 2014). The expression of CD34 has been reported to decrease with the passaging of 
hCFs, but low levels of expression have been observed beyond P3 (Branch et al., 2012). This 
can be recovered by culturing keratocytes in either low-glucose, serum-free media (Foster et 
al., 2015) or in 10% FBS on amniotic membrane (Espana et al., 2004). Corneal cells cultured 
in ≥ 10% FBS have also been found to express CD73 and this study supports these findings 
(Choong et al., 2007; Sidney and Hopkinson, 2018). Diffuse α-SMA expression was observed 
however the staining does not show strong microfilament bundles as would be expected in 
myofibroblasts (West-Mays and Dwivedi, 2006; Myrna et al., 2009; Torricelli and Wilson, 
2014). Ainscough et al. have previously shown via western blotting that there is a gradient 
of α-SMA expression, with expression lowest in corneal cells followed by limbal cultures and 
finally scleral cultures (Ainscough et al., 2011). Given that the cells used in this study were 
isolated from a corneoscleral ring, it is very likely that some of these cells will express α-SMA, 
supporting the staining observed in the present study.   
The corneal stroma is composed primarily of collagen; the most common types being 
I and V. In this study we found that the hCFs weakly expressed type I collagen but not collagen 
types V and VI. Interestingly, no expression of type III collagen was observed, which has 
previously been shown to be elevated in fibroblasts and myofibroblasts (Funderburgh et al., 
2003). The hCFs in this chapter were not treated with ascorbic acid, a co-factor thought to 
be essential for the synthesis of collagen (Murad et al., 1981, 1983; Hata and Senoo, 1989). 
It is therefore likely that treating the hCFs with ascorbic acid would stimulate the synthesis 
and deposition of collagen as shown in previous studies (Guo et al., 2007; Saeidi et al., 2012a; 
Wu et al., 2014a).  
hCFs have been used routinely when attempting to replicate the corneal stroma 
(Guo et al., 2007; Karamichos et al., 2010; Couture et al., 2016). Here they displayed weak 
expression of markers usually associated with keratocytes, such as lumican and CD34, which 
may be a result of the cells used being at a low passage number (Branch et al., 2012). The 
use of hCFs warrants further investigation into their ability to replicate the corneal stroma 
as it has previously been shown that supplementation with ascorbic acid can lead to the 
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production of stroma-like constructs (Guo et al., 2007). Furthermore, a more metabolically 
active cell type may be of benefit when pursuing a bottom-up to engineering of the corneal 
stroma. Fibroblasts are known to actively synthesise and deposit ECM, unlike quiescent 
keratocytes, and may in fact be a more suitable cell type. 
 
2.6.2 Characterisation of hCSSCs 
A population of cells in the corneal stroma have been identified with characteristics 
consistent with those laid out in the ISCT for defining MSCs (Dravida et al., 2005; Du et al., 
2005; Funderburgh et al., 2005; Dominici et al., 2006; Choong et al., 2007; Polisetty et al., 
2008; Branch et al., 2012). Funderburgh and colleagues found that, along with the typical 
MSC markers, these cells also express ABCG2 and PAX6 (Du et al., 2005; Funderburgh et al., 
2005). These CSSCs possess the ability to be differentiated into keratocytes where an 
increase in the expression of keratocan and ALDH3A1 was observed in addition to the 
deposition of a collagenous ECM (Du et al., 2007; Wu et al., 2012, 2013, 2014a). Therefore, 
CSSCs could be a suitable cell source to use to accurately recapitulate the native stroma.  
CSSCs have been described as being small, polygonal cells that form colonies when 
cultured in vitro (Kureshi et al., 2014). A heterogeneous population of cells were isolated in 
this study using different methods of isolation and culture conditions. Whilst populations of 
small polygonal cells were observed, larger spindle-shaped cells were also detected and 
these were more prevalent in passaged populations which were isolated using Method 1. 
CSSCs with this morphology have been seen in populations from passage 4 and are 
associated with a transition to a fibroblast phenotype (Y. Sun et al., 2020). 
Cells within the corneal limbus, with a similar phenotype to MSCs, have been found 
to express CD90 and CD73 but had low CD105 expression (21.4%) (Polisetty et al., 2008). 
Method 1-isolated cells expressed CD73 with variable expression of CD90, likely due to the 
heterogeneous population of cells that are obtained. As the expression of CD90 is consistent 
across all MSC-like cells commonly isolated from the corneal/limbal-stroma, it is unlikely that 
the cells isolated here shared the phenotype of those previously reported, or they were a 
mixed population (Polisetty et al., 2008; Branch et al., 2012; Li et al., 2012; Kureshi et al., 
2014; Sidney et al., 2015). ICC analysis revealed that some of the cells isolated using method 
2 expressed ABCG2, OCT-4A and PAX6, markers associated with precursor cells (Riekstina et 
al., n.d.; Zhou et al., 2001; Funderburgh et al., 2005; Adewumi et al., 2007; Ding et al., 2010; 
Wee et al., 2016). The gene expression of SOX2 is associated with pluripotent cells and has 
been found in both CSSCs (Funderburgh et al., 2016) and in multipotent fibroblast-like cells 
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isolated from the corneo-limbal region (Dravida et al., 2005), but protein expression was not 
observed in this study.  
The gene expression profile of stem cells isolated from the corneal/limbal-stroma 
show greater expression of NOTCH1, ABCG2 and NES when compared to keratocytes (Du et 
al., 2007; Basu et al., 2014). Similarly, the stem cells have little expression of genes associated 
with keratocytes such as KERA, ALDH3A1, AQP1 and PTGDS (Du et al., 2007; Basu et al., 
2014). Unfortunately, due to the difficulty of obtaining freshly excised human corneas with 
a high cell number and minimal RNA degradation, the gene expression of hCSSCs could not 
be directly compared to that of keratocytes. Donor variation was evident in this study, with 
some donors showing greater expression of NES, NOTCH1 and ABCG2 – genes associated 
with stem cells. However, these same cells also expressed KERA, PTGDS, ALDH3A1 and AQP1 
at similar levels and so are unlikely to be stem cells. One possible method for identifying and 
isolating cells that meet the necessary criteria is that of magnetic-activated cell sorting 
(MACs). MACs works by using primary antibodies specific for cell surface antigens combined 
with a magnetically labelled secondary antibody. The cells that express the specific surface 
antigens can then be isolated and a more homogenous population of cells can then be sub-
cultured. In the case of hCSSCs, the possible markers include: CD90, CD73, CD105, ABCG2 
and SSEA-4. The use of such a method may improve the yield of hCSSCs and the sub-culturing 
of a pure population, with minimal contamination from other cell types, may improve the 
propagation of the stem cells, improving the yield. Alternatively, after applying MACs to 
isolate cells, single-cell cloning could be used to expand the cells. Although MACs provides a 
method of isolating cells that positively express a specific surface antigen, it can be damaging 
to the target cell membrane and can make it difficult to isolate a high percentage of cells 
(Faraghat et al., 2017). For this reason, MACs typically requires a large number of cells and 
so would need to be applied with caution if used to isolate hCSSCs.   
In the present study, difficulties arose when trying to expand CSSCs to a high cell 
number, necessary for tissue engineering. A heterogeneous population of cells was isolated 
which varied both in size and in the expression of CSSC markers. Furthermore, the cells 
readily increased in size, losing their characteristic polygonal shape which suggests they had 
transitioned into a more fibroblast-like cell. There are many possible explanations for the 
problems encountered in obtaining CSSCs. Given that most of the tissue used in this study 
was clinical waste from corneal surgeries, one such explanation could be the size and position 
of the corneal graft used for transplants prior to cell isolation. Occasionally, the tissue 
supplied from the RLUH had a corneal button removed that was not central and 
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encompassed part of the limbus, and which had been performed to increase the number of 
peripheral endothelial cells present in the graft (Romano et al., 2015). As the CSSCs have 
been shown to reside below the limbal niche it could be possible that these cells were 
included in the corneal button used for surgery (Branch et al., 2012; Pinnamaneni and 
Funderburgh, 2012; Hertsenberg and Funderburgh, 2015; Funderburgh et al., 2016). If this is 
the case, there would be fewer CSSCs present in the remaining corneoscleral rim received 
post-transplant reducing the chance of successful isolation. Furthermore, with the corneal 
button traversing the limbus the resident stem cells may become activated and transition 
into a keratocyte/fibroblast phenotype. Acquired limbal stem cell deficiency (LSCD), such as 
from surgeries involving the limbus or from chemical injuries, can result in either a loss of or 
the dysfunction of limbal epithelial stem cells (LESCs) (Ahmad, 2012; Sejpal et al., 2013). 
Given that wounds to the limbal niche can have a detrimental effect on the LESCs, it is 
plausible that a similar effect will be observed on the CSSCs.  
The length of time between donor death and cell isolation may have had a 
deleterious effect on the stem cells within the corneal stroma. The first identified CSSCs were 
isolated from corneoscleral rims which had been stored in Optisol medium which are 
typically stored at 4°C for up to 2 weeks (Kaufman et al., 1991; Lindstrom et al., 1992; Du et 
al., 2005). It has been reported that CSSCs can still be isolated from corneoscleral rims that 
have been stored in organ culture medium at 31 – 37°C for up to 4 weeks (Pels, 1997; Kureshi 
et al., 2014). In this study the average length of time between donor death and cell isolation 
was 41.6 ± 16.3 days (see Appendix D). However, for donors isolated using Method 1, this 
assumes that the tissue was stored in organ culture medium for no more than 3 weeks prior 
to supplementing the medium with dextran, but this could be as great as 5 weeks (Pels, 
1997). Limited information regarding the time between enucleation and corneal stroma 
stem cell isolation has been published and so the true effects of this are currently unknown. 
It has been shown that an increase in storage time can have deleterious effects on cell 
numbers, notably on those isolated using digestion methods (Iftimia-Mander et al., 2013). It 
is possible that the extended period of time between enucleation and cell isolation reduced 
the number of stem cells present within the limbal region and so only a heterogeneous 
population could be isolated with a greater ratio of fibroblast-like cells. 
An additional explanation for the difficulties encountered in this study could be 
related to the culture conditions of the CSSCs. It has been well reported that stem cells are 
sensitive to their cultured environment, including the substrate on which they are seeded 
(Eroshenko et al., 2013; Gerardo et al., 2019). It can therefore be hypothesised that the cell 
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culture flask used can impact cell propagation; as this information is rarely reported it is 
impossible to keep this variable consistent across research groups. Furthermore, FBS batch-
to- batch variation can also affect stem cell attachment and proliferation (Honn et al., 1975; 
Menendez et al., 2013). The batches of FBS used could be another problematic factor of 
isolating CSSCs in this study, although this has not been found by others working with CSSCs 
(Alvena Kureshi, personal communication, 2017). 
There are many variables that can influence the successful isolation and expansion 
of CSSCs. Two methods of propagating stem cells were trialled using a total of 65 donor 
tissues but, unfortunately, neither produced cells which were positively classified as stem 
cells. This is despite a visit to two labs (University College London and The University of 
Pittsburgh) to learn the technique first-hand. It is because of these reasons, and the trouble 
with accurately identifying the cells isolated, the use of hCSSCs as a cell source for an in vitro 
model of the stroma was not taken forward.  
 
2.6.3 Characterisation of hMSCs  
The corneal stroma is formed by neural crest cells, derived from the surface ectoderm, that 
migrate into the developing cornea (Feneck et al., 2019). It would, therefore, be logical to 
use neural crest stem cells which can differentiate into keratoblasts and/or keratocytes. 
Whilst human neural crest cells have been isolated from adult tissue, they are rare with 
restricted self-renewal capacity (Achilleos and Trainor, 2012). Although adipose-derived 
MSCs are believed to originate from the mesoderm, they have been used in corneal tissue 
engineering and differentiate into keratocytes in vitro (Du et al., 2010; Zhang et al., 2013; 
Ahearne et al., 2014; Lynch and Ahearne, 2017; Miwa and Era, 2018). Given the success 
found with adipose-derived MSCs, the feasibility of expanding bone marrow-derived MSCs 
for this purpose was investigated and hMSCs from three donors were characterised.  
 The expression of MSC markers varied greatly between donors, with the percentage 
of cells that expressed CD90, CD73 and CD105 ranging from 4 to 95% at passages 3-4. Despite 
this, all 3 donors displayed differentiation potential towards adipocyte lineage. The analysis 
of GAG content, after chondrogenic induction, suggests that donor 1 may be susceptible to 
phenotypic drift towards the chondrocyte lineage. Unfortunately, donor information from 
both donors 1 and 2 was unavailable; we can, therefore, only hypothesise the reason behind 
the variation observed between donors. MSC preparations from female donors have been 
found to contain cells that are slightly, but significantly, smaller in diameter and they tend to 
have more colony forming cells than male donors (Siegel et al., 2013). However, trilineage 
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differentiation potential does not seem to be affected by donor gender (Siegel et al., 2013) 
or age (Wagner et al., 2009; Siegel et al., 2013). Similarly, the expression of typical MSC 
markers, as defined by the ISCT, does not vary between genders (Siegel et al., 2013). Donor 
age has been linked to a proportional increase in the number of senescence-associated, β-
galactosidase-positive MSCs, a phenotype associated with decreased adipogenic 
differentiation potential and increased osteogenic potential (Wagner et al., 2008; Zhou et 
al., 2008). Conversely, a recent study by Andrzejewska and others (2019) concluded that 
donor age had little impact on the MSC phenotype (Andrzejewska et al., 2019). It is possible 
that hMSCs isolated from donors 1 and 2 were from donors older than donor 3 (23 yrs) which 
may give rise to an explanation behind the differences observed. 
A third hypothesis for the variance between donors is the method of isolation of 
MSCs. Donors 1 and 2 were isolated from unprocessed bone marrow aspirates, whereas 
donor 3 was purchased as a cryovial of mononuclear cells which were isolated using density 
gradient separation. Moreover, due to reasons beyond our control (customs clearance), 
there was a delay in the time between bone marrow aspirate extraction from donor 1 and 
the cells then being subjected to plastic adherence. Differences in the growth rate of MSCs 
isolated from the same donor but at different time points have been observed, leading the 
authors to conclude that heterogeneity can be produced by the method of harvest (Phinney 
et al., 1999). It may, therefore, be possible that the donor variation observed is as a result of 
both the harvest and the method of isolating/expanding MSCs.  
The reported number of adipose-derived MSCs required to induce keratocyte 
differentiation varies from 1 x 104 cells/cm2 in monolayer to 1.2 x 107 cells in fibrin gel (Du et 
al., 2010; Zhang et al., 2013; Ahearne et al., 2014; Lynch and Ahearne, 2017). For this reason, 
the hMSCs required expansion up to P5 to achieve the desired cell number. The phenotype 
of primary cells in culture is known to change with passaging and this is seen in MSCs too. 
Morphological changes such as an increase in cell diameter and cell volume between P3 and 
P6 have been observed in MSCs isolated from elderly patients (72.2 ± 7.5 yrs.) (Andrzejewska 
et al., 2019). The same study also found that the expression of CD105 decreases after 
passaging which supports the flow cytometry data of donors 1 and 3 in this study. In contrast, 
the expression of CD105 increased in donor 2 whilst the typical negative markers (CD45, 
CD34, CD11b, CD79A, HLA-DR) decreased with passaging. Interestingly, at the late passage 
donor 1 also experienced a decrease in the expression of negative markers whereas donor 3 
increased expression of these markers. The increased expression of these markers could 
suggest that the cells had either begun to differentiate or a sub-population of MSCs, that 
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were positive for these markers, out-competed other sub-populations. Alternatively, as 
there is only one technical replicate for each donor, these results may not be representative 
and result from technical variation alone. The flow cytometry data for donor 2 at both 
passages and donor 3 at P1 were provided by colleagues so it is possible that the culture 
methods and protocol for flow cytometry differed slightly thus causing a discrepancy with 
the published literature.  
Despite the hMSCs not expressing the cell surface markers defined by the ISCT, they 
were assessed for their trilineage capability. It has been found that human MSCs at passage 
8 (P8) had reduced osteo- and adipo-genic differentiation capacity when compared to cells 
at P4 (Yang et al., 2018). In the present study, hMSCs at the later passages were at P3 and P4 
and still successfully exhibited adipogenic differentiation. Whilst this study did not 
investigate the effects of cell culture expansion on trilineage differentiation capabilities, both 
donors 2 and 3 were successfully differentiated down all three lineages. Due to a lack of cell 
number, donor 1 could only be subjected to adipogenic differentiation for histological 
analysis. A study by Muraglia et al. across 185 human bone marrow-derived MSC clones 
observed that MSC clones that displayed the potential to differentiate towards the 
adipogenic lineage could also be differentiated towards the osteo- and chondro-genic 
lineages. No unipotent or bipotent adipogenic clones were observed (Muraglia et al., 2000). 
These findings have been contradicted by other studies which have shown that unipotent 
adipogenic differentiation is possible, as is bipotent differentiation down adipo-/osteo-genic 
and adipo-/chondro-genic lineages (Okamoto et al., 2002; Bajpai et al., 2012). The 
discrepancies in the literature could be attributable to the source of MSCs which differ from 
immortalised MSCs (Okamoto et al., 2002) to those derived from human hair follicles (Bajpai 
et al., 2012). The observation of the lack of unipotent and bipotent adipogenic clones may 
indicate that the cells from donor 1 could have successfully differentiated down by 
osteogenic and chondrogenic lineages.  
The GAG analysis in this study supports the histological staining with Alcian blue 
which shows chondrogenic differentiation in 2 out of 3 of the donors. Donor 1 did not show 
any differences in the total GAG content however, the hMSCs in growth medium alone (no 
chondrogenic induction) showed a much higher GAG content than donors 2 and 3. This data 
could suggest that perhaps the cell pellets from donor 1 had already started differentiating 
into chondrocytes, hence the high GAG content. The expression of CD73 has been found to 
remain consistently high in chondrocytes across passaging whereas the flow cytometry data 
Chapter 2 Discussion 
96 
 
in this study found a sharp decrease in the number of cells expressing this particular antigen 
(Cournil-Henrionnet et al., 2008).  
Given that the hMSCs still maintained their trilineage differentiation potential at 
later passages, their ability to differentiate into keratocytes was investigated. The vast 
majority of MSCs that have been successfully differentiated into keratocytes are those that 
are derived from adipose tissue (Du et al., 2010; Zhang et al., 2013; Ahearne et al., 2014; 
Harkin et al., 2015; Lynch and Ahearne, 2017). A study by Park et al. (2012) found that bone 
marrow-derived MSCs cultured in α-MEM expressed keratocan (Park et al., 2012). When 
these MSCs were subjected to conditioned medium, termed keratocyte conditioned 
medium, there was an increase in lumican expression. Interestingly, the keratocyte 
conditioned medium contained 10% FBS which has previously been associated with 
keratocytes differentiating into fibroblasts, the repair phenotype of keratocytes (Beales et 
al., 1999; Long et al., 2000; Pei et al., 2004). Liu et al. reported that murine bone marrow-
derived MSCs did not express keratocan when cultured on tissue culture plastic (Liu et al., 
2012). When transplanted into the stroma of keratocan knockout mice these MSCs 
expressed keratocan, suggesting the potential for bone-marrow MSCs to differentiate into 
keratocytes in vivo (Liu et al., 2012). Due to the limited number of papers differentiating 
bone marrow-derived MSCs into keratocytes, a preliminary experiment was conducted. The 
expression of two proteoglycans, keratocan and lumican, were investigated as these are 
markers that are typically associated with keratocytes (Corpuz et al., 1996, 2000; Liu et al., 
1998; Carlson et al., 2005; Park et al., 2012). Similar to the findings of Liu et al., the present 
study did not observe any keratocan expression in undifferentiated hMSCs (Liu et al., 2012). 
After keratocyte induction for 21 days, the hMSCs revealed expression of keratocan and 
lumican. Interestingly, hMSCs in both media conditions (KDM and SCM) expressed lumican. 
One possible explanation for the unexpected lumican expression of hMSCs in SCM is the 
length of time cells were in culture for. The immunofluorescent images suggest that the cells 
in SCM proliferated more and became confluent which may have caused the hMSCs in SCM 
to experience phenotypic drift and become fibroblastic. However, this has been contradicted 
by a group that did not observe any phenotypic drift with increased cell density (Haack-
Sørensen et al., 2013).  
The F-actin staining in this study showed that the hMSCs in KDM exhibited a different 
morphology to those in the control SCM. The differentiated cells had a smaller cell body with 
a more spindle-like shape when compared to the cells in the control medium which had a 
large, flattened cell shape. The F-actin of keratocytes is typically in the cortical region of the 
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cell and the stress pattern, fibres running transversely across the cell, is associated with 
fibroblasts and myofibroblasts (Jester et al., 1994; Funderburgh et al., 2003; Yam et al., 
2015). The hMSCs in KDM still exhibited transverse F-actin fibres indicative of a more 
fibroblast phenotype.  
It has been reported that bovine keratocytes spontaneously formed spheres in 
adherent monolayer culture (Scott et al., 2011). This study found evidence of sphere 
formation of hMSCs treated with KDM which could provide further evidence of successful 
differentiation into keratocytes. Human keratocytes have not previously shown the ability to 
spontaneously form keratocytes from adherent cultures (Scott et al., 2011). However, they 
can successfully form spheres when cultured on low-adhesive surfaces and these spheres 
had an increased expression of keratocyte markers compared to their adherent counterparts 
(Uchida et al., 2005; Funderburgh et al., 2008; Scott et al., 2011; Lai and Tu, 2012). CSSCs 
differentiated on unmodified, micropatterned silk substrates have been shown to aggregate 
and form spheres (Wu et al., 2014b). These spheres also exhibited increased expression of 
typical keratocyte markers such as keratocan and carbohydrate sulfotransferase 6 (CHST6) 
compared to fibroblasts. Interestingly, when the micropatterned substrates were modified 
with arginine-glycine-aspartic acid (RGD) peptide, the expression of keratocan and CHST6 
increased further still. Whilst these results suggest that an RGD peptide is necessary for CSSC 
attachment to silk, it could also suggest that the micropatterned topography is necessary to 
enhance the differentiation of stem cells into keratocytes (Wu et al., 2012). Together, these 
results suggest that the hMSCs may be a suitable cell source for a corneal stroma model. 
Although the cells in KDM showed transverse F-actin fibres, properties associated with 
fibroblasts, they expressed both keratocan and lumican. It is possible culturing cells on a 
substrate that encourages alignment may enhance the keratocyte phenotype to allow the 
production of a stroma-like matrix. 
 
2.7 Conclusions 
In this study three potential cell sources were characterised and assessed for their potential 
use in creating a stroma equivalent. hCFs were readily expanded and maintained their 
spindle-shaped morphology throughout passaging. They are a frequently used cell type when 
studying the corneal stroma and whilst they do not maintain all characteristics of 
keratocytes, at low passage numbers they exhibit CD34 – a characteristic of the quiescent 
keratocyte. Conversely, hCSSCs could not be isolated in sufficient quantity and quality for 
subsequent use. They transitioned into a more fibroblast-morphology after passaging and a 
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heterogeneous population was obtained. There was inter- and intra-donor variability in the 
expression of stem cell markers which was likely a result of the heterogeneous populations 
obtained. Similarly, inter-donor variability was observed in the hMSCs, particularly in the 
expression of cell surface markers CD90, CD73 and CD105. Despite this variability, two 
donors were successfully differentiated down osteogenic, adipogenic and chondrogenic 
lineages. hMSCs also showed potential to be differentiated into keratocytes with expression 
of keratocan and lumican.  
 
2.8 Limitations and future work 
The limitations of this study include, but are not limited to, a low number of biological 
replicates and high donor variation. An increase in the number of biological and technical 
replicates of hMSCs analysed via flow cytometry would have greatly improved these data 
and allowed more concrete conclusions to be drawn. Unfortunately, cell number was a 
limiting factor here and so this could not be easily remedied. Despite the hMSCs not 
expressing all of the cell surface markers defined by the ISCT to be positively identified as 
mesenchymal stromal cells, they were capable of trilineage differentiation. Preliminary 
studies suggest that the hMSCs also display the potential to differentiate into keratocytes, 
and although further experiments are required, a spheroid was identified, a phenotype that 
has been displayed by keratocytes in vitro.  
To accurately model the stroma in vitro, keratocytes that synthesise an organised 
ECM are preferable. As keratocytes are neural crest-derived, differentiating neural crest 
stem cells, as opposed to mesenchymal stromal cells, may offer an alternative cell source. Of 
note are induced pluripotent stem cells which can be reprogrammed into neural crest cells 
before differentiation into keratocytes (Foster et al., 2017). Whilst these cells still express 
genes associated with keratocytes at a much lower level than those in vivo it could have been 
interesting to compare these with hMSCs and hCFs (Naylor et al., 2016). 
The data presented in this chapter suggest that hCFs and hMSCs are a suitable cell 
source for development of a corneal stroma model; the cells are readily available and can be 
easily expanded in vitro. Furthermore, the differentiation potential of hMSCs offers promise 
of a cell type that closely resembles keratocytes and can, with substrate influence, begin to 
mimic the stroma. For these reasons, hCFs and hMSCs were taken forward and used to 
optimise an in vitro stroma model. 
 
 
Chapter 3. An in vitro model of the corneal 
stroma




Both hCFs and MSCs have previously been used in the tissue engineering of the corneal 
stroma (Guo et al., 2007; Karamichos et al., 2011). To ensure that an organised matrix is 
deposited, cells are seeded onto substrates with topographical cues that result in cell 
alignment. Polytetrafluoroethylene nanofibres (PTFE-nf) have been shown to align 
fibroblasts and result in the deposition of aligned type I collagen (Kearns et al., 2010; 
Schofield et al., 2011). PTFE-nf can also support corneal stromal cell growth and alignment 
and were therefore selected as an appropriate substrate (Gouveia et al., 2013). Another 
substrate used to develop stroma models is a polycarbonate Transwell membrane (Guo et 
al., 2007; D. Karamichos et al., 2014). This substrate has been shown to feature nanoscale 
grooves which is believed to support the deposition of orthogonally arranged collagen fibrils 
(Dimitrios Karamichos et al., 2014). This chapter focuses on the development of an in vitro 
model of the corneal stroma. hCFs and hMSCs were cultured on both PTFE-nf and Transwell 
membranes and the cell phenotype, alignment and collagen deposition were analysed. 
 
3.2 Aims and Objectives 
The aim of this chapter was to identify a suitable cell type and substrate for the 
development of an in vitro corneal stroma model.  
 
The objectives of this chapter were: 
1. To culture cells (hCFs and hMSCs) on substrates that provide topographical cues 
2. To measure the alignment of hCFs on glass, PTFE-nf and Transwell membranes 
3. To differentiate hMSCs into keratocytes, assessed via ICC and RT-qPCR, with a view 
to determining how keratocytes behave on each substrate  
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3.3 Materials  
Sigma/Merck (Germany): Agarose (A9539); Amicon Ultra-15 Centrifugal Filter Unit 
(UFC901008); Ampicillin sodium salt (A0166); BL21(DE3) Singles Competent Cells (70235-3); 
BugBuster Ni-NTA His-Bind Purification Kit (70751-3); Isopropyl β- d-1-thiogalactopyranoside 
(IPTG; 420322); Luria broth (LB broth; Miller) (L3522); LB Broth with agar (Lennox) (L2897); 
Resazurin sodium salt (R7017); 4X SDS Sample Buffer (70607-3) 
Thermo Fisher (USA): Pierce bicinchoninic acid (BCA) Protein Assay Kit (23227); CellTracker™ 
Red CMTPX Dye (C34552); Pierce Dimethylformamide (DMF; 20673); DyLight 488 NHS Ester 
(46402); GelCode Blue Stain Reagent (24590); Novex™ Sharp Pre-stained Protein Standard 
(LC5800); NuPAGE™ 4-12% Bis-Tris Protein Gels (NP0335BOX); TrackIt 1 Kb Plus DNA ladder 
(10488085) 
Fisher Scientific (USA): 22 x 22 mm glass coverslips, no. 1.5 (12363138); Corning™ 
Transwell™ Multiple Well Plate with Permeable Polycarbonate Membrane Inserts 
(10301031) 
Qiagen (Germany): QIAshredder (79654); qPCR primers 
Promega (USA): PureYield™ Plasmid Miniprep System (A1223) 
Roche (Switzerland): cOmplete™ ULTRA Tablets, Mini, EDTA-free EASYpack Protease 
Inhibitor Cocktail (REF05892791001) 
Goodfellow (England): 1 mM PTFE sheet (FP303050) 
New England Biolabs (USA): BamHI-HF (R3136S); PstI-HF (R3140S) 
VWR (USA): PeqGREEN (732-3196) 









3.4.1 Preparation and analysis of substrates 
3.4.1.1 Semi-automated friction transfer 
To create aligned nanofibers of polytetrafluoroethylene (PTFE) a specifically designed 
apparatus was used, termed the friction transfer machine (Beamson et al., 1996; Kearns et 
al., 2010). The machine is composed of three main parts: the heater block, the motor, and a 
clamp to hold the PTFE blade (Figure 3.1 A). The blade was cut from a sheet of 1 mm thick 
PTFE in to a 20 x 10 mm rectangle and one of the longer edges was bevelled where it 
contacted the substrate. A glass coverslip was placed on the heating block set to 250°C, giving 
a surface temperature of approximately 235°C, and allowed to reach thermal equilibrium for 
approximately 5 min. The PTFE blade was lowered onto the surface of a glass coverslip and 
drawn across at a constant speed of 0.6 mm/s whilst under a 1 kg load, as depicted in Figure 
3.1 B.  
 To ensure the fibres were present, the glass substrate was sprayed with 70% ethanol 
and held vertically. When nanofibers had successfully been transferred onto the glass the 
solvent ran off the glass along the fibres in straight lines. The coverslips were then rinsed 
with distilled water and sterilised on both sides using a CL-1000 Ultraviolet crosslinker (UVP; 
Cambridge) at 1500 µJ/cm2 for 5 min. This substrate is referred to as PTFE nanofibres (PTFE-
nf) throughout.  




Figure 3.1 The semi-automated apparatus used for performing friction transfer. A: Images 
of the friction transfer machine show the main components required to create PTFE 
nanofibres. B: Diagram depicts the basic components of the machine in one image. The PTFE 
blade traverses the coverslip at 0.6 mm/s. 
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3.4.1.2 White light interferometry 
To enable the visualisation of the PTFE nanofibres the glass coverslips had to be made 
partially reflective. A Q150T-ES Turbo-Pumped sputter coater with a chromium target 
(Quorum) was used to coat the coverslips with approximately 40 nm of chromium (120 mA 
for 120 s).  
A white light interferometer was used to analyse the surface topography of the PTFE-
coated coverslips. The light intensity was adjusted to just below saturation and the substrate 
was brought into focus. The objectives were tilted to null the fringe which minimises the scan 
length needed to measure the surface. Vertical scanning interferometry (VSI) was used and 
two to three fringes were in the field of view. Data were captured using a backscan of 10 μm 
and a length of 12 μm and presented in the form of contour topographical representations. 
 
3.4.1.3 Scanning electron microscopy 
Samples were kindly prepared and imaged by Dr. Lucy Bosworth. The 0.4 μm pore, 
polycarbonate Transwell membranes were cut out of the plastic holder prior to being sputter 
coated with 10 nm of gold and palladium (AuPd). Areas of the polycarbonate Transwell 
membrane were imaged at random using a FEI Quanta 250 FEG SEM operating at high 
vacuum with 5 keV electron beam.  
 Image analysis was then performed on 4 fields of view using FIJI and pore size, 
number and porosity were calculated using the Analyse Particles plugin (Schindelin et al., 
2012). 
 
3.4.2 Expression of CNA35 
A collagen probe, CNA35, enables the fluorescent labelling of collagens (Krahn et al., 2006). 
pQE30CNA35 plasmid DNA, containing the collagen binding part of the A domain of 
Staphylococcus aureus collagen adhesion, fused to an N-terminal His tag, was kindly provided 
to Dr Elizabeth Laird (supervisor) by Prof. Magnus Höök at Texas A & M University, USA (Xu 
et al., 2004).  
 
3.4.2.1 Preparation of Luria Broth (LB) and LB agar plates 
LB broth (12.5 g) (Miller) was dissolved in dH2O (500 ml) and autoclaved. Once cool, ampicillin 
was added to a final concentration of 100 μg/ml. 
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 LB broth with Agar (11.65 g) (Lennox) was dissolved in dH2O (333 ml), autoclaved 
and allowed to cool. Prior to pouring, ampicillin was added to a final concentration of 100 
μg/ml and mixed thoroughly. Plates were poured in a Class II Microbiological Safety Cabinet.  
 
3.4.2.2 pQE30CNA35 plasmid transformation 
The pQE30CNA35 plasmid (Appendix C) was transformed into BL21 (DE3) competent cells. A 
single vial was slowly thawed on ice then the pQE30CNA35 plasmid (1 μl) was added directly 
to the cells and gently mixed. The suspension was incubated on ice for 5 min, heat-shocked 
at 42°C for 30 s and again placed on ice for a further 2 min. Room temperature SOC medium 
(250 µl) was then added to the vial and incubated at 37°C for 1 h, shaking at 250 rpm. The 
cell suspension was then spread across the LB ampicillin plate using an L-shaped spreader 
and incubated inverted at 37°C overnight.  
 
3.4.2.3 Bacterial amplification and protein expression 
A single colony was selected and transferred to LB broth with ampicillin (25 ml) in a 50 ml 
Falcon tube using aseptic technique and incubated overnight, shaking at 250 rpm. Following 
overnight incubation, LB broth (500 ml) with ampicillin was inoculated with the bacterial 
culture (25 ml) in a 1 L conical flask. The culture was incubated at 37°C, 250 rpm and 
monitored until OD600 reached 0.1, approximately 1 hour later. Isopropyl β-D-1-
thiogalactopyranoside (IPTG) was added to the culture to a final concentration of 1 mM and 
incubated for a further 6 h. An aliquot (500 μl) used to inoculate LB broth with ampicillin (5 
ml) and cultured overnight for use with PureYieldTM Plasmid Miniprep System to isolate the 
plasmid DNA. The remainder of the culture was transferred into 50 ml Falcon tubes and 
centrifuged at 104 x g for 10 min to pellet cells. The wet weight of the pellet was determined 
and then stored at -20°C until required.  
 
3.4.2.4 Isolation of plasmid DNA  
Following overnight incubation, to eliminate the effect of the IPTG induction, 3 ml of the 
culture was transferred into a microcentrifuge tube and centrifuged at 13000 x g for 30 s to 
pellet cells. Plasmid DNA was extracted using PureYieldTM Plasmid Miniprep System following 
the manufacturer’s protocol: ‘Alternative Protocol for Larger Culture Volumes’. Eluted DNA 
was quantified using a NanoDropTM 2000 Spectrophotometer and stored at -20°C until 
required. 
 
Chapter 3 Methods 
106 
 
3.4.2.5 Restriction enzyme digest 
To determine whether or not the selected E. coli colonies had incorporated the plasmid with 
the inserted CNA35 gene, a restriction enzyme digestion was performed. The enzymes 
(BamHI and PstI) were predicted to excise the insert from the multiple cloning site of the 
vector (Appendix C).  
 Agarose (1 g) was dissolved in 1X Tris-acetate-EDTA (100 ml) buffer by heating in a 
microwave with intermittent stirring. Agarose was poured into a gel tank and peqGREEN (5 
μl) was added and stirred into the gel before placing the comb and allowing to set.  
 Plasmid DNA (1 µg), CutSmart buffer (5 µl), BamHI-HF (1 µl), PstI-HF (1 µl) were 
added to a microcentrifuge tube and the total volume made up to 50 μl with nuclease free 
H2O. The solution was incubated at 37°C for 15 min and the 6X gel loading dye (10 µl) was 
added to the tube. The DNA ladder and sample were loaded into the agarose gel and run at 
90 V for 1 h. The gel was imaged using a ChemiDoc XRS+ (Biorad). 
 The digest revealed two bands consistent with both the pQE30 vector size, 3461 bp, 
and the size of CNA35 gene, 948 bp suggesting the pQE30CNA35 plasmid was correctly 
inserted (Figure 3.2). 
 
Figure 3.2 Agarose gel electrophoresis of restriction-enzyme-digested plasmid for 
confirmation of CNA35 gene insertion. The gel shows two products: one at approximately 
3500 bp and the other ar approximately 900 bp. These values are consistent with the pQE30 
vector (3461 bp) and CNA35 (948 bp) expected to be excised by the restriction enzymes used. 
 
3.4.2.6 Protein extraction  
The cell pellet (from 3.4.2.3) was resuspended in BugBuster Protein Extraction Reagent and 
the soluble fraction was prepared as per the manufacturer’s protocol: ‘BugBuster Protein 
Extraction Reagent User Protocol TB245 Rev. F 1108’. A 50 μl aliquot of the bacterial lysate 
was taken for SDS-PAGE analysis.  
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3.4.2.7 Protein purification 
A 1X Ni-NTA Bind Buffer, 1X Ni-NTA Wash Buffer and 1X Ni-NTA Elute Buffer were prepared 
as described in the manufacturer’s protocol: ‘Ni-NTA His•Bind Resins User Protocol TB273 
Rev. D 0412JN’. A chromatography column from the BugBuster Ni-NTA His-Bind Purification 
Kit was prepared by pipetting Ni-NITA His•Bind Resin (2 ml) into the column and allowing to 
settle before Bind Buffer (5 ml) was added to equilibrate the column. Imidazole was added 
to the bacterial lysate to a final concentration of 10 mM before applying to the column. The 
flow-through was collected. The column was washed twice with 8 ml of the Wash Buffer and 
the flow-through collected. The protein was then eluted with 6 runs of 1 ml Elute Buffer and 
each run was collected in a separate microcentrifuge tube. A 50 μl aliquot from each flow-
through was taken for SDS-PAGE analysis.  
 
3.4.2.8 SDS-PAGE analysis 
Equal volumes of sample and 4X SDS Sample Buffer were mixed together and heated to 85°C 
for 3 min. Samples and the Protein Standard were loaded on to a 4-12% precast Bis-Tris gel 
and run with MES buffer for 30 min at 200 V. After running, the gels were fixed in 50% 
methanol, 7% acetic acid for 15 min and stained with GelCode Blue as per the manufacturer’s 
instructions. The gel was imaged using a ChemiDoc XRS+. 
 Samples from each step in the protein purification process, along with the 6 eluates, 
were run on an SDS-PAGE gel (Figure 3.3). Eluates 1 to 3 had the highest amount of protein 
with a prominent band at 35 kDa, the size of CNA35. To ensure there was enough CNA35 
protein, eluates 1 and 2 were pooled together, as were eluates 3 and 4. Eluates 3 and 4 gave 
consistent BCA assay readings and were therefore taken forward for further use. 
 
 




Figure 3.3 SDS-PAGE gel of samples eluted from column after protein extraction using the 
BugBuster Ni-NTA His-Bind Protein Purification kit. The gel shows large amounts of protein 
at 35 kDa, the size of CNA35. Eluates 3 and 4 were pooled together and were subsequently 
used. 
 
3.4.2.9 Buffer exchange 
1X Protease Inhibitor Cocktail was added to all 6 eluates. Based on the SDS-PAGE gel eluates 
3 + 4 were pooled together. The eluates were added to Amicon Ultra-15 Centrifugal Filter 
Devices and centrifuged at 4000 x g for 20 min at 4°C. The flow-through was discarded and 
10 ml 0.1 M sodium bicarbonate buffer was added and centrifuged at 4000 x g for 20 min at 
4°C, this was repeated twice. 1X Protease Inhibitor Cocktail was added to the eluates in the 
sodium bicarbonate buffer.  
 
3.4.2.10 Bicinchoninic acid (BCA) assay 
The protein concentration was calculated using a BCA Protein Assay using a 1 in 10 dilution 
of the samples as per the manufacturer’s instructions (Smith et al., 1985). A protein standard 
curve was created using 0.1 M sodium bicarbonate as the diluent (Figure 3.4). Briefly, 50-
parts of BCA Reagent A and 1-part BCA Reagent B were mixed together to create the working 
reagent. Each standard and unknown sample (10 µl) were added to a 96-well plate. The 
working reagent (200 µl) was added to each well, mixed and incubated at 37°C for 30 min. 
The absorbance was measured at 562 nm using a BMG SPECTROstar Nano microplate reader. 
The protein concentration was determined using the equation derived from the standard 
curve. 
 




Figure 3.4 Standard curve to determine protein concentration via a BCA assay. Samples 
were analysed in triplicate to account for pipetting errors.  
 
3.4.2.11 Fluorescent labelling 
The BCA assay showed that the pooled eluates (3 & 4) had a protein concentration of 4.2 
mg/ml. 2.1 mg of protein was used and DyLight 488 NHS Ester was prepared as described in 
the manufacturer’s instructions. The amount of dye to be added to the labelling reaction was 
calculated using (Eq. 3.4.2.1):  
 
𝑎𝑚𝑜𝑢𝑛𝑡 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 (𝑚𝑔)
𝑀𝑊 𝑜𝑓 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 
× 15 × 𝑀𝑊 𝑜𝑓 𝑓𝑙𝑢𝑜𝑟 (Eq. 3.4.2.1) 
 
 An Amicon Ultra-15 Centrifugal Filter Device was used to remove the unbound dye 
and replace the buffer with PBS by centrifuging at 4000 x g for 20 min three times. 1X 
Protease Inhibitor Cocktail was added to the protein in PBS. The absorbance of the labelled 
protein was measured at 280 nm and 495 nm. The protein concentration and degree of 
labelling were calculated as described in the manufacturer’s instructions using (Eq. 3.4.2.2) 
to (Eq. 3.4.2.5): 
 
 𝑃𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐. (𝑀) =  
[𝐴280 − (𝐴495 × 𝐶𝐹)]
𝜀𝑝𝑟𝑜𝑡𝑒𝑖𝑛
× 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟 (Eq. 3.4.2.2) 
 
Where CF = correction factor and is 0.147 
 
 
[1.72 − (5.412 × 0.147)]
33176
= 27.86 × 10−6 𝑀  (Eq. 3.4.2.3) 




 𝑀𝑜𝑙𝑒𝑠 𝑑𝑦𝑒 𝑝𝑒𝑟 𝑚𝑜𝑙𝑒 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 =  
𝐴495 × 𝑑𝑖𝑙𝑢𝑡𝑖𝑜𝑛 𝑓𝑎𝑐𝑡𝑜𝑟
𝜀𝑓𝑙𝑢𝑜𝑟 × 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 𝑐𝑜𝑛𝑐.
 (Eq. 3.4.2.4) 
 
 






Hence, each CNA35 protein was predicted to contain almost 3 fluorescent labels, consistent 
with previous reports (Krahn et al., 2006). 
 
3.4.3 hCF seeding and culture on substrates 
3.4.3.1 Culturing hCFs  
hCFs at P4 – 6 were seeded onto PTFE-nf and glass coverslips at a seeding density of 5 x 103 
cells/cm2 or onto a 6-well polycarbonate Transwell membrane at a density of 1.06 x 105 
cells/cm2 and allowed to attach for 2.5 h before being topped up with hCF growth medium 
(Table 2.1) and incubated overnight. The following day, the medium was switched to medium 
supplemented with 1 mM L-ascorbic acid 2-phosphate sesquimagnesium salt (A2P) (Gouveia 
et al., 2013, 2015; Wu et al., 2014a) and cells were cultured for up to 30 days. Information 
pertaining to the use of different biological donors in each experiment can be found in Table 
3.2. 
 
3.4.3.2 PicoGreen analysis of cell attachment to substrates 
hCFs were seeded onto PTFE-nf, glass coverslips and Transwell membranes as described 
above. After an incubation period of 2.5 h, the wells were rinsed with growth medium which 
was collected and any unattached cells were pelleted by centrifugation at 360 x g for 5 min. 
The cell pellets were then washed in PBS, pelleted again and lysed with lysis buffer (500 µl). 
The remaining cells attached to each substrate were rinsed with PBS buffer and lysis buffer 
(500 µl) was added to each well. The wells were scraped prior to the transfer of cell lysate to 
a microcentrifuge tube. Samples were stored at -80°C until analysed. 
 Lysates were thawed to room temperature and a PicoGreen assay was carried out 
as described in 2.4.8.1, with exception that the volume of cell lysate and working PicoGreen 
solution were both increased to 100 µl. The proportion of cells attached to the substrate was 
calculated as described in (Eq. 3.4.3.1). 
 
 𝑃𝑟𝑜𝑝𝑜𝑟𝑡𝑖𝑜𝑛 𝑎𝑡𝑡𝑎𝑐ℎ𝑒𝑑 =
𝑁𝑜. 𝑎𝑡𝑡𝑎𝑐ℎ𝑒𝑑
𝑁𝑜. 𝑎𝑡𝑡𝑎𝑐ℎ𝑒𝑑 + 𝑁𝑜. 𝑖𝑛 𝑚𝑒𝑑𝑖𝑎
 (Eq. 3.4.3.1) 
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3.4.3.3 Cell growth and metabolic activity 
To determine the metabolic activity of hCFs cultured in growth medium and in medium 
supplemented with 1 mM L-ascorbic acid 2-phosphate sesquimagnesium salt hydrate, a 
resazurin assay was used. Resazurin sodium salt was dissolved in PBS to create a stock 
solution at a concentration of 0.1 mg/ml which was stored at 4°C in the dark prior to use. 
Cells were seeded in to a 48-well plate at a density of 5 x 103 cells/cm2 and at days 1, 3, 5, 7, 
14 and 21 the culture media were aspirated from the cells and the wells were rinsed with 
PBS to remove any serum. The resazurin stock solution was further diluted to a concentration 
of 0.01 mg/ml in serum-free medium and 500 µl was added to each well along with a cell-
free resazurin blank. The hCFs were placed back into the incubator, in the dark, for 2.5 h. 100 
µl aliquots of the resazurin medium were transferred to a black 96-well plate in duplicate. 
The plates were analysed immediately using FLUO star OPTIMA plate reader at 
excitation/emission of 560/590 nm, using the optimal gain for each plate. The average of the 
cell-free resazurin blanks were deducted from their respective readings to correct for the 
autofluorescence of resazurin. To correct for variations in gain, samples were read at gains 
from 1000 – 2000. A standard curve was generated (Figure 3.5) and the equation of the curve 
was used to correct the data.  
 Following the resazurin assay, the cell number was also determined. The 
quantification of DNA per well using a PicoGreen assay was used to calculate the cell number 
as described in 2.4.8.1. This experiment was performed on one occasion comparing growth, 
medium supplemented with A2P (A2PM), and FC with the same data being reported in both 
Chapter 2 (2.5.1.2) and Chapter 4 (4.5.4). 
 
 
Figure 3.5 Gain curves for correcting hCF Resazurin data. Experimental samples were then 
read at their optimal gain and corrected for using the above equation. 
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3.4.3.4 ICC of deposited collagens 
To analyse the deposition of collagen types I, III, V and VI, hCFs were fixed in 10% NBF for 10 
– 15 min at room temp. Samples were subjected to an immunocytochemistry staining 
procedure as described in Chapter 2 (2.4.4), however cells were not permeabilised. Primary 
antibodies used were: anti-collagen I, anti-collagen III, anti-collagen V, and anti-α-SMA (Table 
2.2). Anti-collagen VI was also used; however, this was from a different supplier (Table 3.1). 
Where co-staining with CNA35 and anti-collagen I was performed, 0.5 µM CNA35 was added 
in conjunction with the primary antibody. Conjugated phalloidin was added in conjunction 
with secondary antibodies to label F-actin (Table 2.3). Images were acquired using a Zeiss 
LSM 800 microscope.  
 CNA35 was also used to stain collagen prior to cell fixation and cells were co-labelled 
with CellTracker Red (CTR). CTR was diluted in DMSO (7.2 µl) to form a stock at 10 mM. The 
stock solution was further diluted to 10 µM in serum-free medium before adding to the 
attached hCFs for 45 min. CTR was then aspirated out of the well and rinsed with medium 
supplemented with A2P (A2PM). 0.5 µM of the CNA35 488-labelled probe was added to 
A2PM for 90 min. Cells were then rinsed with PBS prior to fixation in 10% NBF. 
 
Table 3.1 Primary antibody used for ICC of hCF-deposited type VI collagen. 








3.4.3.5 Imaging processing 
Samples were imaged using a Zeiss LSM 800 and Zen Blue software (v 2.3). For cultures where 
cells had stratified into at least two layers, a z-stack image was acquired by finding the first 
and last view of the sample and using the ‘optimal’ function to image optical sections, where 
each section has a 50% overlap with the previous section. Following z-stack acquisition, 
images were analysed using FIJI (v 1.52p) (Schindelin et al., 2012). Maximum (max.) z-
projections were then created to visualise each slice in a single image and these are 
presented throughout this chapter. For tiled images, a 3 x 3 grid was imaged with a 10% 
overlap between each tile to allow for automated stitching performed by the Zen blue 
software. 
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3.4.3.5.1 Cell alignment analysis 
For each sample, 5 regions of interest (ROI) were selected, as depicted in Figure 3.6 A and a 
z-stack image was acquired at each region (Figure 3.6 B). The orientation of phalloidin-
stained F-actin was analysed using the OrientationJ plugin from FIJI, as previously described 
(Rezakhaniha et al., 2012; Franco-Barraza et al., 2016). OrientationJ characterises the 
orientation of a region of interest based on the evaluation of structure tensors of each pixel, 
where the pixels represent F-actin filaments. The distribution was determined by running 
OrientationJ Distribution with a Gaussian Gradient and the local window, σ, set to 3 pixels. 
OrientationJ Analysis was used to achieve a colour survey, an image where hue represents 
the angle of orientation; saturation represents coherency; and brightness is the same as the 
input image. To ensure that the plugin was working as expected, images from one sample 




Figure 3.6 Image acquisition for OrientationJ analysis. A: 5 ROIs were selected and images 
were acquired from these regions. B: At each region of interest, a z-stack was acquired. For 
PTFE-nf and glass coverslips, the substrate was positioned closest to the objective; for those 
on Transwell membranes, the top of the cell layer was closest to the objective. For 
OrientationJ analysis, slices from the top, middle and bottom (substrate) were selected for 
analysis. 
 
The OrientationJ plugin was used on slices that corresponded to the substrate and 
the distribution at each of the 5 ROI were summed for each sample. The distribution for each 
sample was then normalised to the cumulative dominant direction by identifying the modal 
angle of distribution. This angle was subtracted from the rest of the angles which corrected 
the mode value to 0°. Where angles were then greater than 90°, 180° was subtracted from 
the angle; and where the angles were then smaller than -90°, 180° was added to the angle, 
maintaining the angle distribution between -90° and 90°. The normalised distributions were 
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used to compare the three substrates, PTFE-nf, glass and Transwell membranes. To analyse 
the percentage of pixels that were aligned within a certain degree of the dominant direction, 
the absolute (non-negative) value of angles were taken and the distribution collated into 20° 
bins (e.g. ±10°), as depicted in Figure 3.7. To observe the possible change in orientation as 
cells stratify, 3 slices of the z-stack (top, middle and substrate) were selected and the 
distributions across the 5 ROI were again summed. The data from each donor were 
presented separately. 
OrientationJ was also performed on 1 representative ROI to quantify the alignment 
of collagens and CNA35 on slices corresponding to the substrate, with the exception of 
images where individual z-slices are shown. The percent of collagen alignment within ± 10° 
is reported in the text. 
 
 
Figure 3.7 Normalised OrientationJ distribution analysis. To analyse the percentage of 
alignment with respect to the dominant direction, the distribution was grouped in to 10° bins 
representing ± 10° of the dominant direction (shaded with grey crosshatch) followed by 10° 
increments (10° to 20°+ -10 to -20°; teal squares) up to 90° and -90°. 
 
3.4.4 Live cell imaging of hCFs  
A 22 x 22 mm glass coverslip with PTFE nanofibres drawn across it was inserted into a 1 well 
Chamlide CMS chamber (Figure 3.8) to create a glass bottomed dish with PTFE-nf. 3 x 103 
hCFs at P4 were seeded onto PTFE-nf in the Chamlide CMS. Cells were incubated in hCF 
growth medium (100 µl) for 3 h to allow the cells to attach before topping up with 1 ml 
medium and incubating overnight. The following day, CTR was diluted in serum-free medium 
and added to hCFs, as previously described (3.4.3.4). CTR was then aspirated out of the 
Chamlide CMS and rinsed with growth medium. 0.5 µM of the CNA35 488-labelled probe 
was added to 1 ml of A2PM. Cells were imaged every 60 min using a Zeiss laser scanning 
microscope (LSM) 710 with a stage-top incubator (to ensure the same field of view was 
imaged). For each of the lasers (488 and 561 nm) a laser power of 1% was used to avoid cell 
damage. A z-stack of 3 slices was imaged to account for evaporation of culture medium 
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affecting the working distance. Images were analysed using ImageJ and max. z-projections 




Figure 3.8 The Chamlide CMS chamber (Live Cell Instrument) used for live cell imaging. The 
Chamlide chamber allowed the incorporation of the coverslip coated with PTFE-nf.  
 
 Cell alignment analysis was performed using the OrientationJ plugin for ImageJ as 
previously described (3.4.3.5.1) however, only one field of view was assessed over time. The 
distribution was normalised to the direction of the nanofibres. The percentage of fibrils that 
were aligned within ±10° of the PTFE-nf was also calculated. To quantify the amount of 
collagen deposited the integrated density (fluorescence intensity) was measured via ImageJ. 
Three regions with no fluorescence were also measured and were averaged to give 
background readings. The corrected fluorescence was calculated using (Eq. 3.4.3.1): 
 
 𝐶𝐹 = 𝑖𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − (𝑎𝑟𝑒𝑎 × 𝐵𝐺 𝑓𝑙𝑢𝑜𝑟𝑒𝑠𝑐𝑒𝑛𝑐𝑒) (Eq. 3.4.4.1) 
Where CF = corrected fluorescence; area = area of ROI; BG = mean background fluorescence. 
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Table 3.2 Details of hCF donors used in each experiment. 
Donor 
number 
Age (sex)* Days between 
date of death 
and cell isolation 
Experiments performed 
Donor 6  57 (M) 37 A2PM: ICC analysis on glass, PTFE-nf and 
Transwell membranes; OrientationJ 
analysis; attachment to substrate; growth 
curves and metabolic activity. 
 
Donor 7  Unknown 40 A2PM: ICC analysis on glass, PTFE-nf and 
Transwell membranes; OrientationJ 
analysis; growth curves and metabolic 
activity. 
 
Donor 8  Unknown 66 A2PM: ICC analysis on glass, PTFE-nf and 
Transwell membranes; phase contrast 
images; OrientationJ analysis; growth 
curves and metabolic activity. 
 
Donor 9  Unknown 41 A2PM: Attachment to substrate. 
 
Donor 10  Unknown 47 A2PM: Attachment to substrate. 
 
Donor 11† 35 (M) 8 A2PM: ICC of intracellular collagen at 24 
days; visualisation of cell stratification after 
28 days utilising CNA35/CTR  
 
Donor 12† 35 (M) 8 A2PM: ICC of intracellular collagen at 24 
days; live cell imaging of collagen 
deposition. 
†tissue donated by the same biological donor but treated separately.  
 
3.4.5 hMSC differentiation in keratocyte differentiating medium 
3.4.5.1 Metabolic activity of hMSCs 
Cell metabolic activity of hMSCs in SCM and KDM was measured using resazurin sodium salt, 
as described in 3.4.3.3. hMSCs were seeded at 5 x 103 cells/cm2, as previously described 
(Chapter 2, 2.4.8.2). At days 1, 3, 5, 7, 14 and 21 the culture media were aspirated from the 
cells and the assay was performed. The average of the cell-free resazurin blanks were 
deducted from their respective readings to enable the comparison between phenol-
containing and phenol-free media. To correct for variations in gain, a subset of samples were 
read at gains from 1000 – 2000. A standard curve was generated (Figure 3.9) and the 
equation of the curve was used to correct the data and allow for comparisons between 
plates. 
 





Figure 3.9 Gain curves for correcting hMSC Resazurin data. A: Samples in SCM were read at 
each gain to create a standard curve. B: A standard curve was also created for samples in 
KDM. Experimental samples were then read at their optimal gain and corrected for using the 
above equations. 
 
3.4.5.2 Growth curve of hMSCs 
Following the resazurin assay, the cell number in each well was also determined. The 
quantification of DNA per well using a PicoGreen assay was used as an estimate of cell 
number as described in Chapter 2 (2.4.8.2). To correct for the variation in gain used, a subset 
of samples from day 7 in KDM were read at gains from 1000-2000 and a standard curve was 
generated which was used to correct the data. These data were then compared to growth 
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3.4.5.3 Differentiation of hMSCs on substrates  
hMSCs were seeded onto glass coverslips at a density of 5 x 103 cells/cm2 or onto a 6-well 
polycarbonate Transwell membrane at a density of 1.06 x 105 cells/cm2 and allowed to attach 
for 2.5 h before additional hMSC growth medium was added. The following day, the medium 
was switched to KDM, as described in Chapter 2 (2.4.11), and cells were cultured for 21 days. 
Control hMSCs were cultured in stromal cell medium (SCM) (Table 2.5).  
 
3.4.5.4 ICC of differentiated cells 
To characterise the differentiated hMSCs, cells were fixed, permeabilised and stained for 
keratocan, lumican, aldehyde dehydrogenase 3A1, CD34, α-SMA and collagen types I, III, V 
and VI as described in Chapter 2 (2.4.4). Where co-staining with CNA35 and anti-lumican was 
performed, 0.5 µM CNA35 was added in conjunction with the primary antibody. 
 OrientationJ analysis was also performed on 1 representative ROI to quantify the 
alignment of F-actin on slices corresponding to the substrate. The percent of cell alignment 
at ± 10° is reported in the text. 
 
3.4.5.5 RNA extraction, reverse transcription and RT-qPCR 
RNA was extracted from cells cultured on coverslips as described in Chapter 2 (2.4.6) using 
Qiagen’s RNeasy Plus Micro Kit. hMSCs cultured on Transwell membranes were subjected to 
treatment with Qiagen’s RLT buffer followed by passing through a QiaShredder to 
homogenise the sample. RNA was then extracted as described previously.  
 RNA was converted to cDNA as described in Chapter 2 (2.4.7). The relative gene 
expression of keratocyte markers and collagens were analysed using primers designed using 
Primer-BLAST, found in the literature or purchased from Qiagen (see Table 3.3) (described in 
Chapter 2, section 2.4.7). Following GeNorm analysis (Appendix B), GAPDH was selected as 
the housekeeping gene and expression was normalised to GAPDH. Relative gene expression 
was calculated according to the comparative Ct method and primer efficiency was corrected 














Table 3.3 Forward and reverse primer sequences. 
Gene Forward Reverse Source 
GAPDH ATGGGGAAGGTGAAGGTCG TAAAAGCAGCCCTGGTGACC (McDermott 
et al., 2016) 
ALDH1A1 CTGGTTATGGGCCTACAGCA ATTGTCCAAGTCGGCATCAG (Park et al., 
2012; Yam 
et al., 2015) 
ALDH3A1 CATTGGCACCTGGAACTACC GGCTTGAGGACCACTGAGTT (Du et al., 
2007) 
AQP1 CCACTGGATTTTCTGGGTG CCAGACCCCTTCTATTTGGGC Designed 
CHST6 CTCACCGGGTGTCGCTTAAT GGTTCCTCAGCACCCCAAAG Designed 
KERA CCTGGAAGGCAAGGTGCTA AGTAGGAAAACTGGGTGGGC Designed 
LUM GCAGTGTCAAGACAGTAAGGATT TTGGGTAGCTTTCAGGGCAG Designed 
PTGDS CCTGCCCCAAACCGATAAT CAGAGACATCCAGAGCGTGG Designed 
COL1A1 GTTCAGCTTTGTGGACCTCCG GATTGGTGGGATGTCTTCGTCT (Williamson 
et al., 2020) 
COL3A1 Hs_COL3A1_1_SG QuantiTect Primer Assay Qiagen 
COL5A1 Hs_COL5A1_1_SG QuantiTect Primer Assay Qiagen 
COL6A1 Hs_COL6A1_1_SG QuantiTect Primer Assay Qiagen 
 
3.4.6 Statistical analysis 
Statistical analyses were performed using MiniTab (v 19.2020.1), SPSS (IBM; v 26), SigmaPlot 
(v 14.0) and/or GraphPad Prism 9 (v 9.0.0) software. A significance level of p < 0.05 was set 
for all experiments. Data were reported as mean ± 1 standard deviation (SD). To ensure all 
data were normally distributed, a Shapiro-Wilk test was performed. Where data were not 
normally distributed, Box-Cox transformations were applied to determine a suitable 
transformation. Datasets were re-tested for normality and equal variances before 
parametric tests were used. One-way ANOVA with Tukey’s post hoc test for multiple 
comparisons was performed to report both cell attachment and alignment data and a Brown-
Forsythe test was used to ensure equal variances. For comparing three or more groups with 
two factors, a two-way ANOVA was performed and a Spearman’s test for heteroscedasticity 
was used to ensure equal variances. With RT-qPCR data, where no expression was detected, 
this value was eliminated from the analysis. If the residuals after fitting the model were not 
normally distributed and data could not be suitably transformed, either a one-way ANOVA 
(where data were normally distributed) or a Kruskal-Wallis one-way ANOVA was performed. 
Multiplicity adjusted p values are reported.                     
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3.5 Results  
3.5.1 Characterisation of substrates 
3.5.1.1 PTFE nanofibres 
The deposition of PTFE nanofibres on to glass coverslips was explored using white light 
interferometry. The VSI scan showed aligned, parallel features traversing the glass coverslip 
(Figure 3.10). At a low magnification the colour scale indicates that these fibres are between 
1 – 100 nm in height whilst the higher magnification revealed that the fibres are mostly 
between 5 – 30 nm in height (Figure 3.10 A and B respectively). The height range was similar 
across all 4 samples. The average roughness of the surface (Ra) was 6.94 ± 3.23 nm and the 
root mean square roughness (Rq) was 9.94 ± 4.99 nm (Table 3.4).  





Figure 3.10 Representative white light interferometry 3D plot of PTFE nanofibres coating a 
glass coverslip. A: The nanofibres had an average roughness (Ra) of < 10 nm as observed at 
21.32X magnification. B: Sample at 105.47X magnification. Ra, average roughness; Rq, root 
mean square roughness; Rt, maximum height of the profile. 
 
Table 3.4 Surface roughness values for PTFE nanofibres. 
Roughness value1 PTFE nanofibres (nm)* 
Ra 6.94 ± 3.23 
Rq 9.94 ± 4.99 
Rz 144.39 ± 79.98 
1 Ra, average roughness; Rq, root mean square roughness; Rz, average maximum height of the profile. 
* Data presented as mean ± SD from n = 4 samples. 
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3.5.1.1.1 Polycarbonate Transwell membrane 
Polycarbonate Transwell membranes have been used to culture corneal fibroblasts in vitro 
and have previously been shown to present parallel grooves across the surface (Guo et al., 
2007; Dimitrios Karamichos et al., 2014). SEM was used to analyse the surface of the 
Transwell membranes and to investigate the presence of parallel grooves. FIJI analysis of the 
SEM images determined the average diameter of the pores to be 0.43 µm (SD = 0.01), slightly 
larger than the manufacturer reports (Table 3.5). The average number of pores per cm2 was 
measured as 8.75 x 107 (SD = 8.21 x 105) and the pores covered approximately 12% of the 
membrane surface.  
 The random distribution of pores can be seen at relatively low magnification SEM 
images (Figure 3.11 A and B). These images also reveal a possible explanation for the 
increased pore diameter observed, several of the pores overlap and create one large pore. 
At higher magnifications parallel features were observed traversing patches of the 
membrane (Figure 3.11 C and D). These features were considerably smaller in width than the 
diameter of the pores and the increased magnification revealed small areas where these 
features were absent suggesting these were not consistent across the membrane. 
 




Number of pores / 
cm2 
% area covered 
Reported by Corning 0.4 1 x 108 Data not supplied 
Measured using FIJI * 0.43 ± 0.01 8.75 x 107 ± 8.21 x 105 12.36 ± 0.58 
* Data presented as mean ± SD from n = 4 fields of view.  




Figure 3.11 Ultrastructure of a polycarbonate Transwell membrane. A: Representative SEM 
image at 5000X view show the 0.4 µm pores in the Transwell membrane and the highlighted 
region (black box) is magnified in B. B: At 10,000X view the non-uniform distribution of the 
pores can be seen and the region within the black box is magnified in C. C: Faint lines can be 
seen on the surface of the membrane at 20,000X view (white arrows). D: A stitched image at 
an increased magnification of 50,000X shows the lines running across the surface of the 
membrane are visible (black arrows). Scale bars represent A: 10 µm; B: 5 µm; C: 4 µm; D: 1 
µm.  
 
3.5.2 hCFs in an in vitro model of the stroma 
Three substrates were investigated for their suitability in a model of the corneal stroma: 
glass, PTFE-nf and Transwell membranes. A PicoGreen assay indicated that over 90% of cells 
that were seeded onto each substrate had attached after 2 h (Figure 3.12).  
The effect of A2P supplementation on cell number and metabolic activity was also 
investigated using both a PicoGreen assay and a resazurin assay. Cells continued to 
proliferate with no significant change in cell number when A2P was added to the medium 
(A2PM) (Figure 3.13 A). Media type was shown to significantly affect metabolic activity (p = 
0.045) however, when correcting for multiple comparisons, no significant differences were 
observed (Figure 3.13 B). A table of p values for each of these experiments can be found in 
(Appendix F).  




Figure 3.12 Initial hCF attachment to substrates. A PicoGreen assay was used to investigate 
the number of cells that attached to glass coverslips, PTFE-nfs or Transwell membranes. Cells 
were seeded onto each substrate and allowed to attach for 2 h prior to PicoGreen analysis 
on the substrates and on the media wash. n = 3 and error bars represent mean ± 1 SD. One-
way ANOVA was performed on the fraction attached to the substrate. No significant 
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Figure 3.13 Growth and metabolic activity of hCFs in normal (growth) and ascorbic acid 
supplemented (A2PM) conditions. A: A PicoGreen assay was used to compare the 
proliferation of hCFs in A2PM (magenta) to normal, growth medium (grey). A logistic growth 
curve was applied where R2 = 0.896 and 0.892 for Growth (as in Chapter 2, 2.5.1.2) and A2PM 
respectively. B: Cell metabolic activity was assessed using a resazurin sodium salt 
colorimetric assay over 21 days. C: To take into consideration the effect of an increase in cell 
number on the overall metabolic activity, the relative fluorescence was normalised to cell 
number. n = 3 biological replicates for all samples except for the cell number for A2PM at 
day 5 where n = 2; lines represent the mean in B and C. This experiment was performed on 
one occasion comparing growth, A2PM and FC with the same data being reported in Chapter 
4 (4.5.4). Where data were normally distributed a two-way ANOVA was performed 
otherwise, a one-way ANOVA was performed with Tukey’s post hoc test for multiple 
comparisons. No significant differences were observed.  
 
3.5.2.1 hCFs aligned parallel to PTFE nanofibres 
Phase contrast microscopy was used to visualise the hCFs growing over time (Figure 3.14). 
When cultured on the glass substrate hCFs were randomly oriented up to 24 h. By day 7 short 
range order was observed with areas of the fibroblasts appearing to align in different 
directions. By day 21 evidence of cell stratification could be seen with the hCFs forming a 
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layer of randomly oriented cells. In contrast, some hCFs could be seen aligning parallel to the 
PTFE-nf from as early as 3 h post-seeding. This continued as the cells proliferated however, 
by day 21 stratification was evident with cells orienting at different angles to the PTFE-nf.  
 
 
Figure 3.14 Representative phase contrast images of hCFs cultured over time. Cells were 
cultured on either control glass coverslips (left) or PTFE-nf (right) for 21 days. Scale bar 
represents 200 µm.  
 
 The alignment of hCFs on PTFE-nf was further investigated by analysing the 
orientation of the cytoskeleton using OrientationJ (Figure 3.15 & Figure 3.16). The 
normalised distributions of cells cultured on PTFE-nf showed a sharp peak at 0°, confirming 
that most cells are aligned in the dominant direction, running parallel to the nanofibres 
(Figure 3.15 A). Conversely, there is no sharp peak in the distribution when cultured on both 
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glass and Transwell membranes, indicating the cells are less aligned on these substrates 
(Figure 3.15 B and C, respectively). On Transwell membranes, a shallow broad peak is evident 
which suggests that whilst some alignment may be observed, this is not uniform across the 
sample. Investigating the deviation from the dominant direction revealed that 72.5% of 
pixels (representing filaments) were aligned within ± 10° of the dominant direction on PTFE-
nf, three times greater than those on glass and two times greater than those on Transwell 
membranes (Figure 3.15 D) (p = 0.0002 and 0.0008 respectively). Few filaments are oriented 
between 40.1° – 50° from the dominant direction on PTFE-nf (0.3%) whereas on both glass 
and Transwell membranes this was greater than 5% (9.6% and 6.0% respectively) (Figure 3.15 
E). Interestingly, only cultures on glass showed filaments oriented between 80.1° – 90° from 
the dominant direction (8.2%), significantly more than that observed on PTFE-nf (p = 0.0485) 
and Transwell membranes (p = 0.0478) (Figure 3.15 F).  
 OrientationJ was also used to analyse the change in orientation observed as cells 
stratify on each of the three substrates (Figure 3.16). When in contact with the PTFE-nf, the 
distribution of F-actin filament orientation was aligned with the nanofibres. The seventh 
donor appeared to maintain this alignment throughout the z-stack with minimal change in 
the distribution of F-actin filament. However, the other two donors displayed a decrease in 
alignment towards the middle of the cell construct, with a shallow broad peak observed. At 
the top of the cell construct, at least two separate distributions were observed suggesting 
that as the cells stratify they rotate and change orientation. The degree in which the cells 
rotated varied between 30° and 55°. The three donors behaved similarly when cultured on 
glass, with little alignment observed on any layer of the construct. However, the eighth donor 
also showed rotation by approximately 30° as the cells stratified. Broad, shallow peaks were 
observed on the substrate level of all donors on Transwell membranes suggesting that whilst 
there may be some alignment, this was not uniform across the sample. As with cultures on 
PTFE-nf, the cells rotated as they stratified but the distribution remained broad. The shift in 
the peak varied between donors and ranged from 18° to 77°. 
 The alignment of stratified cells appeared to be reduced but shifted when cultured 
on PTFE-nf. To quantify this, the alignment at each of the two main peaks in the top layer of 
cells was quantified (Figure 3.17). hCFs continued to align within ± 10° of the direction of the 
nanofibres (42.4%; Figure 3.17 A) but 36.1% of cells were aligned towards the second peak, 
suggesting that cells had rotated as they stratified. Few cells were oriented between ± 40-
50° of either peak 1 (6.2%) or peak 2 (10.5%) (Figure 3.17 B). Less than 5% of cells were 
aligned within ± 80-90 ° of peak 1 (2.5%) and peak 2 (0.06%) (Figure 3.17 C).  




Figure 3.15 OrientationJ analysis of F-actin distribution at the substrate level, normalised 
to the modal direction. A: Distribution of cell orientation cultured on PTFE-nf (black). B: 
Distribution of cell orientation cultured on glass (magenta). C: Distribution of cell orientation 
cultured on Transwell membranes (teal). D-F: The alignment compared to the dominant 
direction was also investigated by grouping the distribution into 10° bins from the dominant 
direction. D: Quantification of the distribution aligned within ± 10° from the dominant 
direction on PTFE-nf (grey), glass (magenta) and on Transwell membranes (teal). E: 
Quantification of the distribution of actin filaments aligned between ± 40-50° of the 
dominant direction on PTFE-nf (grey), glass (magenta) and Transwell membranes (teal). F: 
Quantification of the distribution aligned within ± 80-90° of the dominant direction on PTFE-
nf (grey), glass (magenta) and on Transwell membranes (teal). n = 3 biological replicates with 
the means ± 1 SD shown. A one-way ANOVA was performed on each 10° bin followed by 
Tukey’s post hoc test for multiple comparisons; multiplicity adjusted p values: a = < 0.001; b 
= 0.0058; c = 0.0453; d = 0.0485; e = 0.0478.  













































































































Figure 3.16 Stratification of hCFs cultured on PTFE-nf, glass and a Transwell membrane for 
30 days. For each substrate, the distribution is split to show the alignment of cells on the 
substrate (black), those in the middle (blue) and those on top (orange) of the cell construct. 
Each donor has been shown separately (one donor per row; donors 6-8). The distributions of 
hCFs on PTFE-nf (left) show alignment on the substrate (same data as presented in Figure 
3.15). The stratification of hCFs on glass (middle) and on Transwell membranes (right) are 
also shown.  







































































































Figure 3.17 Alignment of the top layer of stratified hCFs on PTFE-nf. OrientationJ analysis of 
cell alignment on PTFE-nf showed that alignment is reduced but shifted as cells stratify. A: 
Quantification of the distribution aligned within ± 10° of the first (grey) and second (orange) 
peak (Figure 3.16). Peak 1 corresponds to the direction of the nanofibres. B: Quantification 
of the distribution aligned between ± 40-50° of peak 1 (grey) compared to peak 2 (orange). 
C: Quantification of the distribution aligned within ± 80-90° either peaks 1 and 2 (grey and 
orange, respectively). n = 3 for peak 1; n = 2 for peak 2, where a shift in angle was not 
observed for one donor.  
 
3.5.2.2 hCFs deposit collagen types I, V and VI 
ICC analysis was used to visualise collagen deposition by hCFs in media supplemented with 
1 mM A2P (A2PM) on glass, PTFE-nf and on Transwell membranes. Initially, cells were 
permeabilised prior to the application of the primary antibody which revealed intracellular 
type I collagen expressed by hCFs cultured on PTFE-nf (Figure 3.18). Co-staining with 
phalloidin, which labels the F-actin of the cells, confirmed that the cells were aligned in the 
direction of the PTFE-nf.  
 As the deposition and alignment of extracellular collagens is of great importance 
when modelling the corneal stroma, hCFs were no longer permeabilised prior to the addition 
of the primary antibodies (Figure 3.19, Figure 3.20 and Figure 3.21). The maximum z-
projections of hCFs show diffuse staining for type I collagen on all three substrates, which 
appears more aligned in cells cultured on PTFE-nf (59% aligned within ± 10° of the dominant 
direction; n = 3) than on either glass (30% aligned; n = 3) or the Transwell membrane (18% 
aligned; n = 13) (Figure 3.19). The staining of type I collagen on the Transwell membrane is 
diffuse but this is likely due to the higher cell number, and thus increase in deposited 
collagen. There is what appears to be intracellular staining of type III collagen on all 
substrates which is likely non-specific staining (Figure 3.20), although the staining observed 
is stronger than in the IgG control (Figure 3.22). Type V collagen was deposited by hCFs on 
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all substrates, with alignment again observed on PTFE-nf (72% aligned within ± 10° of the 
dominant direction; n = 2) but also on the glass substrate (42% aligned; n = 2). On the 
Transwell membranes type V collagen appears disorganised with little alignment (28% 
aligned; n = 3). Similarly, type VI collagen was deposited on all substrates (Figure 3.21) with 
that deposited by hCFs on PTFE-nf appearing the more aligned (67% aligned; n = 3) than the 
type VI collagen deposited on glass (29% aligned; n = 3) or the Transwell membrane (22% 
aligned; n = 3). A diffuse staining for α-SMA was observed with no actin fibrils evident, 
indicating non-specific staining in cells that were not permeabilised prior to ICC. A summary 
of collagen expression can be found in Table 3.6 at the end of the results section. 
  To further investigate the deposition of collagens, CTR and CNA35 were added to live 
cell cultures in vitro, prior to fixation (Figure 3.23 & Figure 3.24). The distribution of CNA35 
labelled collagens showed some alignment with the cells (labelled with CTR) appearing to 
show short-range order when cultured on glass (Figure 3.23). Collagens can be seen in all 
layers as the cells stratify over 10 µm with the collagen orientation rotating by 25.3°. When 
cultured on PTFE-nf, the cells remained aligned along the nanofibres with the collagen 
orientation closely following the cells (Figure 3.24). Interestingly, as the cells stratified on 
PTFE-nf they also rotated 39.5° whilst still maintaining alignment.  
 Tiled images were acquired across an area covering approximately 3 mm2 to assess 
the distribution of collagens across each sample after 30 days (Figure 3.25). The larger field 
of view confirms the random orientation of the deposited collagens when hCFs were cultured 
on glass, with there being no observable directionality. In contrast, when cultured on PTFE-
nf the CNA35-labelled collagen can be seen following the direction of the nanofibres in the 
layer closest to the substrate. As also observed in Figure 3.24, there is a shift in the 
orientation of collagen in the subsequent layers yet this still appears aligned. 
 




Figure 3.18 Representative ICC analysis of intracellular type I collagen expressed by hCFs 
cultured on PTFE-nf for 24 days. Intracellular expression of type I collagen (Col I; magenta) 
when hCFs were cultured in medium supplemented with 1 mM A2P and permeabilised prior 
to antibody staining. Cells were co-stained with phalloidin (F-actin; yellow). IgG control 
(magenta) is also shown. White arrows on merged images represents direction of PTFE-nf. n 
= 2 biological replicates. Scale bar represents 100 µm. 




Figure 3.19 Representative max. z-projections from ICC analysis of extracellular type I collagen expressed by hCFs cultured on glass, PTFE-nf and Transwell 
membranes for 30 days. The extracellular expression of collagens (CNA35), specifically type I collagen (Col I; magenta) was analysed. Cells were co-stained 
with phalloidin (F-actin; yellow) and DAPI (blue) and the negative controls are shown in Figure 3.22. These same images were used for OrientationJ analysis 
(Figure 3.15) and as a comparison for macromolecular crowding (Chapter 4, 4.5.2). White arrow on merged image represents direction of PTFE-nf. n = 3 
biological replicates. Scale bar represents 100 µm.




Figure 3.20 Representative max. z-projections from ICC analysis of extracellular collagen 
types III and V expressed by hCFs cultured on glass, PTFE-nf and Transwell membranes for 
30 days. Collagen types III (Col III; green) and type V (Col V; magenta) are shown. These data 
were also used as a comparison for macromolecular crowding (Chapter 4, 4.5.2). Cells were 
co-stained with DAPI (blue) and the negative controls are shown in Figure 3.22. White arrow 
on merged image represents direction of PTFE-nf. n = 2 biological replicates except for on 
the Transwell membrane where n = 3. Scale bars represent 100 µm. 
 




Figure 3.21 Representative max. z-projections from ICC analysis of extracellular type VI 
collagen and α-SMA expressed by hCFs cultured on glass, PTFE-nf and Transwell 
membranes for 30 days. α-SMA (green) and type VI collagen (Col VI; magenta) are shown. 
These data also were used as a comparison for macromolecular crowding (Chapter 4, 4.5.2). 
Cells were co-stained with DAPI (blue) and the negative controls are shown in Figure 3.22. 
White arrow on merged image represents direction of PTFE-nf. n = 3 biological replicates. 
Scale bars represent 100 µm. 
 
 
Figure 3.22 IgG negative controls for mouse and rabbit primary antibodies. Cells were co-
stained with phalloidin (yellow) and DAPI (blue) with the merged images also shown. White 
arrow on merged image represents direction of PTFE-nf. n = 1 biological replicate. Scale bar 
represents 100 µm.  




Figure 3.23 Montage of 1 µm slices from a confocal Z-stack of hCFs cultured on glass for 28 
days. Cells were labelled with CTR (magenta) and collagen was labelled with CNA35 (green). 
0 µm represents the cell layer closest to the glass substrate. Fibril orientation distribution of 
each layer normalised to the dominant direction at 0 µm is also shown. n = 1 biological 
replicate. Scale bar represents 100 µm. 
 




Figure 3.24 Montage of 1 µm slices from a confocal Z-stack of hCFs cultured on PTFE-nf for 
28 days and labelled with CTR (magenta) and CNA35 (green). Images acquired show cells 
stratifying and depositing collagen with 0 µm representing the cell layer closest to the 
substrate. Fibril orientation distribution of each layer normalised to the direction of PTFE-nf 
is shown. White arrow represents direction of PTFE-nf. n = 1 biological replicate. Scale bar 
represents 100 µm.




Figure 3.25 ICC analysis of extracellular collagen deposited by hCFs cultured on glass and PTFE-nf for 30 days and labelled with CTR (magenta) and CNA35 
(green). Cells were co-stained with DAPI (blue) with the merged images also shown. Tiled images were acquired to show fibrillar collagen over a large field of 
view. White arrow on merged image represents the direction of the PTFE-nf. n = 1 biological replicate. Scale bars represent 200 μm.
Chapter 3 Results 
139 
 
3.5.3 Live cell imaging of collagen deposition  
A model of the corneal stroma can be used for a variety of applications from evaluating the 
efficacy of drug treatments to understanding the mechanisms of wound healing. Live cell 
imaging of collagen deposition could enable the further understanding of collagen alignment 
and it was for this reason that PTFE-nf was selected as a substrate. Co-labelling hCFs with 
CTR and CNA35 enabled the visualisation of live cells, cultured on PTFE-nf, secreting collagen 
(Figure 3.26 A). At time point 0, there was no apparent collagen staining but hCFs had started 
to align parallel to the PTFE-nf. By hour 32, collagen could be clearly seen and this appeared 
to increase up to hour 64 (Figure 3.26 B). The distribution was normalised to the direction of 
the PTFE-nf and OrientationJ analysis showed a small, sharp peak around 0° which confirmed 
that the collagen was aligned at the start of imaging (Figure 3.26 C). As more collagen was 
deposited, alignment was maintained and appeared to slightly increase (Figure 3.26 D). The 
full time-series can be seen in Appendix G.




Figure 3.26 Live cell imaging and analysis of hCFs cultured on PTFE-nf. A: Images at 16-hour intervals are shown. Cytoplasm is labelled with CTR (magenta) 
and collagen is labelled with CNA35 (green). White arrow represents direction of PTFE-nf. Sale bars represent 100 µm. B: Fluorescence intensity shows that 
collagen increased with time. C: Normalised OrientationJ analysis shows collagen distribution over time. D: Distribution aligned within ± 10° of the PTFE-nf. 
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3.5.4 hMSCs in an in vitro model of the stroma 
MSCs are a potential source of cells for corneal stroma engineering. Progenitor cells, such as 
hMSCs, can be differentiated into keratocytes and incorporated into in vitro models where 
they are reported to deposit an ECM that more accurately resembles the stroma (Du et al., 
2010; Syed-Picard et al., 2015; Dos Santos et al., 2019). Therefore, the potential of bone 
marrow-derived MSCs to differentiate into keratocytes and secrete an organised matrix were 
evaluated.  
 
3.5.4.1 hMSCs proliferated and expanded in both SCM and KDM 
The growth and metabolic activity of hMSCs in differentiating medium was assessed and 
compared to cells cultured in SCM (Figure 3.27). There was no significant difference in cell 
number between media conditions at any of the time points, however there was greater 
variation between donors cultured in KDM (Figure 3.27 A). A logistic growth curve was 
applied to the data, this gave an R2 value of 0.91 for the cells cultured in SCM but the variation 
between donors cultured in KDM resulted in a low R2 value of 0.66.  
 No differences in the overall metabolic activity between the two culture conditions 
were observed across the 21-day period (Figure 3.27 B). The trend observed is similar to that 
seen in the growth curve with metabolic activity increasing up to day 14 before starting to 
plateau between days 14 and 21. To determine whether the observed increase in metabolic 
activity over time was because of the increase in cell numbers, the relative fluorescent units 
(RFU) per cell was calculated (Figure 3.27 C). No differences in the average metabolic activity 
per cell were observed however the variation between both donors and media conditions is 
reduced by day 7. The results here suggest that the average metabolic activity per cell is 
greatest at early time points, but varies between donors. However, because this is an 
average, and single cell metabolic activity was not assessed, it is not clear whether the 
increased metabolic activity at days 1 – 5 is as a result of a small sub-population of cells that 
are more metabolically active or if this is truly representative of the entire population.  




Figure 3.27 Growth and metabolic activity of hMSCs over 21 days. A: PicoGreen assay was 
used to compare the growth of hMSCs in KDM (blue) to those in SCM (orange). A logistic 
growth curve was applied. R2 = 0.91 and 0.66 for SCM and KDM respectively. B: Cell metabolic 
activity was assessed using resazurin sodium salt colorimetric assay over 21 days. C: To take 
in to consideration the effect of an increase in cell number on the overall metabolic activity, 
the relative fluorescence was normalised to cell number. n = 3 biological replicates and the 
lines represent the mean. Where data were normally distributed a two-way ANOVA was 
performed otherwise a Kruskal-Wallis one-way ANOVA was performed. No significant 
differences were observed.  
 
3.5.4.2 hMSCs formed spheres in KDM  
The morphology of hMSCs undergoing differentiation in KDM was investigated via phase 
contrast microscopy (Figure 3.28). In both SCM and KDM, hMSCs cultured on glass appeared 
randomly oriented throughout the culture period whereas those cultured on PTFE-nf aligned 
parallel to the nanofibres. Interestingly, hMSCs cultured on PTFE-nf and in KDM started to 
detach from the substrate at day 7. This phenomenon progresses during the remaining 14 
days of culture and areas with cell spheres are formed (Figure 3.28 inset).  






































































Figure 3.28 Representative phase contrast images of hMSCs cultured in SCM or KDM. Cells were cultured for 21 days on either glass coverslips or PTFE-nf. 
Cell contraction can be seen as early as day 7 with a cell cluster forming. This progresses throughout the culture period and amongst the aligned cells cell 
spheres can be seen at day 21 (inset). n = 2 biological donors. Scale bars represent 200 µm.  
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3.5.4.3 hMSCs cultured on Transwell membranes spontaneously formed cell spheres 
In both media conditions hMSCs were observed forming spheres when cultured in Transwell 
membranes (Figure 3.29). These spheres were commonly observed when cells were cultured 
in KDM but sphere formation did occasionally occur when cultured in SCM. 
 
 
Figure 3.29 Macroscopic image of hMSCs cultured on Transwell membranes for 7 days. Cell 
spheres were occasionally formed when cultured in SCM (left; black arrow) and were often 
formed when cultured in KDM (right; white arrow).  
 
3.5.4.4 hMSCs did not express keratocyte specific proteins  
The expression of typical keratocyte markers (keratocan, lumican and CD34), in addition to 
proteins associated with fibroblasts (CD90) and myofibroblasts (α-SMA), were analysed using 
ICC. A summary of protein expression can be found in Table 3.6. On glass, hMSCs cultured in 
SCM showed little organisation (36%; n =3) (Figure 3.30). When cultured in differentiating 
medium (KDM), cells started to stratify and concentrate in small regions which again resulted 
in little alignment (38%; n = 3). F-actin staining revealed that as with hCFs, hMSCs cultured 
in SCM followed the topographical cues provided by the PTFE-nf and appeared to align 
accordingly (69%; n = 3) (Figure 3.31). However, the formation of pellets in KDM, as also 
observed in Figure 2.26, disrupted the alignment of hMSCs (42%; n = 3). Similar results were 
observed when cells were cultured on Transwell membranes with little alignment in both 
SCM (33%; n = 3) and KDM (30%; n = 3) (Figure 3.32). 
hMSCs in KDM did not appear to express keratocan, with only diffuse staining 
observed in cells cultured on PTFE-nf, glass coverslips and on Transwell membranes (Figure 
3.31, Figure 3.30 & Figure 3.32 respectively). A similar observation was made for CD34 when 
cultured on PTFE-nf and glass. Lumican was expressed ubiquitously on all substrates in both 
conditions; interestingly the expression appeared to be predominantly intracellular with 
little colocalization with collagens (CNA35; Figure 3.31 & Figure 3.30). IgG controls showed 
minimal non-specific staining (Figure 3.33). 




















Figure 3.30 Representative max. z-projections from ICC analysis of keratocyte markers expressed by hMSCs cultured on glass in differentiating (KDM) and 
control (SCM) media for 21 days. Keratocyte markers: keratocan (KERA; magenta), lumican (LUM; magenta) and CD34 (magenta). Collagens were also labelled 
(CNA35; green). Cells were co-stained with phalloidin (F-actin; yellow) and DAPI (blue) and the negative controls are shown in (Figure 3.33). n = 3 biological 
replicates for all except CD34 where n = 2. Scale bar represents 100 µm. 




Figure 3.31 Representative max. z-projections from ICC analysis of keratocyte markers expressed by hMSCs cultured on PTFE-nf in differentiating (KDM) 
and control (SCM) media for 21 days. Keratocyte markers: keratocan (KERA; magenta), lumican (LUM; magenta) and CD34 (magenta). Collagens were also 
labelled (CNA35; green). Cells were co-stained with phalloidin (F-actin; yellow) and DAPI (blue) and the negative controls are shown in (Figure 3.33). n = 3 
biological replicates for all except CD34 where n = 2. Scale bars represent 100 µm. 




Figure 3.32 Representative max. z-projections from ICC analysis of keratocyte markers expressed by hMSCs cultured on Transwell membranes in 
differentiating (KDM) and control (SCM) media for 21 days. Keratocyte markers: keratocan (KERA; magenta) and lumican (LUM; magenta). Cells were co-
stained with phalloidin (F-actin; yellow) and DAPI (blue) and the negative controls are shown in (Figure 3.33). n = 3 biological replicates. Scale bar represents 
100 µm.




Figure 3.33 IgG negative controls for mouse and rabbit primary antibodies on hMSCs 
cultured in KDM. Cells were counterstained with phalloidin (yellow) and DAPI (blue) with the 
merged images also shown. n = 1 biological replicate. Scale bar represents 100 µm. 
 
3.5.4.5 hMSCs exhibited varied deposition of collagens found in the stroma 
Type I collagen was consistently expressed by hMSCs cultured in both SCM and KDM on all 
three substrates (Figure 3.34, Figure 3.35, Figure 3.36). A summary of collagen expression 
can be found in Table 3.6. Collagen types III and VI were also observed in hMSCs cultured in 
KDM on glass as the cells started to form pellets (Figure 3.34). Unfortunately, some pellets 
were lost during sample processing, leaving behind few remaining cells which may explain 
the absence of type V collagen. No expression of α-SMA was evident, with only non-specific 
staining observed but a low expression of CD90 could be seen. These findings differ to those 
cultured in SCM on glass where type V collagen expression was observed, alongside α-SMA. 
There was little deposition of type III collagen when hMSCs were cultured in SCM on glass. 
Α-SMA is a marker for myofibroblasts, the wound repair phenotype found in corneal wounds, 
and is often expressed in conjunction with type III collagen, but this was not observed here.  
 hMSC pellets formed on PTFE-nf (in KDM) expressed collagen types I, V and VI but 
not type III collagen (Figure 3.35). There also appears to be expression of both CD90, a 
fibroblast marker, and α-SMA, a protein associated with myofibroblasts. Given the pelleted 
nature of the cells, it is hard to distinguish actin filaments and the apparent expression of α-
SMA may be non-specific staining. hMSCs cultured in SCM displayed expression of collagen 
types I and V but not collagens type III and VI. Α-SMA expression was also observed in SCM, 
with SMA fibres clearly distinguishable.  
 Cultures on Transwell membranes displayed similar expression to those on glass, 
with no type V collagen expression observed in KDM, but diffuse staining of the other 
collagens (Figure 3.36). Positive α-SMA expression was observed in hMSCs cultured in both 
KDM and SCM on Transwell membranes. As with cultures on glass, hMSCs in SCM on 
Transwell membranes expressed collagen types I, V and VI with diffuse type III collagen and 
were positive for CD90. 




Figure 3.34 Representative max. z-projections from ICC analysis of collagens and fibroblast markers expressed by hMSCs cultured on glass in differentiating 
(KDM) and control (SCM) media. Cornea-specific collagen types I (Col I; magenta), V (Col V; magenta) and VI (Col VI; magenta). The expression of fibroblast 
and myofibroblast markers CD90 (green), type III collagen (Col III; green) and α-SMA (green) was also analysed. Cells were co-stained with DAPI (blue) and 
the negative controls are shown in (Figure 3.33). n = 2 biological replicates except for Col V, α-SMA and CD90 where n = 1. Scale bars represent 100 µm. 




Figure 3.35 Representative max. z-projections from ICC analysis of collagens and fibroblast markers expressed by hMSCs cultured on PTFE-nf in 
differentiating (KDM) and control (SCM) media. Cornea-specific collagen types I (Col I; magenta), V (Col V; magenta) and VI (Col VI; magenta). The expression 
of fibroblast and myofibroblast markers CD90 (green), type III collagen (Col III; green) and α-SMA (green) was also analysed. Cells were co-stained with DAPI 
(blue) and the negative controls are shown in (Figure 3.33). n = 2 biological replicates except for Col V, α-SMA and CD90 where n = 1. Scale bar represents 
100 µm. 




Figure 3.36 Representative max. z-projections from ICC analysis of collagens and fibroblast markers expressed by hMSCs cultured on Transwell membranes 
in differentiating (KDM) and control (SCM) media. Cornea-specific collagen types I (Col I; magenta), V (Col V; magenta) and VI (Col VI; magenta). The 
expression of fibroblast and myofibroblast markers CD90 (green), type III collagen (Col III; green) and α-SMA (green) was also analysed. Cells were co-stained 
with DAPI (blue) and the negative controls are shown in (Figure 3.33). n = 2 biological replicates. Scale bars represent 100 µm.
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3.5.4.6 hMSCs did not show an increase in keratocyte marker gene expression 
Keratocytes are typically characterised by their expression of keratocan and lumican, as 
shown in the ICC data, but also their expression of aldehyde dehydrogenase (ALDH), 
prostaglandin D2 synthase (PTGDS), carbohydrate sulfotransferase 6 (CHST6) and aquaporin 
1 (AQP1). To further characterise the hMSCs and to determine if hMSCs had the potential to 
differentiate towards the keratocyte lineage, gene expression analysis was used. RT-qPCR 
revealed that the expression of genes typically associated with keratocytes was not increased 
in hMSCs in KDM compared to those in SCM (Figure 3.37 A). The following, where Ct values 
exceeded 35 or were not obtained at all, have an n of 2: (SCM (Glass): LUM and COL3A1; 
KDM (Glass): ALDH3A1 and CHST6; SCM (PTFE-nf): COL6A1; and KDM (Transwell): ALDH3A1 
and AQP1). For the majority of the keratocyte markers, no significant changes were observed 
between media nor between substrates. The expression of ALDH1A1 was reduced between 
hMSCs cultured in SCM on glass and Transwell membranes (p = 0.0468). The expression of 
collagens typically associated with the stroma (types I, V and VI) did not change much 
between media and substrate. Only the expression of COL5A1 increased between hMSCs 
cultured on PTFE-nf in SCM and those on Transwell membranes in KDM (p = 0.0048) (Figure 
3.37 B). COL3A1 expression, a collagen associated with scar tissue within the stroma, was 
increased in cultures on Transwell membranes in KDM compared to hMSCs on glass in SCM 
(p = 0.0317), on PTFE-nf in SCM (p = 0.0114) and on PTFE-nf in KDM (p = 0.0466). 
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Figure 3.37 Gene expression analysis of keratocyte markers and collagens in hMSCs. hMSCs 
were cultured on glass coverslips (squares), PTFE-nf (triangles) or on Transwell membranes 
(circles) in either SCM (orange) or KDM (blue) for 21 days. A: The expression of typical 
keratocyte markers were analysed via qPCR. B: Expression of collagens were also analysed. 
Values are shown on a logarithmic scale and normalised to GAPDH. n = 3 biological replicates 
except for hMSCs in SCM on Transwell membranes, where n = 2. In some samples expression 
was undetectable and so n = 2 for the following: SCM (Glass): LUM and COL3A1; KDM (Glass): 
ALDH3A1 and CHST6; SCM (PTFE-nf): COL6A1; and KDM (Transwell): ALDH3A1 and AQP1. Bar 
represents the geometric mean. 2-way ANOVAs were performed on each gene after Box-Cox 
transformations. Multiplicity adjusted p values are reported: a = 0.0468; b = 0.0048; c = 
0.0317; d = 0.0114; e = 0.0466.
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SMA 
CD90 % alignment* Comments 
hCF Glass + + + - N/A N/A N/A - N/A 23  




+ + + - N/A N/A N/A - N/A 35 Broad distribution of orientations suggests 




Glass + + + - - + - + - 36‡  









Glass + - + + - + - - + 38‡ Formed pellets 
 




+ - + + - + N/A + - 30‡ Formed pellets 
 
*alignment within ± 10°; N/A, not assessed; †expression likely non-specific staining; ‡average alignment based on 1 ROI per donor. 




The aim of this chapter was to determine a suitable cell type and substrate for creation of an 
in vitro model of the corneal stroma. The results obtained in this study suggest that hCFs are 
a more suitable cell choice than hMSCs for the in vitro model. hCFs aligned parallel to the 
PTFE-nf, with the cells rotating as they stratify, mimicking the architecture of the stroma. 
hCFs were also shown to deposit collagen types I, V and VI whereas hMSCs did not 
consistently express type V collagen across all substrates. In addition, hMSCs cultured in KDM 
had the tendency to form cell pellets, despite the provision of topographical cues, thus losing 
the structure that resembled the stroma. Furthermore, differentiated hMSCs did not express 
the proteins nor proteoglycans that are used to characterise keratocytes, signifying that their 
differentiation was unsuccessful.  
 
3.6.1 hCFs in an in vitro model 
The corneal stroma is composed of aligned collagen fibrils which form lamellae that are 
oriented roughly orthogonally throughout. An ideal model of the stroma would be composed 
of an organised and aligned ECM, a result of cellular alignment which can be influenced by 
substrate nanotopography. There are a range of topographical cues that can be employed in 
tissue engineering, from pillars and pits to aligned grooves and fibres (Bettinger et al., 2009; 
Nikkhah et al., 2012). Topographical cues have been shown to influence the behaviour of 
cells from cell morphology and alignment to cell phenotype and gene expression (Myrna et 
al., 2012; Nguyen et al., 2016). The alignment of corneal stromal cells on an aligned 
microgrooved substrate has been shown to result in the deposition of aligned collagen fibrils, 
a result not always seen with other cell types (Guillemette et al., 2009). The deposited matrix 
has a structure that more closely resembles that found in situ, compared to those cultured 
on randomly oriented substrates (Wu et al., 2012). The structure and organisation of the 
matrix has been shown to affect the transparency of the constructs too, with a more 
organised ECM being more transparent (Guillemette et al., 2009; Phu et al., 2011). In this 
study three materials, glass, PTFE-nf and polycarbonate Transwell membranes, were 
compared to identify which could be used as a substrate for cells to emulate the stroma. 
Analysis of the PTFE coated coverslips created for the study confirmed the presence of 
nanofibres 5 – 30 nm in height whilst SEM of the Transwell membranes revealed the 
presence of parallel grooves, both of which could provide cues to the hCFs, as previously 
described (Gouveia et al., 2013; Dimitrios Karamichos et al., 2014). hCFs cultured on PTFE-nf 
were more aligned (72% within ± 10° of the dominant direction) than both those on Transwell 
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membranes (35%) and those on the glass coverslip control (23%). Furthermore, the 
deposited collagen types I, V and VI were all most aligned on PTFE-nf. The analysis of collagen 
alignment was performed on a single ROI on each biological sample and therefore does not 
consider the variability across each sample. Interestingly, the SEM images of Transwell 
membranes in this study suggests that these grooves were not consistent across the 
membrane, with small areas either absent of grooves or with a random, textured 
topography. This could explain the non-uniform alignment of hCFs cultured on Transwell 
membranes observed in this study. Pore size is also known to influence cell behaviour. The 
0.4 µm pores in the Transwell membrane are approximately less than 0.1% the size of cells 
and the pores should, therefore, prevent transmigration (Chung et al., 2018).  Providing hCFs 
with aligned, linear nanotopography has previously been shown to prevent the 
transdifferentiation of hCFs to myofibroblasts, as characterised by the expression of a-SMA 
(Myrna et al., 2012). In the present study, α-SMA filaments were not observed via ICC and so 
it was concluded that the staining was non-specific. However, to better image the deposited 
collagen, as opposed to intracellular collagen, the cells had not been permeabilised prior to 
ICC analysis. Although there have been reports of successful staining with the anti-α-SMA 
antibody without permeabilisation, there is a small possibility that if the cells were first 
permeabilised the staining would reveal more specific expression of α-SMA.  
 Ascorbic acid is thought to be essential for the deposition of collagen as it is an 
essential cofactor for both prolyl- and lysyl hydroxylases, required for the conversion of 
proline and lysine to hydroxyproline and hydroxylysine respectively (Gelse et al., 2003). In 
the absence of hydroxyproline, the collagen triple helix cannot be formed and hydroxylysine 
is required for the cross-linking of collagen fibrils (Canty and Kadler, 2005; Eyre and Wu, 
2005). Therefore, to stimulate the production of collagen, culture medium was 
supplemented with 1 mM of A2P as previously described (Guo et al., 2007; Ren et al., 2008; 
Gouveia et al., 2013, 2017b; Foster et al., 2015). Mammalian cells are typically exposed to 
concentrations in the range of 10 – 70 µM in vivo (Padayatty and Levine, 2016) yet, for the 
purpose of expanding cells, hCFs were not supplemented with ascorbic acid (Guo et al., 2007; 
Gouveia et al., 2017a). Whilst the absence of ascorbic acid is non-fatal, it is possible that 
these cells were not representative of normal, healthy corneal fibroblasts. 1 mM of ascorbic 
acid was used in this study as it approximates the ascorbic acid concentration in the cornea 
(0.22 mg/g, equivalent to 0.76 mM) (Ringvold et al., 2000). The addition of ascorbic acid 
when hCFs were seeded into the in vitro model may have rescued the cells, returning them 
to a normal phenotype, or irreversible epigenetic alterations may have occurred. A resazurin 
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assay was used to confirm that the supraphysiologic concentration of ascorbic acid did not 
result in any cytotoxic effects, as has been previously reported (Clément et al., 2001; 
Padayatty and Levine, 2016).  
 In the centre of the stroma, collagen lamellae are oriented roughly orthogonally. In 
the present study fibroblast layers formed an angle shift between 30° – 55° on PTFE-nf and 
between 18° – 77° on Transwell membranes, relative to the first layer of cells. The rotation 
of hCFs was observed as the cells stratified and is important not only for recapitulating the 
structure but, it may also provide mechanical support to the construct (Quantock et al., 
2015). This rotation has been reported before in hCFs but was not observed in dermal 
fibroblasts and it is thought to be an intrinsic characteristic of corneal stromal cells, involving 
cell-cell contact guidance (Guillemette et al., 2009; Then et al., 2011). The first layer of cells 
aligns along the topographical cues and it is likely that these cues are somehow propagated 
through the cell and result in multi-layered cell orientation. One possibility is that there is a 
change in the expression of integrins and cadherins in the first layer of cells that results in 
the subsequent alignment of the matrix and the second layer of cells (Le Saux et al., 2020).  
 The degree of collagen alignment within the cornea varies depending on the depth 
(anterior or posterior) and nasal-temporal position. Collagen fibrils in the centre of the 
cornea are oriented roughly orthogonally whilst the shift in angle is reduced at the periphery 
(Aghamohammadzadeh et al., 2004). In this study, hCFs were isolated from the corneoscleral 
rims, after a corneal button had been removed for transplantation. Here, in the peripheral 
cornea, the preferred direction of collagen fibrils has been shown to be circumferential at 
the limbal region. It may, therefore, be possible that stromal cells isolated from this region 
behave differently to those from the centre of the cornea, where collagen fibrils are oriented 
roughly orthogonally. Perhaps, if stromal cells were isolated from the centre of the cornea, 
the shift in angle would have been closer to 90°. Incorporating an aligned biological matrix 
as a positive control would help to confirm the observations made in this study. An aligned 
matrix, such as that found in tendon or the corneal stroma, would allow for comparisons to 
be drawn between the ECM deposited on PTFE-nf and Transwell membranes and that found 
in vivo. Furthermore, the alignment and rotation of hCFs on PTFE-nf could be directly 
compared to these tissues to determine the degree of alignment necessary to recapitulate 
the tissue. For example, if a decellularised corneal stroma were used as a control, it would 
be possible to determine the shift in angle necessary to recapitulate the centre/periphery of 
the cornea. 
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 The results discussed here suggest that PTFE-nf is the superior substrate for the 
growth of a stroma equivalent, with the cells more strongly aligned (73%) than when cultured 
on Transwell membranes (35%). Furthermore, PTFE-nf supported the rotation of cells as they 
stratified, resembling the lamellae of the stroma. 
 
3.6.1.1 Comparison to other corneal stroma models 
The hCF Transwell model was first established by (Guo et al., 2007). It has since been used, 
with minor modifications, for several purposes from modelling a keratoconic cornea to 
investigating the stroma-nerve interaction in a diabetic corneal model (Karamichos et al., 
2012; Priyadarsini et al., 2017b). In previous Transwell-based models, hCFs have been shown 
to stratify and create roughly orthogonal lamellae when supplemented with ascorbic acid 
(Guo et al., 2007). Furthermore, hCFs in the Transwell model have been shown to deposit 
collagen types V and VI, which the data in the present study also supports (Guo et al., 2007; 
Karamichos et al., 2010). The deposition of type III collagen is typically associated with 
corneal fibroblasts cultured in media supplemented with 10% serum (as in the present study) 
and is upregulated when compared to keratocytes cultured in 1% serum (Karamichos et al., 
2013; Dimitrios Karamichos et al., 2014). In the present study, the staining of type III collagen 
appears to be intracellular and is likely to be non-specific staining given that the hCF 
constructs were not permeabilised prior to ICC analysis. The staining is also of a similar level 
to the background staining seen in the IgG controls. This is further supported by a study 
which found little secretion of type III collagen by hCFs, unless stimulated with TGF-β1 
(Karamichos et al., 2010). As mentioned above, α-SMA fibrils were not observed in the 
Transwell model in this study. These data combined suggest that hCFs can be cultured long-
term at a high cell density whilst maintaining their phenotype and not transdifferentiating 
into myofibroblasts.  
 The human corneal stroma is typically between 461.8 – 465.4 µm thick (Reinstein et 
al., 2009). Although not measured in this study, the Transwell model typically ranges 
between 20 – 40 µm in thickness at 4 weeks, just a fraction of the thickness of the human 
corneal stroma (Guo et al., 2007; Karamichos et al., 2010; Dimitrios Karamichos et al., 2014). 
Constructs cultured on Transwell membranes can be peeled and stacked to create a thicker 
construct, more representative of the entire corneal stroma (Priyadarsini et al., 2017a). This 
technique has the potential to be a useful method for generating 3D constructs greater than 
300 µm thick in under 4 weeks. However, when employed in the present study this method 
failed with the cell sheet breaking and contracting, showing it to be a particularly technically 
Chapter 3 Discussion 
160 
 
challenging methodology. Other groups have reported the successful stacking of sheets of 
fibroblasts for the formation of a corneal model (Carrier et al., 2009; Couture et al., 2016). 
However, these models tend to focus on the formation of a construct that macroscopically 
resembles the cornea, with a stratified epithelium and minimal haze, and neglect mimicking 
the alignment of cells and ECM (Proulx et al., 2010). The fibroblast sheets first used in the 
model of Carrier et al. were cultured in flasks prior to stacking, which would suggest that 
both the cells and the deposited collagen are randomly oriented, although the 
microarchitecture was not analysed. The stacking of corneal stromal cells adhered to 
electrospun nanofibres has also been used to model the stroma (Wilson et al., 2012). Here, 
stromal cells were cultured on aligned nanofibres which were subsequently stacked at 90° 
to one another, with a filter paper ring acting as a spacer between the layers and a collagen 
hydrogel cast into the construct. The addition of nanofibres, providing topographical cues, 
improved the alignment of stromal cells. Stromal cells were also found to have a reduced 
expression of fibroblast and myofibroblast markers CD90 and α-SMA when cultured in this 
construct compared to those cultured on tissue culture plastic. However, collagen hydrogels 
typically have larger collagen fibrils and thus the microarchitecture of the corneal stroma 
would not be captured making it an unsuitable model (Saeidi et al., 2012a). 
 PTFE-nf have previously been used as substrate for corneal stromal cells but with the 
addition of a peptide amphiphile coating (Gouveia et al., 2013). Interestingly, despite the 
authors finding that the addition of a peptide amphiphile coating covered the PTFE-nf, 
creating an irregular topography, they found that cells successfully aligned. The present 
study not only confirmed the deposition of aligned collagen types I and V, as reported by 
Gouveia et al., but revealed that PTFE-nf can support a shift in the alignment of collagen 
fibres (Gouveia et al., 2017a). Gouveia et al. also showed that the sheets of aligned stromal 
cells could support the attachment of epithelial cells (Gouveia et al., 2017a). Whist not 
investigated in the present study, these previous findings suggest that hCFs cultured on PTFE-
nf would support the growth of epithelial cells if the corneal model were to be developed 
further. The shift in alignment of collagen fibrils as hCFs stratify on PTFE-nf has not previously 
been reported and this model better resembles the corneal stroma. 
 Other attempts at creating a construct that can recapitulate the corneal stroma have 
focused on the use of hCSSCs. In the present study, isolation of hCSSCs was unsuccessful 
(Chapter 1) but others have reported that stimulating CSSCs cultured on aligned electrospun 
poly(ester urethane) urea with TGF-β3 results in the secretion of collagen with orthogonal 
orientation (Wu et al., 2013). Simultaneously differentiating hCSSCs in KDM supplemented 
Chapter 3 Discussion 
161 
 
with FGF-2 and TGF-β3 resulted in a construct approximately 70 µm thick, approximately 
15% of the thickness of the human stroma (Wu et al., 2013). Wu et al. directly compared 
hCSSCs and hCFs and their ability to create a structure that mimicked the corneal stroma 
(Wu et al., 2014a). The authors showed the successful differentiation of hCSSCs to 
keratocytes and used ICC and histology to show that hCSSCs secreted more ECM and created 
thicker constructs. Second harmonic generation microscopy and TEM revealed the 
orthogonal orientation of collagen deposited by hCSSCs (Wu et al., 2014a). This could suggest 
that perhaps the in vitro culture conditions of hCFs are not optimal for an in vitro model and 
that differentiating progenitor cells into keratocytes would be preferable.  
 
3.6.2 Live cell imaging of collagen deposition  
To date, the most common method of analysing collagen fibrillogenesis is through the use of 
fixed models. This often involves the fixation of cells (or tissue) and using electron 
microscopy, particularly transmission electron microscopy (TEM), to study collagen fibril 
secretion and formation (Kadler et al., 1996). This, however, means that much of what is 
currently known about the secretion and deposition of collagen is based on static images 
which may only show part of the process. In order to look at fibrillogenesis dynamically Krahn 
et al. created a probe using a collagen binding domain (CNA) isolated from Staphylococcus 
aureus which binds to fibrillar collagens (Krahn et al., 2006). This probe, CNA35, has been 
used to observe the initial secretion of collagen up to 52 h (Boerboom et al., 2007). Here, the 
culture time was extended to 64 h and hCFs were cultured on PTFE-nf to induce the 
alignment of cells and collagen. Over time, the deposition of collagen continued to increase 
and was somewhat aligned in the direction of the nanofibres. The percentage of aligned 
collagen fibrils did not greatly increase over the 64 hours but this, combined with the ICC 
analysis of hCF alignment suggests that as the cells proliferate it remodels and aligns the 
deposited collagen. The use of CNA35 in the corneal stroma model can provide further 
insight in to the mechanisms behind collagen fibrillogenesis. This method is a much simpler 
technique than other reported methods for the live cell imaging of collagen fibrillogenesis, 
such as the tagging of type I collagen using GFP-tagging or tagging with a photoswitchable 
protein Dendra2; though, the photoswitchable nature of Dendra2 does enable the 
differentiation of old and new fibrils (Pickard et al., 2018). Although not investigated in this 
study, the stroma model could also be used to investigate cell stratification and to reveal at 
what point the shift in cell orientation occurs.  
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3.6.3 hMSCs in an in vitro model 
The potential of stem/progenitor cells to differentiate into keratocytes has been explored 
for both tissue engineering (Du et al., 2010; Wu et al., 2013) and wound healing purposes 
(Du et al., 2009). Along with CSSCs (Syed-Picard et al., 2016), adipose-derived MSCs (Du et 
al., 2010), bone marrow-derived MSCs (Dos Santos et al., 2019), umbilical cord stem cells 
(Dos Santos et al., 2019) and dental pulp stem cells (Syed-Picard et al., 2015) have all shown 
some potential to differentiate into keratocytes after culture in KDM.  
 Bone marrow-derived MSCs have previously been used in corneal stroma research 
and have shown the potential to differentiate into keratocytes both in vitro and in vivo, hence 
their use in the present study (Liu et al., 2012; Park et al., 2012; Dos Santos et al., 2019). 
Bone marrow-derived MSCs have been intrastromally transplanted into keratocan-null 
mouse corneas where they differentiated into keratocytes, expressing keratocan with a 
dendritic cell body (Liu et al., 2012). In vitro studies have included the culturing of MSCs in 
keratocyte-conditioned culture media which resulted in an increased expression of lumican 
and ALDH1A1 (Park et al., 2012). Recently, bone marrow-derived MSCs differentiated in 
KDM, media supplemented with TGF-β3 and FGF-2, showed an increase in the gene 
expression of CHST6 (involved in keratan sulphate biosynthesis) compared to 
undifferentiated cells (Dos Santos et al., 2019). The growth factors FGF-2 and TGF- β3 have 
both been used to differentiate corneal stromal stem and stem-like cells into keratocytes 
(Wu et al., 2013; Sidney and Hopkinson, 2018). FGF-2 reportedly stimulates cells to secrete 
aligned collagen fibrils in a single direction and TGF-β3 induces stratification and orthogonal 
rotation of cells (Wu et al., 2013; Sidney and Hopkinson, 2018). However, it is important to 
remember that bone marrow-derived MSCs are progenitors of skeletal tissue such as bone, 
cartilage and adipocytes and they may be susceptible to differentiating down one of those 
three lineages (Bianco et al., 2001). FGF-2 can, in fact, enhance the osteogenic differentiation 
potential of bone marrow-derived MSCs, which may explain the pellet formation observed 
in this chapter (Zellin and Linde, 2000; Luong et al., 2012). 
 Previously, progenitor cells have been pelleted or cultured in a fibrin gel prior to 
keratocyte differentiation (Du et al., 2010; Syed-Picard et al., 2015; Yam et al., 2018). The 
differentiation of MSCs to keratocytes was successful in a 3D system but alignment was not 
assessed (nor evident) in these models. In order to mimic the highly organised structure of 
the corneal stroma the cells require topographical cues to induce alignment. Therefore, the 
present study investigated culturing hMSCs on PTFE-nf and polycarbonate Transwell 
membranes to induce the deposition of an aligned and organised matrix. hMSCs were 
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observed to form spheres when cultured in KDM on both PTFE-nf and Transwell membranes, 
although pellets were also formed in SCM on Transwell membranes. The formation of 
spheres on a substrate prepared with topographical cues is unusual, with previous studies 
reporting the successful differentiation of stem cells and the creation of a cell sheet, 
representative of a lamella within the stroma (Karamichos et al., 2011; Syed-Picard et al., 
2015). Bovine keratocytes can form spheres under adherent conditions unlike human 
keratocytes where spheres only tend to form in low attachment conditions (Scott et al., 
2011). Moreover, the phenotype of bovine keratocytes can be enhanced when cultured as a 
sphere, as assessed by the expression of keratan sulphate (Funderburgh et al., 2008). Whilst 
these results may suggest that the formation of a sphere is indicative of a keratocyte 
phenotype in vitro, both protein and gene expression analysis suggest differentiation was 
unsuccessful. An alternative explanation is that as the cells in KDM proliferated they 
contracted, resulting in detachment from the substrate. As there was no significant 
difference between the number of cells cultured in SCM compared to those in KDM, the 
detachment of cells may not be solely influenced by cell proliferation. It is worth noting, 
however, that cell pellets may have been lost during media changes resulting in a reportedly 
lower cell number. The addition of a Rho-associated coiled-coil kinase (ROCK) protein 
inhibitor to the culture of bone marrow-derived MSCs has been shown to inhibit the 
detachment of cell sheets in vitro (Nakamura et al., 2014). Furthermore, ROCK-inhibitors 
have been shown to decrease the number of focal adhesions formed (Nakamura et al., 2014). 
It could be possible that the culturing of hMSCs in KDM increased the number of focal 
adhesions. This would increase the contractile force, resulting in the detachment of the cell 
sheet and the formation of cell spheres. Although not investigated in the present study, the 
number of focal adhesions may have been greater in KDM cultures. The main hypothesis 
here is a combination of the above-mentioned suggestions. The hMSCs attached to the 
substrate, forming focal adhesions whilst continuing to proliferate. As the cells increased in 
number, a large concentration of sticky matrix molecules such as glycoproteins and GAGs 
were secreted. At the same time, contractile forces (arising from α-SMA) were exerted by 
the cell and resulted in the detachment of the cell sheet from the substrate below. Once the 
cell sheet had detached, the cells bound to the matrix molecules and formed pellets. The 
addition of a ROCK-inhibitor (Y-27632) has been shown to reduce the TGF-β1-induced 
expression of α-SMA in corneal keratocytes, suggesting supplementing the medium with Y-
27632 could also prevent the differentiation of cells to a myofibroblast phenotype (J. Chen 
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et al., 2009). ROCK inhibitors may prevent pellet formation and alter the phenotype of the 
differentiated hMSCs from myofibroblasts to a more keratocyte-like phenotype. 
 Keratocytes are typically characterised based on their dendritic morphology and the 
expression of genes, including keratocan (KERA), lumican (LUM), aldehyde dehydrogenase 
3A1 (ALDH3A1), carbohydrate sulfotransferase (CHST6) and prostaglandin D2 synthase 
(PTGDS) (Wu et al., 2013). The protein expression of keratan sulphate and collagen types I, 
V and VI are also used to characterise keratocytes (Carlson et al., 2005; Pei et al., 2006; Wu 
et al., 2012). The positive expression of the above-mentioned proteins and proteoglycans 
along with negligible expression of α-SMA and type III collagen would suggest that the hMSCs 
had been successfully differentiated in the present study. Unfortunately, both ICC analysis 
and RT-qPCR revealed that keratocan was not expressed by hMSCs in KDM. Similarly, 
ALDH1A1 and ALDH3A1 were not expressed, as determined by RT-qPCR. Lumican was 
expressed by cells in both KDM and SCM, but this may be explained by bone marrow-derived 
MSCs also expressing lumican (Friedl et al., 2007). The lack of evidence for hMSCs 
differentiating into keratocytes in the present study may be due to several factors. One such 
explanation may be that as the hMSCs were not used at very low passages (P4) they may 
have undergone phenotypic drift and started to differentiate down another lineage. Lumican 
is also associated with chondrocytes and chondrogenic differentiation (Friedl et al., 2007). 
Furthermore, collagen types III and VI contribute to the matrix within cartilage, with ICC 
analysis suggesting both of these proteins are expressed in the control (SCM) cultures on 
Transwell membranes (Eyre, 2001). It is possible that hMSCs differentiated into another cell 
type, such as chondrocytes. What is unclear is whether this occurred prior to the start of the 
experiment, or if the long culture period of confluent cells in SCM resulted in the 
differentiation of MSCs. The characterisation studies in Chapter 2 (2.5.3.3) showed that at a 
later passage (P3 – 4) the cells were far outside the criteria set out by the ISCT, but they still 
displayed trilineage differentiation potential. If the hMSCs had started to differentiate, it 
could explain why the treatment with KDM was unsuccessful and why lumican was 
expressed, as this is expressed by chondrocytes. Interestingly, when cultured on the 
Transwell membrane, type III collagen and α-SMA were expressed by hMSCs in both KDM 
and SCM, indicative of myofibroblast formation (Funderburgh et al., 2003). It has been 
shown that bone marrow derived-MSCs applied to a corneal wound model differentiate into 
myofibroblasts, characterised by the expression of α-SMA (Ye et al., 2006). Given the positive 
expression of α-SMA and type III collagen observed, it could be suggested that the 
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environment within the Transwell cultures mimicked that of a wound environment resulting 
in myofibroblast differentiation of hMSCs, but not hCFs.  
 
3.6.3.1 The role of stiffness on keratocyte phenotype 
Substrate stiffness is another material property that, along with topographical cues, can 
regulate cell phenotype (Chen et al., 2020). Corneal stromal cells cultured on stiff substrates, 
such as tissue culture plastic (> 106 kPa), have a decreased expression of ALDH3A1, ALDH1A1, 
CD34 and lumican when compared to a substrate with a stiffness similar to the corneal 
stroma (25 kPa) (Chen et al., 2020). Moreover, an increase in α-SMA expression is seen when 
corneal fibroblasts are cultured on tissue culture plastic compared to those on more 
compliant substrates (Dreier et al., 2013b). With the PTFE-nf used in this study being coated 
on a glass coverslip, the stiffness of the substrate is much greater than the physiological 
stiffness of the human corneal stroma. It is, therefore, possible that the stiffness of the glass 
substrate may have hindered the ability of the MSCs to differentiate into keratocytes. 
Furthermore, the stiffness of the substrate may contribute to the formation of cell spheres 
as opposed to the creation of a cell sheet. Cells form larger, more stable focal adhesions on 
stiffer matrices resulting in an increase in contractile forces exerted by the cell onto the 
surrounding matrix (Wells, 2008). These forces can ultimately lead to the detachment of the 
cell sheet and a reorganisation of the deposited matrix, resulting in the formation of a sphere 
(Fukamizu and Grinnell, 1990; Nakamura et al., 2014). This also applies to the Transwell 
membranes and the same explanation can be used for the inability to differentiate hMSCs 
on the Transwell membranes. Whilst the stiffness of the polycarbonate Transwell membrane 
was not measured in this study, polycarbonate has been reported to have a similar stiffness 
to glass ( > 106 kPa) (Jee and Lee, 2010; Lauridsen and Gonzalez, 2017). This effect may have 
been enhanced by the initial high cell number used in this experiment; more cells exert 
contractile forces on the deposited ECM resulting in the detachment of the cell sheet.  
 
3.7 Conclusions 
In this study, hCFs and hMSCs were cultured on two substrates (PTFE-nf and polycarbonate 
Transwell membranes), and assessed for their use in an in vitro model of the corneal stroma. 
hCFs aligned parallel to PTFE-nf, depositing an organised matrix which resembled the corneal 
stroma. Furthermore, a shift in the orientation of hCFs was observed as the cells stratified, 
further mimicking the ECM of the corneal stroma. Although there was evidence of some cell 
alignment on the Transwell membranes, this was not uniform across the sample, as shown 
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by the broad distribution of angles. hMSCs could not be successfully differentiated into 
keratocytes, perhaps because cells were not used at very low passages in this study. The 
formation of cell pellets on all three substrates when cultured in KDM is likely a result of the 
unsuccessful differentiation but a less stiff substrate may support the growth of 
differentiated cells. 
 The data presented in this chapter suggest that hCFs cultured on PTFE-nf is the most 
suitable combination for bioengineering the corneal stroma. The cells and the collagens 
deposited were highly aligned, mimicking the lamellae of the corneal stroma.  
 
3.8 Limitations and future work 
The limitations of this study include the use of hMSCs beyond P1 when attempting 
keratocyte differentiation. The expansion of hMSCs was necessary due to the high cell 
number required for seeding cells on to both substrates. To further understand why the 
differentiation was unsuccessful it could be attempted with hMSCs from an earlier passage, 
where they have retained their MSC phenotype. As discussed, culture media could be 
supplemented with a ROCK-inhibitor to decrease the number of focal adhesions formed and 
preventing the detachment of cell sheets (Nakamura et al., 2014). Furthermore, a ROCK-
inhibitor could prevent the differentiation of cells to a myofibroblast phenotype (J. Chen et 
al., 2009). The combination of a ROCK-inhibitor and early-passage hMSCs could be key to the 
successful use of bone marrow-derived MSCs in an in vitro model of the stroma. 
 A second limitation is the use of fibroblasts over keratocytes within the model. It is 
well known that keratocytes outperform hCFs with their ability to secrete ECM that 
resembles that found in the stroma. Whilst the use of keratocytes would have been 
preferable, cultured keratocytes are prone to phenotypic drift and becoming fibroblastic. 
Additionally, all attempts at isolating stem cells and inducting keratocyte differentiation were 
unsuccessful in this study. A study has shown that isolated stromal cells can be propagated 
in media supplemented with ROCK inhibitor Y27632, insulin-like growth factor-1, amnion 
stromal extract and low serum concentrations (Yam et al., 2015). Once the cells were 
expanded, the deprival of serum resulted in the stromal cells regaining markers associated 
with keratocytes. Similarly, switching stromal cells to low-glucose, serum-free media after 
expansion can result in the rescuing of the keratocyte phenotype (Foster et al., 2015). Future 
developments of the model would involve comparing both of these conditions to hCFs to 
evaluate their performance in recapitulating the stroma. 
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 Future work for improving the hCF in vitro model would focus on methods to 
increase the rate of ECM deposition, either by supplementing media with a growth factor 
such as TGF-β or by incorporating macromolecules to accelerate matrix deposition, 
investigated in Chapter 4. To further investigate the deposited ECM, the construct could be 
denuded of cells using ammonia hydroxide. This would allow for the analysis of extracellular 
proteins without the risk of interference from cellular proteins and cellular autofluorescence. 
Live cell imaging of the hCF model revealed the beginning of collagen deposition over 64 h, 
becoming visible after approximately 8 h. A longer culture period would enable the 
observation of hCF stratification in combination with their shift in orientation. The 
fluorescent labelling of proteins associated with focal adhesions, such as paxillin, may also 
allow the visualisation of cell alignment via contact guidance, enabling the study of the 
interaction between substrate, matrix and the cell. The stable transfection of red fluorescent 
protein tagged-paxillin comes with the caveat that several passages would be required. 
Therefore, both the 30-day culture and the live cell imaging using just CNA35 should first be 
performed using hCFs at a greater passage, such as P10, to determine that the observations 
of cell alignment and collagen expression are unchanged. Alternatively, collagen could be 
labelled with CNA35 followed by a medium change and live cell imaging. This may allow for 
collagen fibril remodelling to be observed and could contribute to the understanding of 
collagen fibrillogenesis.  
 
 
Chapter 4. Macromolecular crowding 




Bottom-up engineering approaches can take a long period of time to create a construct that 
resembles the native tissue (Griffith and Harkin, 2014). To reduce the necessary culture 
period, macromolecular crowding (MMC) of cell culture media has been employed to 
accelerate the in vitro deposition of ECM components such as collagen (Lareu et al., 2007b; 
Kumar et al., 2015a). This chapter focuses on the use of mono-MMC with carrageenan 
(Kumar et al., 2015b, 2018), a mucopolysaccharide derived from red algae, and mixed-MMC 
with two different molecular weights of Ficoll (Kumar et al., 2015a), a neutral polysaccharide. 
Both PTFE-nf and Transwell membranes were used as substrates in this chapter. Transwell 
membranes were included due to previous characterisation of fibril deposition and 
organisation, analysed using transmission electron microscopy (TEM) (Guo et al., 2007). It is 
possible that the collagen deposited on PTFE-nf is not assembled in the same way and so 
both substrates were evaluated. 
 
4.2 Aims and Objectives 
The aim of this chapter was to use macromolecular crowding to accelerate the deposition 
of collagen in the in vitro corneal stroma model. 
The objectives of this chapter were: 
1. To use dynamic light scattering to quantify the fractional volume occupancy; 
2. To analyse the collagen deposited by hCFs on PTFE-nf and Transwell membranes via 
ICC and TEM; 










Sigma/Merck (Germany): Carrageenan (C1013); Ficoll PM 70 (F2878); Ficoll PM 400 (F4375) 
TAAB (England): Medium premix resin kit (T028); Formvar solution in chloroform (0.25%; 
F145/035); Gilder grid G200HEX CU-100 (GG017/C); Reynolds lead citrate (L037); Sodium 
cacodylate (S008) 
Agar Scientific (England): Glutaraldehyde 25% EM grade 10 (AGR1020); Osmium tetroxide 
4% solution (AGR1024); Uranyl acetate (AGR1260A) 
Malvern Panalytical (England): 12 mm polystyrene cuvette (DTS0012); Polycarbonate folded 
capillary zeta cell disposable cuvette (DTS1070) 
Diatome (USA): Diamond knife 
  




4.4.1 Dynamic light scattering  
Carrageenan, at a concentration of 75 µg/ml, and a Ficoll cocktail (37.5 mg/ml Ficoll PM 70 
and 25 mg/ml Ficoll PM 400) were dispersed in PBS at room temperature (Kumar et al., 
2015a, 2015b). The solution was then transferred to a polystyrene cuvette and dynamic light 
scattering (DLS) measurements were read at 20°C and 37°C using Zetasizer Nano ZS90 to 
obtain the average hydrodynamic diameter (Z-Ave.). Alternatively, the solution was 
transferred to a polycarbonate folded capillary cuvette and the zeta potential measured at 
37°C. Results were analysed using the Zetasizer software v 7.13 (Malvern). 
Fractional volume occupancy (FVO) was calculated using (Eq. 4.4.1.1) to (Eq. 4.4.1.3), 
as described by (Chen et al., 2011): 
 
 𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑟𝑜𝑤𝑑𝑒𝑟 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒 =
4
3
𝜋𝑟3 (Eq. 4.4.1.1) 
Where r = hydrodynamic radius; 
 
 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠 𝑖𝑛 𝑋 𝑚𝑔 =
(𝑋 × 10−3) × (6.022 × 1023)
𝑀𝑊
 (Eq. 4.4.1.2) 
Where X = mass of crowder added per ml; 6.022 x 1023 is the Avogadro number and MW = 
molecular weight of crowder. The MW of CAR was assumed to be was 550 kDa (Uno et al., 
2001). 
 
 𝐹𝑉𝑂 (%) =  
𝑉𝑜𝑙𝑢𝑚𝑒 𝑜𝑓 𝑐𝑟𝑜𝑤𝑑𝑒𝑟 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑚𝑜𝑙𝑒𝑐𝑢𝑙𝑒𝑠 𝑖𝑛 𝑋 𝑚𝑔
× 100 (Eq. 4.4.1.3) 
 
4.4.2 Macromolecular crowding of hCFs 
hCFs at P4 – 6 were seeded onto PTFE-nf and glass coverslips at a seeding density of 5 x 103 
cells/cm2 or onto a 6-well polycarbonate Transwell membrane at a density of 1.06 x 105 
cells/cm2 and allowed to attach for 2.5 h before being topped up with hCF growth medium 
and incubated overnight. Carrageenan, Ficoll PM 70 and Ficoll PM 400 were sterilised under 
UV light in a class II biosafety cabinet for 1 h (NuAire). Following a 24 h incubation period in 
growth medium, cells were switched to either A2PM (Table 4.1) supplemented with 75 µg/ml 
carrageenan (CAR) (Satyam et al., 2014) or A2PM with a Ficoll cocktail consisting of 37.5 
mg/ml Ficoll PM 70 and 25 mg/ml Ficoll PM 400 (FC) (Kumar et al., 2015a). hCFs cultured in 
A2PM alone were used as a control. Media were replaced every 2 – 3 days and cells were 
cultured for up to 30 days. 
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Table 4.1 Media and supplements used for MMC of hCFs. 
Crowder Basal media Supplements 
None (A2PM) DMEM high glucose 
GlutaMAX 
10% FBS, 100 U/ml penicillin, 100 μg/ml 




DMEM high glucose 
GlutaMAX 
10% FBS, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 2.5 µg/ml amphotericin B, 1 mM A2P 
and 75 µg/ml carrageenan 
Ficoll cocktail 
(FC) 
DMEM high glucose 
GlutaMAX 
10% FBS, 100 U/ml penicillin, 100 μg/ml 
streptomycin, 2.5 µg/ml amphotericin B, 1 mM A2P, 
37.5 mg/ml Ficoll PM 70 and 25 mg/ml Ficoll PM 
400. 
 
4.4.3 Immunocytochemistry  
hCFs were fixed in 10% NBF for 10 – 15 min at room temp. Samples were subjected 
to an immunocytochemistry staining procedure as described in Chapter 2 (2.4.4), however 
cells were not permeabilised. Primary antibodies used were: anti-collagen I, anti-collagen III, 
anti-collagen V, anti-α-SMA (Table 2.2) and anti-collagen VI (Table 3.1). Where co-staining 
with CNA35 was performed, 0.5 µM CNA35 was added in conjunction with the primary 
antibody. Alternatively, CTR and CNA35 were added to live cells prior to fixation as previously 
described (Chapter 3, 3.4.3.4). Images were processed as described in Chapter 3 (3.4.3.5). 
OrientationJ was performed on 1 representative ROI to quantify the alignment of collagens 
and CNA35 on slices corresponding to the substrate. The percent of collagen alignment at ± 
10° is reported in the text. 
 
4.4.4 Transmission electron microscopy 
Cells were seeded onto PTFE-nf or into polycarbonate Transwell membranes as described in 
Chapter 3, 3.4.3. Cells were subsequently cultured in A2PM, CAR or FC for 30 days. The 
Biomedical Electron Microscopy unit (University of Liverpool) then fixed the samples in 2.5% 
(w/v) glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4) in a Pelco Biowave®Pro (Ted Pella 
Inc., USA) at 100 W, 20” Hg for 3 min followed by 30 min at room temperature. Samples were 
post-fixed with 2% (w/v) osmium tetroxide in double distilled H2O followed by 2% (w/v) 
aqueous uranyl acetate overnight at 4°C. To prevent precipitation artefacts, cells were 
washed with double distilled H2O between each staining step. Samples were dehydrated in 
a graded ethanol series (30, 50, 70 and 90% followed by 2 x 100% each for 5 min) before 
filtration (2 x 30 min 1:1 ethanol:resin) and embedding in a medium premix resin.  
For transmission electron microscopy, 70 – 74 nm sections were taken perpendicular 
to the substrate surface (parallel to the nanofibres on PTFE-nf as shown in Figure 4.1), using 
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a U6 ultra microtome (Leica Microsystems, Germany) and a diamond knife and collected on 
Formvar (0.25% (w/v) in chloroform) coated 200 mesh copper grids. Grids were post-stained 
with 4% aqueous uranyl acetate followed by 2.66% lead nitrate in Reynolds’ lead citrate 
before images were acquired on a 120 kV Tecnai G2 Spirit BioTWIN (FEI, USA) using a RIO16 
camera (Gatan, USA) and GMS3 software.  
 
 
Figure 4.1 Diagrammatic representation of the sectioning plane used to section samples 
cultured on PTFE-nf. Sections were taken perpendicular to the substrate surface and 
approximately parallel to the PTFE-nf. 
  
4.4.5 Cell growth and metabolic activity 
To determine the metabolic activity of the hCFs during culture in crowded media, cells were 
seeded in to a 48-well plate at a density of 5 x 103 cells/cm2. Following overnight incubation 
in growth medium, media were switched to either A2PM, CAR or FC with media changed 
every 2 – 3 days. A resazurin assay was used as described in Chapter 3 (3.4.3.3). Following 
the resazurin assay, the cell number was also determined. The quantification of DNA per well 
using a PicoGreen assay was used to calculate the cell number as described in Chapter 3 
(3.4.3.3). This experiment was performed on one occasion with growth, A2PM and FC media 
with the same data reported in both Chapter 2 and Chapter 3. 
 
4.4.6 Transparency 
hCFs cultured in crowded conditions on glass or PTFE-nf for 28 days were gently rinsed thrice 
with PBS. Samples were kept submerged in PBS (1 ml) and the absorbance was measured at 
wavelengths between 350 – 650 nm using a SPECTROstar Nano microplate reader (BMG, 
Germany). Three technical repeats were performed and averaged and the results were 
normalised to the absorbance of a plain glass coverslip. Percentage transmission was 
calculated using (Eq. 4.4.6.1): 
 
 % 𝑇𝑟𝑎𝑛𝑠𝑚𝑖𝑠𝑠𝑖𝑜𝑛 = 10(2−𝐴) (Eq. 4.4.6.1) 
Where A = absorbance measured.  
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4.4.7 Statistical analysis 
All statistical analyses were performed using SigmaPlot software (v 14.0) and GraphPad 
Prism 9 software (v 9.0.0). A significance level of p < 0.05 was set for all experiments. Data 
were reported as mean ± 1 standard deviation (SD). To ensure all data were normally 
distributed, a Shapiro-Wilk test was performed. Where there were three or more groups with 
one factor a one-way ANOVA with Tukey’s post hoc test for multiple comparisons was used, 
otherwise where there were just two variables a t-test was performed. A Brown-Forsythe 
test was used to ensure equal variance. For comparing three or more groups with two 
factors, a two-way ANOVA was performed and a Spearman’s test for heteroscedasticity was 
used to ensure equal variances. If the residuals after fitting the model were not normally 
distributed and data could not be suitably transformed, either a one-way ANOVA (where 
data were normally distributed) or a Kruskal-Wallis one-way ANOVA was performed. 
Multiplicity adjusted p values are reported.  
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4.5 Results  
4.5.1 CAR and FC are polydisperse polysaccharides  
DLS was used to assess the size distribution of CAR and FC particles suspended in PBS at 20°C 
(Figure 4.2). The cumulants mean hydrodynamic diameter (Z-average) of carrageenan and 
carrageenan passed through a 0.75 µm filter (CAR filt.) were significantly different (p < 
0.0001), confirming the presence of large particles or aggregates when unfiltered (Figure 4.2 
A). This was further supported by the significant decrease in the polydispersity index after 
filtration, which formed a more monodisperse solution (Figure 4.2 C). The Z-average of FC 
was significantly smaller than both carrageenan solutions (p < 0.0001). However, as FC is a 
cocktail formed using two molecules with different molecular weights, distribution analysis 
was also reported which revealed particles with significantly different hydrodynamic 
diameters (10.13 nm and 65.95 nm respectively; p = 0.0001; Figure 4.2 B). The cocktail of 
two differently sized polysaccharides created a solution with a polydispersity index similar to 
carrageenan (Figure 4.2 C).  
 The hydrodynamic diameter of both carrageenan and the Ficoll cocktail were also 
measured at 37°C, to replicate cell culture conditions. Both macromolecules appeared to 
form aggregates, which ultimately resulted in a measurement error due to the increase in 
polydispersity. Although the sample became too polydisperse to obtain reliable readings, 
initial results showed an increase in the Z-average of carrageenan to 1423 ± 677 nm and the 
polydispersity index increased to 0.861 ± 0.140 (n = 2) (Table 4.2). Similarly, the Z-average of 
the Ficoll cocktail increased to 365.23 ± 242.91 whilst the polydispersity index increased to 
0.586 ± 0.164. The zeta potential, measured at 37°C, confirmed that CAR was negatively 
charged (-8.94 ± 1.30 mV), whereas the Ficoll cocktail could be considered neutral (-2.68 ± 
0.38 mV) (Table 4.2).  
The measured hydrodynamic diameter at 20°C (Table 4.2) was used to approximate 
the fractional volume occupied (FVO) by the crowder. Unfiltered CAR was calculated as 
occupying 41.34% of the total volume of medium. Owing to the fact that a Ficoll cocktail was 











Figure 4.2 DLS measurements of CAR and FC at 20°C. A: The cumulants mean hydrodynamic 
diameter (Z-average) of carrageenan (CAR), CAR passed through a 0.75 µm filter (CAR filt.) 
and FC. B: FC is composed of two polymers with different molecular weights and 
hydrodynamic diameters, shown by the dark and light orange. C: The polydispersity index of 
CAR, CAR filt. and FC is shown. n = 3 and error bars show SD. Where there are three variables 
a one-way ANOVA was performed with Tukey’s post hoc test for multiple comparisons, 
otherwise a t-test was performed: a = < 0.0001; b = 0.0001; c = 0.008; d = 0.0008.  
 
Table 4.2 DLS measurements of CAR and FC at 20°C and 37°C. 
Sample Z-average (d.nm) Polydispersity Index Zeta Potential (mV) 
CAR (20°C) 212.6 ± 6.0† 0.390 ± 0.020† - 
CAR (37°C) 1423 ± 677*¶ 0.861 ± 0.140*¶ - 8.94 ± 1.30† 
FC (20°C) 16.23 ± 0.19† 0.465 ± 0.002† - 
FC (37°C) 365.23 ± 242.91§¶ 0.586 ± 0.164§¶ -2.68 ± 0.38‡ 
Results presented as mean ± SD. *n = 2; †n = 3; ‡n = 4; §n = 9; ¶sample too polydisperse for accurate 
cumulant analysis but data reported for comparison. 
 
4.5.2 ICC analysis suggests collagen aggregates when cells are crowded with a 
negatively charged crowder 
ICC analysis was used to visualise the collagen deposited after culture in non-crowded 
(control) and crowded conditions on glass, PTFE-nf and on Transwell membranes. From as 
early as day 2, an apparent increase in the deposition of Col I was observed when crowded 
with CAR (Figure 4.3). The collagen deposited in crowded conditions appeared to align with 
the hCFs after both 2 and 7 days, and CAR did not seem to affect cell alignment along PTFE-
nf. The IgG negative control did not show any fluorescence suggesting that the secondary 
antibody is not non-specifically binding to residual carrageenan. To determine whether the 
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appearing as if there is an increase in collagen deposition, the collagen probe (CNA35) was 
used to visualise collagens (Figure 4.4). Medium that was not supplemented with A2P was 
also used as a control, as ascorbic acid is thought to be essential for the synthesis of collagen 
(Pinnell, 1985; Canty and Kadler, 2005). hCFs cultured for 7 days in uncrowded medium 
without A2P showed minimal collagen deposition. Conversely, cells cultured in crowded 
conditions, in the absence of A2P, appeared to deposit collagen. When supplemented with 
A2P cells in both normal and crowded conditions deposited collagen. Interestingly, under 
crowded conditions, the collagen appears to align to what could be carrageenan aggregates 
in media both with and without A2P supplementation with large structures present. CNA35 
was added to CAR medium in a cell-free system to determine if carrageenan was non-
specifically labelled by CNA35 (Figure 4.5). The lack of staining suggests that CNA35 does not 
bind to carrageenan. The areas of intense fluorescence are likely to be dust or serum 
aggregates.  
 




Figure 4.3 ICC analysis of deposited type I collagen by hCFs cultured on PTFE-nf in uncrowded and crowded (CAR) conditions. The deposition of type I 
collagen (magenta) in uncrowded (A2PM) and carrageenan-crowded (CAR) conditions at days 2 and 7 is shown. Cells were co-stained with phalloidin (F-actin; 
yellow) and DAPI (blue). n = 1 biological replicate. Scale bars represent 100 µm. 
 





Figure 4.4 Max. z-projection from ICC analysis of deposited collagen by hCFs cultured on PTFE-nf in uncrowded and crowded (carrageenan) conditions. The 
deposition of collagens (CNA35; green) in uncrowded and crowded conditions are shown. The hCFs (CTR; magenta) were cultured both with and without 
ascorbic acid supplementation to stimulate collagen deposition. Cells were co-stained with DAPI (blue). White arrows on merged images represents direction 
of PTFE-nf. n = 1 biological replicate. Scale bars represent 100 µm.




Figure 4.5 Orthogonal max. z-projections of cell-free CAR medium with CNA35. CNA35 
(green) did not appear to bind to carrageenan in CAR medium where cells were not present. 
The small areas of intense fluorescence are likely autofluorescence from dust particles on 
top of the medium. Scale bar represents 100 µm.  
 
The deposition of collagens type I, III, V and VI were also analysed after 30 days of 
culture. As reported in Chapter 3, the staining for type I collagen was diffuse and showed 
little organisation when cultured on glass in A2PM (30%, n = 3) (Figure 4.6). The deposition 
of collagens appeared to increase with MMC. Interestingly, when crowded with Ficoll type I 
collagen resembled that deposited under normal (uncrowded) (46%; n = 2) whereas cultures 
in CAR appeared to form collagen aggregates with little alignment (32%; n = 3). This 
phenotype was also observed with CNA35 labelling, with only 18% (n = 2) of labelled 
collagens aligning within ± 10°, less than that of cultures in A2PM (37%; n =3) and FC (47%; n 
= 3). When cultured on PTFE-nf, hCFs in A2PM aligned parallel to the nanofibres, following 
topographical cues and depositing aligned type I collagen (59%; n = 3) (Figure 4.7). Again, 
there was an apparent increase in type I collagen deposited in FC (50% alignment; n = 2) 
whilst aggregates disrupted collagen alignment in CAR cultures (34%; n = 3). Aggregated 
collagen was also observed on the Transwell membrane using CNA35 labelling in the CAR 
culture (24%; n = 3), but staining was diffuse in control conditions (18%; n = 3) (Figure 4.8). 
The deposition of type III collagen was only enhanced when hCFs were cultured in 
CAR – this also appeared to be in an aggregated form and typical fibrils were not observed 
(Figure 4.9 & Figure 4.10). However, this may be non-specific binding of the antibody to 
residual carrageenan. The staining observed on samples cultured on Transwell membranes 
isn’t as defined as those on glass or on PTFE and this is likely due to the higher cell number, 
and thus increase in deposited collagen (Figure 4.11). Type V collagen also appeared to be 
aggregated when cultured in CAR and this was most evident on PTFE-nf, disrupting alignment 
(44%; n = 3) (Figure 4.10). There was an apparent increase of type V collagen cultured on 
PTFE-nf in medium crowded with the Ficoll cocktail although alignment was reduced (58%; 
n = 3) when compared to A2PM cultures (72%; n =2) (Figure 4.10).  
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 α-SMA expression was investigated to determine if the hCFs transitioned into 
myofibroblasts after crowding. No α-SMA expression was observed when hCFs were cultured 
on glass and PTFE-nf, independent of media condition (Figure 4.12 & Figure 4.13). An 
apparent decrease in the expression of α-SMA was observed when hCFs were cultured on a 
Transwell membrane in CAR compared to the A2PM control; however, actin filaments are 
not evident and this is likely non-specific staining (Figure 4.14). Crowding appeared to result 
in the increase of type VI collagen on all substrates but aggregates were again observed when 
cells were cultured in CAR. Cultures on glass showed little alignment whether cultured in 
A2PM (29%; n = 3), CAR (44%; n = 3) or FC (25%; n = 3) (Figure 4.12). Crowding with Ficoll 
maintained the alignment of type VI collagen deposited by hCFs cultured on PTFE-nf (78%; n 
= 2) whereas aggregates disrupted alignment in CAR cultures (38%; n = 3). To quantify 
collagen content, a hydroxyproline assay was trialled in uncrowded and carrageenan-
crowded samples but the assay did not detect any collagen. 




Figure 4.6 Representative max. z-projections from ICC analysis of deposited type I collagen by hCFs cultured on glass in uncrowded (A2PM) or crowded 
(CAR or FC) media for 30 days. The deposition of collagens (CNA35; green) and, specifically, type I collagen (Col I; magenta) was analysed. Cells were co-
stained with phalloidin (F-actin; yellow) and DAPI (blue). Merged images are also shown. n = 3 biological replicates except for FC, where n =2. Scale bar 
represents 100 µm. 




Figure 4.7 Representative max. z-projections from ICC analysis of deposited type I collagen by hCFs cultured on PTFE-nf in uncrowded (A2PM) or crowded 
(CAR and FC) media for 30 days. The deposition of collagens (CNA35; green) and, specifically, type I collagen (Col I; magenta) was analysed. Cells were co-
stained with phalloidin (F-actin; yellow) and DAPI (blue). Merged images are also shown. White arrows on merged images represents direction of PTFE-nf. n 
= 3 biological replicates except for FC, where n =2. Scale bar represents 100 µm. 




Figure 4.8 Representative images from ICC analysis of deposited type I collagen by hCFs cultured on Transwell membranes in uncrowded (A2PM) or 
crowded (CAR) media for 30 days. The deposition of collagens (CNA35; green) and, specifically, type I collagen (Col I; magenta) was analysed. Cells were co-
stained with phalloidin (F-actin; yellow) and DAPI (blue). Merged images are also shown. n = 3 biological replicates. Scale bars represent 100 µm. 




Figure 4.9 Representative max. z-projections from ICC analysis of deposited collagen types 
III and V by hCFs cultured on glass in uncrowded (A2PM) or crowded (CAR and FC) media 
for 30 days. Collagen types III (Col III; green) and type V (Col V; magenta) are shown. Merged 
images with DAPI-stained nuclei (blue) are also shown. n = 3 biological replicates except for 
A2PM, where n =2. Scale bar represents 100 µm. 




Figure 4.10 Representative max. z-projections from ICC analysis of deposited collagen 
types III and V by hCFs cultured on PTFE-nf in uncrowded (A2PM) or crowded (CAR and FC) 
media for 30 days. Collagen types III (Col III; green) and type V (Col V; magenta) are shown. 
Merged images with DAPI-stained nuclei (blue) are also shown. White arrows on merged 
images represents direction of PTFE-nf. n = 3 biological replicates except for A2PM, where n 








Figure 4.11 Representative images from ICC analysis of deposited collagen types III and V 
by hCFs cultured on Transwell membranes in uncrowded (A2PM) or crowded (CAR) media 
for 30 days. Collagen types III (Col III; green) and type V (Col V; magenta) are shown. Merged 
images with DAPI-stained nuclei (blue) are also shown. n = 3 biological replicates. Scale bars 
represent 100 µm. 
  




Figure 4.12 Representative max. z-projections from ICC analysis of deposited type VI 
collagen and α-SMA expression in hCFs cultured on glass in uncrowded (A2PM) or crowded 
(CAR and FC) media for 30 days. α-SMA (green) and type VI collagen (Col VI; magenta) are 
shown. Merged images with DAPI-stained nuclei (blue) are also shown. n = 3 biological 
replicates. Scale bars represent 100 µm. 
 




Figure 4.13 Representative max. z-projections from ICC analysis of deposited type VI 
collagen and α-SMA expression in hCFs cultured on PTFE-nf in uncrowded (A2PM) or 
crowded (CAR and FC) media for 30 days. α-SMA (green) and type VI collagen (Col VI; 
magenta) are shown. Merged images with DAPI-stained nuclei (blue) are also shown. White 
arrows on merged images represents direction of PTFE-nf. n = 3 biological replicates. Scale 








Figure 4.14 Representative images from ICC analysis of deposited type VI collagen and α-
SMA expression in hCFs cultured on Transwell membranes in uncrowded (A2PM) or 
crowded (CAR) media for 30 days. α-SMA (green) and type VI collagen (Col VI; magenta) are 
shown. Merged images with DAPI-stained nuclei (blue) are also shown. n = 3 biological 
replicates. Scale bar represents 100 µm. 
 
4.5.3 MMC with CAR appears to change ultrastructure of deposited collagen 
TEM was employed to evaluate the ultrastructure of collagen fibrils deposited by hCFs after 
30 days in culture on PTFE-nf (Figure 4.15) and on Transwell membranes (Figure 4.16). 
Culturing of hCFs on PTFE-nf in uncrowded medium showed minimal ECM deposition with 
no evident collagen fibrils visible. Conversely, crowding with CAR appeared to produce an 
amorphous ECM again with no evidence of typical collagen fibrils (Figure 4.15). Large fibrillar 
structures with an unusual banding pattern were observed in areas both adjacent to the cell 
and between cell layers in carrageenan-crowded cultures. Collagen-like fibrils, identified by 
the distinct periodic banding pattern, could be seen when hCFs were crowded with FC. These 
fibrils could be seen orienting parallel and perpendicular to the plane of sectioning. 
Interestingly, the hCFs cultured in FC exhibited large vacuoles within the cell, a phenotype 
not observed in the control A2PM cultures or those in CAR.  
 Dues to the increased cell seeding density, more hCFs and thus more ECM was 
observed in the Transwell cultures even without crowding (Figure 4.16). Collagen fibrils, 
characterised by the periodic banding, could be seen running parallel and perpendicular to 
the hCFs. Loose, lamellar-like structures were observed, with the orientation of collagen 
appearing to change direction in the control A2PM culture, consistent with previous studies 
(Guo et al., 2007; Karamichos et al., 2010). The amorphous matrix seen in samples cultured 
in CAR on PTFE-nf was also found in the CAR Transwell samples. Here, however, the large 
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fibrillar structures with the unusual banding pattern were more apparent and were seen 
spanning the space between cells. Collagen-like fibrils were observed in the FC culture 
however the lamellar-like architecture was not apparent. Similar to the PTFE-nf FC culture, 
the hCFs in FC culture possessed large vacuoles (Figure 4.16 inset).  
To further investigate the fibrillar structures observed in CAR the boxed areas of each 
image in Figure 4.17 were magnified and rotated to allow for a direct comparison. The 
distinct banding pattern seen in A2PM is the same as that observed in FC cultures, suggesting 
that these are the same fibrillar structures, likely type I collagen. The structures seen in CAR 
not only seem to aggregate laterally and span approximately 600 nm but the banding pattern 
differs. The distinct banding observed in A2PM and FC samples was lost in CAR samples and 
the periodicity appeared to increase. Comparing the bands observed in CAR cultures to those 
found in cultured dermis, fibroblasts and in pathologic Bruch’s membrane (Figure 4.18 A – C) 
show similarities between the banding patterns and periodicity. 
  




Figure 4.15 TEM of hCFs cultured on PTFE-nf for 30 days. hCFs were cultured on PTFE-nf in 
uncrowded medium (A2PM; top), medium crowded with carrageenan (CAR; middle), or 
medium crowded with Ficoll (FC; bottom). The hCFs (black arrow) cultured in FC have a large 
number of vacuoles (red asterisks). Collagen is evident in FC with collagen fibrils orienting 
both parallel (closed white arrow) and perpendicular (open white arrow) to the section. The 
ECM deposited by hCFs in CAR (white asterisks) is unusual with large banded structure. Three 
different magnifications are shown for each condition with scale bars indicated on the 
images.  
 




Figure 4.16 TEM of hCFs cultured on Transwell membranes for 30 days. hCFs were cultured 
on Transwell membranes in uncrowded medium (A2PM; top), medium crowded with 
carrageenan (CAR; middle), or medium crowded with Ficoll (FC; bottom). hCFs (black arrows) 
can be seen adjacent to collagen fibrils which are oriented both parallel (closed white arrows) 
and perpendicular (open white arrows) to the section in A2PM and FC. The hCFs cultured in 
FC have a large number of vesicles (red asterisks and inset). The ECM deposited by hCFs in 
CAR (white asterisks) appears amorphous. Three different magnifications are shown for each 
condition with scale bars indicated on the images. 
  




Figure 4.17 TEM of fibrillar structures from hCFs cultured on Transwell membranes for 30 
days. hCFs were cultured on Transwell membranes in uncrowded medium (A2PM; left), 
medium crowded with carrageenan (CAR; middle), or medium crowded with Ficoll (FC; right). 
Banded fibrils (boxed regions) were magnified and images rotated for direct comparison. 
Scale bars represent 200 nm.  
 
 
Figure 4.18 TEM of different collagen aggregates observed in the literature. A: Filamentous 
aggregate observed in cultured dermis. Image adapted from Kobayasi et al. (1985) and the 
scale bar was absent from the figure (Kobayasi et al., 1985). B: Human skin fibroblast cultures 
were immunolabelled with anti-type VI collagen where the secondary antibodies were 
conjugated to colloidal gold particles. Image adapted from (Bruns et al., 1986). C: Double-
banded aggregate found in the Bruch’s membrane of a patient with age-related macular 
degeneration. Image adapted from (Knupp et al., 2006). Scale bars represent 200 nm (B and 
C). 
 
4.5.4 Cell number is not affected by MMC with FC  
Given the ultrastructural appearance of hCFs cultured in FC, a PicoGreen and resazurin assay 
were carried out on cells cultured in a 48-well plate to investigate the effect of MMC on cell 
number and cellular metabolic activity respectively (Figure 4.19). Culturing hCFs in medium 
supplemented with A2P did not affect cell number when compared to those cultured in 
growth medium (Figure 4.19 A). Similarly, the addition of FC as a crowder exhibited no effect 
on cell number (Figure 4.19 A). Media type was shown to significantly affect metabolic 
activity (p = 0.045) however, when correcting for multiple comparisons, no significant 
differences were observed (Figure 4.19 B). A table of p values for each of these experiments 
can be found in Appendix F. To determine whether the rise in metabolic activity observed 
was likely due to the increase in cell number the relative fluorescent units (RFU) per cell were 
calculated (Figure 4.19 C). These results show that there may be a small increase in the 
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metabolic activity at day 3 in both media conditions. After this initial peak, metabolic activity 
decreased to levels similar to day 1 and remains consistent across the measured time frame. 
Surprisingly, crowding with carrageenan resulted in cell death and so data were not 
obtained. This phenomenon was only observed when hCFs were cultured in CAR in a 48-well 
plate. When cultured on substrates with a greater surface area (coverslips and the Transwell 
membranes in 6-well plates) cell death did not occur. No other differences were observed.   




Figure 4.19 Growth and metabolic activity of hCFs in normal (A2PM) and crowded (FC) 
conditions. A: PicoGreen assay was used to compare the growth of hCFs in growth (grey; 
Chapter 2, 2.5.1.2) A2PM (magenta; Chapter 3, 3.5.2) and FC (orange) media. hCFs cultured 
in CAR at low cell numbers did not survive beyond day 1 and thus data was not included. A 
logistic growth curve was applied where R2 = 0.896, 0.892 and 0.908 for growth, A2PM and 
FC respectively. B: Cell metabolic activity was assessed using resazurin sodium salt 
colorimetric assay over 21 days. C: To take into consideration the effect of an increase in cell 
number on the overall metabolic activity, the relative fluorescence was normalised to cell 
number. n = 3 biological replicates for all samples except for the cell number for A2PM at 
day 5 where n = 2; lines represent the mean. This experiment was performed on one occasion 
with growth, A2PM and FC with the same data being reported in Chapter 3. Where data were 
normally distributed a two-way ANOVA was performed otherwise, a one-way ANOVA was 
performed with Tukey’s post hoc test for multiple comparisons. No significant differences 
were observed.  
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4.5.5 Macromolecular crowding affects transparency of in vitro stroma model after 
30 days in culture 
The corneal stroma must maintain transparency to allow the transmittance, and subsequent 
refraction, of light on to the retina. Along with the epithelium, the keratocytes within the 
corneal stroma protect the eye against potential UV damage. In particular, corneal crystallins 
such as ALDH3A1 can metabolise the toxic by-products of UV-induced oxidative stress 
(Abedinia et al., 1990; Estey et al., 2007).To give an indication of how amorphous collagen 
deposition affected transparency, and thus the function of the in vitro model, the 
transparency of hCF constructs was assessed at wavelengths from 300 – 650 nm (Figure 4.20 
A). The data were normalised to a glass coverslip and the cell-free PTFE-nf substrate was 
comparable with plain glass, indicating that the nanofibres do not interfere with the 
transmission of light. As the transparency of each hCF culture varies with wavelength, a 
wavelength within the ultraviolet range (UV; 350 nm) and one in the middle of the visible 
range (560 nm) were selected for comparison. In the UV spectrum no difference was 
observed between uncrowded (A2PM) and crowded (CAR and FC) samples (Figure 4.20 B). 
Similarly, no significant difference was observed between the glass and PTFE-nf substrates. 
However, in the middle of the visible range, at 560 nm, there was a reduction in transmission 
between hCFs cultured on glass in A2PM and those cultured in FC (p = 0.0266) (Figure 4.20 
C). There was also a decrease in transmission between hCFs in A2PM on glass and those in 
FC cultured on PTFE-nf, but this was not statistically significant (p = 0.0507). Interestingly, 
there was no difference between hCFs cultured in A2PM on glass compared to those cultured 
on PTFE-nf at 350 and 560 nm. Equally, no significant differences were observed between 
hCFs cultured on PTFE-nf in A2PM and those in crowded conditions at these two 
wavelengths. 
  




Figure 4.20 Transparency of hCFs cultured in normal (A2PM) and crowded (CAR and FC) 
conditions for 30 days on glass or PTFE-nf. A: The average transmittance of samples 
measured at wavelengths from 300 to 650 nm normalised to glass (control). B: Transmittance 
at wavelength of 350 nm (UV) was compared. C: Transmittance at 560 nm was also 
compared. n = 3 biological replicates and SD error bars are shown. One-way ANOVA was 








































































































































The aim of this chapter was to use macromolecular crowding to amplify the production of 
the ECM, specifically collagens type I, V and VI. The results obtained in this study suggest that 
although MMC may increase the deposition of collagen, supporting previously published 
data, the ultrastructure can also be affected. Long-term crowding with carrageenan appears 
to result in the aggregation of collagens. Conversely, the use of the neutrally charged Ficoll 
cocktail does not result in protein aggregates, but the cellular uptake of Ficoll may affect cell 
transparency – a potential issue should this model be adapted for clinical use. Although the 
ultrastructure of the ECM was not investigated in short-term cultures, ICC of hCFs cultured 
in medium crowded with carrageenan suggest that similar aggregates may be seen but on a 
much smaller scale. 
 
4.6.1 Carrageenan 
Carrageenans are polysaccharides derived from red seaweed that are used as thickening 
agents in the food industry. As previously mentioned, they can be distinguished by the 
number of sulphates per disaccharide unit (Carneiro-Da-Cunha et al., 2011). In this study the 
carrageenan source was predominantly κ-carrageenan with some λ-carrageenan, with κ-
carrageenan having one sulphate group and λ-carrageenan having three. 
 
4.6.1.1 Characterisation of carrageenan source 
It has been reported that the optimal concentration of carrageenan, for increasing collagen 
deposition, is 75 µg/ml and that at this concentration carrageenan has a hydrodynamic 
diameter of approximately 1600 nm (Satyam et al., 2014). Although this optimal 
concentration was determined using WS-1 fibroblasts (a cell line derived from human skin), 
the same trend was observed in human tenocytes and osteoblasts and 75 µg/ml carrageenan 
was later used with human corneal fibroblasts (Satyam et al., 2014; Kumar et al., 2015b, 
2018). The reported hydrodynamic diameter of carrageenan varies from approximately 200 
nm to 1600 nm and has been shown to increase with concentration (Satyam et al., 2014; 
Gaspar et al., 2019a). Where the larger diameter (approximately 1600 nm) was reported, 
carrageenan was dispersed in distilled water at 25°C (Satyam et al., 2014). However, smaller 
diameters have been recorded when carrageenan is dispersed in Hank’s Balanced Salt 
Solution (approximately 260 nm at 100 µg/ml), although the temperature, which is likely to 
be a key factor, was unreported (Gaspar et al., 2019a). In this study, when dispersed in PBS 
at 20°C, the hydrodynamic diameter of carrageenan was 212.6 nm which is comparable to 
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the literature. Although unreliable due to measurement uncertainty (likely a result of the 
sample being too polydisperse), when dispersed in distilled water the hydrodynamic radius 
of carrageenan was 422 nm, almost double that measured when dispersed in PBS. This is 
further supported by Carneiro-da-Cunha et al. who found that increasing the ionic strength 
of the solvent, through the addition of sodium chloride, resulted in a lower reported 
hydrodynamic radius of κ-carrageenan (Carneiro-Da-Cunha et al., 2011). The variation in 
results highlights the importance of mimicking physiological conditions to understand the 
effect of MMC in cell culture.  
The polydispersity of carrageenan has previously been reported with nanoparticle 
tracking analysis, demonstrating that a solution of 75 µg/ml carrageenan contains molecules 
with sizes ranging from 10 nm – 2000 nm, although the solvent used was not stated (Satyam 
et al., 2014). In the present study the polydispersity index was 0.39; lower than the 0.6 that 
has been found elsewhere (Gaspar et al., 2019a). To investigate the potential presence of 
large aggregates when dispersed in PBS a carrageenan solution was passed through a 0.75 
µm filter and both the hydrodynamic diameter and the polydispersity index were 
significantly reduced. These results suggest that when dispersed in PBS large molecules are 
present in carrageenan solutions which could have an effect on the crowding within culture 
media. In this study, and in previously published reports, the media supplemented with 
carrageenan was not filtered, therefore these large carrageenan aggregates are expected 
(Satyam et al., 2014; Kumar et al., 2015b). The presence of larger aggregates explains the 
increased the polydispersity index of unfiltered carrageenan when compared to the filtered 
version. The polydispersity of the carrageenan solution increased when measurements were 
recorded at 37°C, again highlighting the importance of mimicking physiological conditions. 
Although a measurement error was reported when the temperature was increased, the 
results suggest that carrageenan aggregates at physiologic temperatures. The effect of 
potential carrageenan aggregates on macromolecular crowding has not previously been 
discussed but this may have deleterious effects on collagen deposition. If it is assumed that 
aggregation can increase the effect of MMC, the excluded volume effect may be greater than 
originally expected for cells grown at 37°C. It is possible that increasing the excluded volume 
effect beyond an optimal level can result in over-crowding which may segregate procollagen 
from C-/N-proteinases. This could prevent the cleavage of procollagen and thus reduce the 
amount of type I collagen that is deposited. 
The zeta potential at 37°C showed that CAR is negatively charged, as expected, and 
agrees with published data (Gaspar et al., 2019a). Given that proteins such as procollagen 
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are negatively charged at physiological pH, this can result in a larger excluded volume effect 
with carrageenan repelling procollagen. A greater excluded volume effect is thought to 
accelerate the rate of collagen deposition in vitro, however, as discussed above, there is likely 
a limit before solutions become over-crowded (Lareu et al., 2007a).  
The FVO of carrageenan at 20°C in this study was calculated following conventional 
methods (Chen et al., 2011). In the present study the FVO was reported to be approximately 
40% however this is based on several assumptions: that the macromolecule has a well-
defined molecular weight; that macromolecules are perfect spheres; that the 
macromolecule is electroneutral; and that there is only a single macrosolute present (Hall 
and Minton, 2003; Chen et al., 2011). In the case of carrageenan, many of these assumptions 
are unlikely to be valid. The weight average molecular weight ranges from 450 – 650 kDa, 
with 550 kDa being used in this study (Uno et al., 2001). Serum is used in the cultures 
described in this study and therefore the macromolecule albumin will also be present (Lareu 
et al., 2007a). Despite these assumptions, the FVO is commonly reported when 
macromolecular crowding is employed, with the accepted caveat that it is a crude estimate 
(Rashid et al., 2014; Gaspar et al., 2019a; Gonzalez-Molina et al., 2019). However, the 
assumptions can lead to unrealistic values greater than 100% being reported and thus should 
be used with caution (Gaspar et al., 2019a; Gonzalez-Molina et al., 2019).  
 
4.6.1.2 Short-term crowding with carrageenan 
MMC has been used in cell culture to accelerate the deposition of collagen by cells cultured 
in vitro (Satyam et al., 2014; Kumar et al., 2015b). Carrageenan has been used as a crowder 
in cultures with dermal fibroblasts (Satyam et al., 2016; Gaspar et al., 2019a, 2019b), bone 
marrow stromal cells (Cigognini et al., 2016; Gaspar et al., 2019b), corneal fibroblasts (Kumar 
et al., 2015b, 2018) and tenocytes (Satyam et al., 2014; Gaspar et al., 2019b) at 
concentrations ranging from 1 to 500 µg/ml. In this study, ICC revealed that crowding with 
carrageenan enhanced deposition of type I collagen from as early as day 2, supporting 
previously published data (Kumar et al., 2015b; Cigognini et al., 2016). As previously 
discussed, ascorbic acid is thought to be essential for the deposition of collagen as it is an 
essential cofactor for the hydroxylation of proline and lysine (Gelse et al., 2003). To further 
investigate the effect of carrageenan on collagen deposition, hCFs were cultured without 
A2P supplementation for 7 days. Interestingly, enhanced collagen deposition was again 
observed in cultures crowded with carrageenan but this time without A2P supplementation. 
In the absence of ascorbic acid, it has been shown that small amounts of collagen can be 
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secreted into the culture media by fibroblasts in vitro however, little is integrated into the 
cell layer (Lareu et al., 2007a). The successful deposition of collagens in the absence of A2P 
may be due to alternative reducing agents enabling the hydroxylation of proline in vitro 
(Evans and Peterkofsky, 1976; Chauhan et al., 1985). It is, therefore, possible that 
macromolecular crowding enhanced the conversion of procollagen to collagen fibrils which 
could then be incorporated into the cell layer. For example, crowding may encourage the 
interaction of C-/N-proteinases with procollagen thus resulting in accelerated collagen 
fibrillogenesis. However, if ascorbic acid is necessary for the hydroxylation of proline, it is 
likely that the collagen protein will be incorrectly folded here, in the absence of A2P. Given 
that misfolded proteins cannot easily leave the endoplasmic reticulum, the apparent 
increase in collagen could be a result of the collagen antibodies and CNA35 binding directly 
to carrageenan (Canty and Kadler, 2005). To see if this was true, CNA35 was added to culture 
medium with carrageenan in the cell-free system. CNA35 was shown not to bind to 
carrageenan suggesting that the staining is specific to collagens. Perhaps, in the absence of 
A2P, misfolded collagens can still be secreted but form gelatin-like aggregates which the 
collagen antibodies can bind to. This could explain the unusual morphology of collagen 
observed.  
 
4.6.1.3 Long-term crowding with carrageenan 
Typically, MMC has been used in short-term cultures with few extending beyond 15 days 
(Ang et al., 2014; Graceffa and Zeugolis, 2019; Assunção et al., 2020). In this study, the 
culture period was extended to 30 days in an attempt to promote the thickening of the 
matrix to mimic the corneal stroma. Crowding for 30 days with carrageenan resulted in the 
detection of aggregates using antibodies for collagens type I, III, V and VI, and aggregates 
were also detected using the CNA35 collagen probe. These aggregates disrupted the 
alignment of collagen, particularly when compared to hCFs cultured in A2PM on PTFE-nf. 
There is the caveat that the analysis of collagen alignment was only performed on one region 
of interest on each biological replicate, although the observation that aggregates disrupt 
collagen alignment is likely a true result. The lack of technical repeats is of more importance 
when comparing the alignment between substrates, particularly with glass and Transwell 
membranes where alignment may vary over the substrate. Aggregation has not been 
explicitly described in relation to crowding with carrageenan but has been observed when 
500 kDa dextran sulphate was used (Lareu et al., 2007a, 2007b; C. Chen et al., 2009; Assunção 
et al., 2020). Dextran sulphate is a negatively charged polymer that has been used to enhance 
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ECM deposition in tissue engineering and to create a rapid in vitro model of scar tissue (C. 
Chen et al., 2009). At 100 µg/ml dextran sulphate has a reported FVO of 5.2% (Lareu et al., 
2007b), however as little as 10 µg/ml is sufficient to enhance collagen deposition which 
equates to an FVO of 0.52% (Assunção et al., 2020). Given that this is such a low value, the 
authors proposed that the increase in ECM observed isn’t the result of MMC alone. Assunção 
et al. used Alcian blue staining to observe dextran sulphate deposits in a cell-free system and 
found that they colocalised with type I collagen and fibronectin aggregates (Assunção et al., 
2020). Dextran sulphate did not form deposits in the absence of proteins, suggesting that the 
crowder interacted with the proteins supporting previously published data (Ruoslahti et al., 
1979). It is possible that carrageenan may interact with proteins in a similar way, leading to 
their co-deposition and aggregation. Similar observations have been made when using the 
negatively charged 200 kDa polysodium-4-styrene sulfonate (PSS) (Peng and Raghunath, 
2010). Here, type I collagen and fibronectin were both observed to aggregate after 2 days of 
fibroblast culture when crowded with PSS. Given that the formation of collagen aggregates 
has been reported with the use of other negatively charged crowders, it is likely that the 
apparent aggregation observed in this study was as a result of carrageenan’s negative 
charge.  
 The increase in type III collagen observed here has previously been reported with 
MMC using carrageenan in media supplemented with 0.5% new born calf serum and 0.5% 
human serum (Kumar et al., 2015b). Type III collagen is associated with myofibroblasts and 
scar tissue within the stroma. The presence of type III collagen may suggest that the hCFs 
had started to transition into myofibroblasts but, the lack of α-SMA expression in CAR 
cultures contradicts this. However, to better image the deposited collagen, as opposed to 
intracellular collagen, the cells were not permeabilised prior to ICC. Although there have 
been reports of successful staining with the anti-α-SMA antibody without permeabilisation, 
there is a small possibility that if the cells were first permeabilised the staining would reveal 
specific expression of α-SMA filaments. 
 
4.6.1.3.1 Ultrastructural analysis of collagen deposited in a carrageenan-crowded system 
The impact that MMC has on the ultrastructure of collagen deposited by cells is rarely 
investigated. Given the unusual staining observed at the light microscopy level when cells 
are crowded with carrageenan, TEM was employed to gain a better understanding of the 
effect that MMC has on collagen. Under normal culture conditions (A2PM) very little collagen 
could be found when cells were cultured on PTFE-nf, likely due to the relatively low seeding 
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density used. However, when cultured at a higher cell density on Transwell membranes, 
collagen fibrils were observed. These collagen fibrils formed lamellar-like structures with 
fibril orientation changing direction, similar to the arrangement within the native corneal 
stroma, as has been previously shown (Guo et al., 2007).  
 The addition of carrageenan showed an increase in large, fibrillar extracellular 
components, which was seen in hCFs cultured on both PTFE-nf and on Transwell membranes. 
It is possible that the large banded structures observed are residual carrageenan that has 
bound to the cell layer and remained post-washing. TEM studies of carrageenan gels have 
revealed aggregates that can form fine networks but whose structure differs from the ECM 
seen in this study (Walther et al., 2006). It may also be possible that the observed matrix is 
as a result of the co-deposition of carrageenan and matrix proteins, as discussed previously. 
A 2007 study by Lareu et al. used TEM to view the pericellular matrix 48 hours after culture 
with dextran sulphate (Lareu et al., 2007b). Cell layers were pelleted and embedded in 
agarose prior to EM where aggregates with cross-striation resembling collagen were found 
(Lareu et al., 2007b). However, given the short culture period and the differences in sample 
processing, the results cannot be directly compared. Immuno-electron microscopy, the 
labelling of structures with gold particles prior to TEM, could reveal whether or not the 
structures observed in this study are ECM proteins. 
 
4.6.1.3.1.1 Collagen aggregates may be fibrous long-spacing collagen 
The banding pattern of the aggregates observed indicated a periodicity greater than that 
observed in most fibrillar collagens (67 nm). Fibrous long-spacing (FLS) collagens are 
collagens with a periodicity greater than 67 nm, although typically the periodicity exceeds 
100 nm (Paige et al., 1998). They have been found in pathologic tissues (when found in neural 
tissues these are referred to as Luse bodies (Luse, 1960)) and in vitro (Hashimoto and 
Ohyama, 1974). There are believed to be four different morphologies that the FLS collagen 
can present, dependent on the banding pattern observed via TEM (Paige and Goh, 2001). 
The different morphologies are characterised by the number and the width of bands evident 
after being negatively stained and imaged via TEM (Chapman and Armitage, 1972). FLS I has 
a periodicity of 250 nm with one narrow overlap band per period; FLS II has a periodicity of 
250 nm but possesses two narrow overlap bands that are close together; FLS III (periodicity 
of 100 nm) contains four narrow overlap bands with interbands of a comparable size and FLS 
IV (periodicity of 170 nm) has one broad overlap band (Chapman and Armitage, 1972; Paige 
and Goh, 2001). The composition of the FLS collagen is somewhat unknown with research 
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suggesting it could be derived from the basement membrane and be composed of laminin 
and type VI collagen (Miki et al., 1993). However, FLS collagen can also be prepared in vitro 
by dialysing an acidic type I collagen solution mixed with a glycoprotein (Paige and Goh, 2001; 
Wen and Goh, 2006). 
  FLS collagens have also been referred to as filamentous collagen aggregates that 
have been described in pathological tissues and have been found in collagenase-treated 
tissues (Figure 4.21 A-C) (Kobayasi et al., 1985; Miki et al., 1993; Paige et al., 1998). Based on 
the observation of aggregates in collagenase-treated tissues, it can be hypothesised that the 
fibrillar aggregates found in this study are as a result of collagen degradation. MMC with 
carrageenan can increase the activity of MMPs, specifically MMP-2 (Cigognini et al., 2016; 
Satyam et al., 2016; Tsiapalis et al., 2020) and MMP-9 (Tsiapalis et al., 2020), in cultures up 
to 14 days. Beyond 14 days MMP activity may increase further in crowded conditions and 
result in consistent collagenolysis causing the aggregates observed in this study. However, 
MMC has also been shown to increase the expression of procollagen C proteinase enhancer 
1 (PCPE1) (Lareu et al., 2007b). PCPE1 is a protein that not only enhances the activity of C-
proteinases, and thus the deposition of collagen, but also inhibits MMP-2 (Mott et al., 2000; 
Löffek et al., 2011). Further work into the effect that crowding has on MMP expression and 
ECM remodelling is required to understand the cause of the aggregates observed in this 
study. Specifically, monitoring the activity of MMPs and their inhibitors, TIMPs, over time 
could reveal if there is an imbalance between the degradation and synthesis rate of collagen.  
 Similar aggregate structures have also been found in the Descemet’s membrane of 
diabetic rats (Akimoto et al., 2008) and in the corneal stroma of diabetic patients (Rehany et 
al., 2000; Kowalczuk et al., 2013). It has been proposed that excessive glycation may result 
in the presence of FLS collagen however, the mechanism behind this is unknown. It may be 
possible that MMC with carrageenan results in pockets of concentrated media and 
supplements, such as glucose, resulting in excess glycation.  
 
4.6.1.3.1.2 Collagen aggregate may be aggregates of type VI collagen 
Type VI collagen is a beaded-filament found within the corneal stroma with a beaded repeat 
of 105 nm (Cescon et al., 2015). A 2002 study compared the structures of banded aggregates, 
found in the Bruch’s membrane of pathologic retinas, with type VI collagen using electron 
microscopy (Knupp et al., 2002). The banded aggregates found in the Bruch’s membrane had 
a periodicity of 80 – 110 nm and both single and double banded structures were observed 
(Figure 4.21 D). The single bands were the same width as the double bands suggesting that 
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the gaps could somehow be filled with a protein. Sorsby’s fundus dystrophy, a disease that 
affects the Bruch’s membrane, is characterised by a mutation of TIMP-3. Although the 
mutation does not affect the ability of TIMP-3 to inhibit MMPs, the mutated TIMP-3 is more 
resistant to degradation and thus an accumulation occurs (Knupp et al., 2002). Knupp et al. 
hypothesise that the protein interacting with type VI collagen and filling the gaps in the 
double banded structure is the mutated TIMP-3 (Knupp et al., 2006). These aggregates were 
seen adjacent to typical 105 nm type VI collagen beaded-filaments which led the authors to 
hypothesise that beaded-filaments are a precursor to the aggregates. Knupp et al. also 
showed that intermediates exist where secondary banding is evident, possibly showing the 
interaction of proteins filling the gap in double banded aggregates (Knupp et al., 2006). 
Knupp et al. suggests that the banded structures previously termed fibrous long-spacing 
collagen may in fact be type VI collagen aggregates. This is supported by earlier research by 
Bruns and colleagues who used immuno-EM to confirm that fibrils with a 100 nm periodicity 
are type VI collagen (Bruns et al., 1986). Here, adenosine triphosphate was added to 
fibroblast cultures to induce aggregation of thin filaments (Bruns et al., 1986). Of particular 
interest is their observation of these fibrils coating type I collagen fibrils in rat tail tendons 
(Figure 4.21 E). In this study, TEM did not reveal any typical type I collagen fibrils in 
carrageenan-supplemented cultures despite ICC suggesting the presence of type I collagen 
deposits. If type VI collagen aggregates can cover type I fibrils this may explain the apparent 












Figure 4.21 A comparison of the different collagen aggregates observed. A: Filamentous 
aggregates have been observed in collagenase-treated dermis; B: in the dermis of morphea; 
C: in cultured dermis. Images from (Kobayasi et al., 1985). Scale bars were absent from these 
images. D: Single- and double-banded aggregates have also been found in the retina of 
patients with Sorsby’s fundus dystrophy and these are likely type VI collagen aggregates. Red 
arrow indicates area where double-banded aggregates can be seen. Figure adapted from 
(Knupp et al., 2006). E: Similar aggregates were found by Bruns et al. in rat tail tendon after 
treatment with adenosine triphosphate (Bruns et al., 1986). The aggregates are thought to 
be type VI collagen which partially coat type I collagen fibrils. Scale bars represent 100 nm (D 
and E).  
 
4.6.1.3.1.3 Collagen aggregates may be a result of anomalous diffusion and increased fibril 
nucleation sites 
Anomalous diffusion is defined as diffusion in which the mean squared displacement does 
not increase linearly with time (Dix and Verkman, 2008). MMC with larger molecules can 
result in the anomalous subdiffusion of molecules of interest, such as procollagens, resulting 
in them being restricted to a reduced area (Chau et al., 2020). Whilst this can be beneficial, 
and result in the increased cleavage of procollagens by C-/N-proteinases, it may also have a 
detrimental effect. One model of collagen fibrillogenesis suggests that the process of 
collagen fibril formation is based on diffusion limited aggregation (Parkinson et al., 1995). By 
reducing the rate of diffusion via MMC with large molecules, such as carrageenan, it is 
possible that collagen fibrillogenesis is halted and thus shorter, incomplete fibrils are formed. 
Given that carrageenan has a large hydrodynamic radius and is negatively charged (and thus 
repels procollagen molecules), it is possible that the available area for procollagen molecules 
and proteinases is restricted beyond an optimal level. The aggregates could, therefore, be 
incomplete collagen fibrils which antibodies can also bind to. 
In vivo collagen fibrillogenesis is dependent on the formation of fibronectin, a matrix 
protein that serves as a template for collagens (Kadler et al., 2008). Along with other matrix 
proteins, macromolecular crowding has also been shown to increase fibronectin deposition 
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which, in turn, corresponds to an increase in potential collagen nucleation sites (Kumar et 
al., 2015b, 2018; Graham et al., 2019). When Graham et al. limited the amount of accessible 
fibronectin, by cross-linking a fibronectin coating to a substrate prior to cell seeding, they 
found that crowding with a Ficoll cocktail no longer increased the deposition of type I 
collagen. This highlights the importance of fibronectin in collagen nucleation and 
fibrillogenesis and MMC (Graham et al., 2019). By increasing the number of nucleation sites, 
it is possible that collagen fibrillogenesis begins but that the fibrils cannot elongate either as 
a result of anomalous subdiffusion limiting fibril growth or, simply, because the procollagen 
molecules are incorporated into fibrils at a faster rate than they are secreted by the cells. 
This could result in incomplete collagen fibrils which may resemble those seen in cultures 
crowded with carrageenan. 
 
4.6.1.3.2 The effect of crowding with carrageenan on construct transparency 
Perhaps unexpectedly, the disruption to collagen did not have a detectable impact on the 
transparency of the in vitro model. At both 350 and 560 nm there was no significant decrease 
in light transmission. As the ICC analysis shows, the collagen aggregates are not consistent 
across the sample. There is a small possibility that the light transmission was measured in an 
area adjacent to a collagen aggregate, allowing light to pass through. This may offer a 
potential explanation as to why there was no significant decrease in transmission but, the 
averaging of the technical and biological replicates should have corrected for this. It is also 
interesting that whilst not significantly different, the transmission of light through cultures 
in A2PM on glass compared to those on PTFE-nf was not identical. As a hydrophobic material, 
PTFE-nf restricts the attachment area to some extent which may result in areas of a higher 
cell density and cause a decrease in light transmission (Kearns et al., 2010). Corneal 
fibroblasts are associated with corneal haze and a loss of transparency, compared to 
keratocytes (Jester et al., 1999), specifically the expression of corneal crystallin ALDH3A1 is 
decreased in corneal fibroblasts (Pei et al., 2006). The knockout of ALDH3A1 in mice has been 
linked to an increase in light scattering and corneal haze and therefore, a high cell density of 
fibroblasts may result in a further decrease in transparency (Chen et al., 2017). An alternative 
explanation relates to the orientation of hCFs on each substrate. When cultured on PTFE-nf, 
the cells follow topographical cues to align parallel to the nanofibres and create a structure 
resembling a lamella within the corneal stroma. On glass, where there are no topographical 
cues, hCFs have shown short-range order where they can produce roughly orthogonal layers 
(Figure 4.6). Absorbance measurements taken in areas of short-range order are likely to be 
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less than those taken where cells are randomly oriented, resulting in greater light 
transmission. This could explain the high transmittance values of cultures cultured in A2PM 
on glass (92.4% at 560 nm) compared to those on PTFE-nf (84.8% at 560 nm) and why there 
is no significant difference between uncrowded cultures.  
 
4.6.1.3.3 The effect of crowding with carrageenan on cell viability  
Surprisingly, at low cell numbers, crowding with carrageenan resulted in the death of hCFs 
and so the effect on metabolic activity over time could not be studied. This has not been 
reported in the literature and contrasts the earlier results of this study, where cells survived 
up to day 30 on Transwell membranes and PTFE-nf, when seeded at higher number. For the 
metabolic activity study, cells were seeded on a smaller substrate, and thus at a lower cell 
number, it is possible that seeding more cells provided some sort of protection against 
crowding as they increase in number. To further understand the cytotoxic effects observed 
at a lower cell number, the relative proportion of carrageenan in each culture can be 
calculated. In the main cell culture experiments, carried out in a 6-well plate, carrageenan 
was added to the cells at a concentration of 11.25 ng/cell. In the growth and metabolic 
activity assay, which was conducted in a 48-well plate, carrageenan was added at a 
concentration of 7.8 ng/cell. Although this does not explain the apparent cytotoxicity of 
carrageenan at low cell numbers, similar findings of cell death after crowding with 
carrageenan have been observed elsewhere with hCFs (Ebraheim Ismail, personal 
communication at ARVO, 2019). 
  
4.6.2 Ficoll cocktail 
In this study mixed-MMC was employed using a Ficoll cocktail composed of Ficoll 70 kDa and 
Ficoll 400 kDa. 
 
4.6.2.1 Characterisation of Ficoll cocktail source 
Two particle sizes of approximately 10 nm and 65 nm were found in the Ficoll cocktail at 
20°C. Similar sizes have been reported by Gaspar et al. at approximately 10 nm and 70 nm. 
However, the reported values differ to those obtained when Ficoll 70 and Ficoll 400 were 
measured separately (approximately 10 nm and 25 nm respectively) (Gaspar et al., 2019a). 
The authors suggest that particle aggregation may occur when these molecules are mixed 
together in a compound thus increasing polydispersity (Gaspar et al., 2019a). Furthermore, 
the results of the present study suggest that aggregates also form at temperatures of 37°C. 
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The polydispersity index of the Ficoll cocktail in this study was around 0.5, which agrees with 
previously published data (approximately 0.46). This has been shown to roughly equate to 
the sum of the individual polydispersity indices for Ficoll 70 plus Ficoll 400 (Gaspar et al., 
2019a). Other reported values for the size of Ficoll 70 and Ficoll 400 are 8 nm and 16 nm 
respectively (Chen et al., 2011). Using these values, the authors estimate that that the 
respective FVOs would be 8.7% and 8% and so the cocktail would have an FVO of 17% (Chen 
et al., 2011). Based on the particle sizes observed in this study, 10 and 65 nm, the respective 
FVOs would be 16.9% and 541.2% and so the cocktail would have an estimated FVO of 558%. 
This large value highlights the limitations of FVO and why it should be used with caution 
when studying systems with more than one macromolecule present. It is hard to predict how 
the aggregates would interact with the other Ficoll particles and the macromolecules found 
within cell culture medium, such as albumin, but it is likely to alter the calculated FVO. DLS 
measurements of nanoparticles in cell culture medium supplemented with 10% FBS, as used 
in this study, have been shown to be unreliable thus making it harder to predict the 
interactions between macromolecular crowders and cell culture medium (Gollwitzer et al., 
2016). 
 Ficoll is a neutral polysaccharide and this is thought to result in a weaker volume 
excluding effect, which is supported by the fact that molecules which are similar in molecular 
weight (MW) can have very different hydrodynamic diameters. Harve et al. observed that 
negatively charged dextran sulphate (MW 500 kDa) had a hydrodynamic diameter three 
times greater than Ficoll 400 (MW 400 kDa) (Harve et al., 2006). Charged molecules will 
experience intramolecular electrostatic repulsion resulting in a more open structure, thus 
appearing to have a much greater hydrodynamic diameter. A molecule with a larger 
hydrodynamic diameter will occupy more space (greater FVO). To overcome this Ficoll is 
often combined with a molecule of a different size to create a cocktail with a greater FVO 
than mono-MMC with Ficoll 400, as described in this chapter (Zeiger et al., 2012; Ang et al., 
2014). 
 
4.6.2.2 Long-term crowding with Ficoll cocktail 
Mixed-MMC with a Ficoll cocktail has been used to accelerate collagen deposition in cultures 
of dermal (Gaspar et al., 2019a) and corneal fibroblasts (Kumar et al., 2015a) but has had 
variable effects in bone marrow stromal cell cultures (Zeiger et al., 2012; Cigognini et al., 
2016). In the present study, an apparent increase in type I collagen deposition was observed 
when hCFs were crowded with the Ficoll cocktail and the collagen appeared to have a similar 
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arrangement to the control samples, with little difference in alignment. Unlike crowding with 
carrageenan, the Ficoll cocktail did not appear to increase type III collagen deposition. Type 
III collagen is associated with myofibroblasts and scar tissue within the stroma, the absence 
of which suggests that the hCFs have not transitioned into myofibroblasts. This is further 
confirmed by the apparent absence of α-SMA staining in FC cultures. However, as previously 
mentioned, the cells were not permeabilised prior to ICC and it is possible that 
permeabilisation would reveal more specific α-SMA expression. Previously published data 
has reported that the crowding of hCFs with a Ficoll cocktail does result in an increase in type 
III collagen deposition at days 2, 4 and 6 (Kumar et al., 2015a). The differences observed 
between this study and that reported by Kumar et al. may be caused by the different sources 
and concentrations of sera used. In this study, 10% FBS was used to culture the hCFs whereas 
Kumar et al. used 0.5% human serum to reduce exogenous MMP-2 (Kumar et al., 2015a). 
Serum-free media supplemented with FGF-2 has been shown to increase the expression of 
COL3A1 whilst maintaining low α-SMA expression (Lynch et al., 2016). The additional 
supplementation of insulin-like growth factor 1 (IGF-1) can decrease the expression of 
COL3A1 without increasing α-SMA expression (Lynch et al., 2016). Therefore, it is possible 
that the increased type III collagen deposition observed by Kumar et al. was as a result of the 
low concentration of serum, and growth factors, used. The results of the present study 
indicate that use of a Ficoll cocktail suitably accelerate the production of an in vitro corneal 
stroma model when used in sera containing media. 
 
4.6.2.2.1 Ultrastructural analysis of collagen deposited in a Ficoll-crowded system 
Ultrastructural analysis was used to analyse the orientation of the collagen deposited. It was 
shown that MMC with the Ficoll cocktail appeared to increase the amount of collagen 
deposited by hCFs on PTFE-nf, supporting ICC analysis. However, the hCFs contained many 
large vesicles within each cell, a phenotype not observed when cells were cultured in 
uncrowded or carrageenan-crowded media. This became more apparent when cells were 
cultured at a higher cell density on Transwell membranes and multiple cells could be seen in 
one field of view. These vesicles may be evidence of the uptake of Ficoll by the fibroblasts 
(Zeiger et al., 2012). Following a 24 hour incubation period with fluorescently labelled Ficoll 
400 and Ficoll 70, Zeiger et al. reported that bone marrow derived-MSCs displayed punctate 
intracellular staining, suggesting that Ficoll can be endocytosed by MSCs (Zeiger et al., 2012). 
Zeiger et al. deduced that only minor uptake of Ficoll was observed over 24 hours and this 
was unlikely to increase crowding within the cell. However, the results of the present study 
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suggest that the long-term culture of hCFs with Ficoll can result in large uptake of the 
polysaccharide. The process through which Ficoll is taken up by the cell is through caveolae-
dependent pinocytosis (a form of endocytosis where particles in the extracellular fluid are 
taken up by the cell) (Rashid et al., 2014). Both Ficoll 400 and Ficoll 70 have been shown to 
co-localise with lysosomes post-pinocytosis (Rashid et al., 2014). It is possible that once 
inside the acidic environment found within lysosomes that Ficoll is degraded into sucrose 
moieties. From here the sucrose may act osmotically and draw water into the lysosome, 
resulting in the swelling of the lysosome, which can now be termed a ‘sucrosome’. The large 
vesicles observed in the TEM micrographs in this study may be these swollen sucrosomes. If 
hCFs secrete sucrase, the sucrose can be hydrolysed into glucose and fructose which can 
then be released into the cytosol. As the media were replaced every 2 – 3 days, there will be 
a constant uptake of Ficoll which will result in the constant formation of sucrosomes. 
Although these vesicles were not observed in the carrageenan-crowded hCFs, it is likely that 
the cells also took up carrageenan. The presence of the vesicles in the Ficoll-crowded system 
is not unexpected given the high concentration of particles added – 1000 times greater than 
carrageenan. Unlike crowding with carrageenan, hCFs cultured with a Ficoll cocktail 
deposited collagen fibrils with the typical banding pattern, comparable to those observed in 
uncrowded conditions. Similarly, the collagen fibrils can be seen to change direction when 
cultured on Transwell membranes although these lamellae do not appear to extend over the 
same distance that was observed in uncrowded samples.  
 
4.6.2.2.2 The effect of crowding with a Ficoll cocktail on construct transparency 
Crowding with Ficoll did have a small effect on the transparency of the hCF constructs at 560 
nm. Although no distinguishable differences were observed between hCFs cultured on PTFE-
nf in A2PM compared to constructs cultured in FC, there was a small decrease in transmission 
between hCFs cultured on glass in A2PM and crowded samples. In short-term cultures of 6 
days no differences in transparency have previously been reported with crowded and 
uncrowded samples both exhibiting transmittance close to a PBS control (Kumar et al., 
2015a). The extended culture period used in the present study may account for the 
differences in transparency observed, with a prolonged culture period resulting in an 
increase in cell number. The endocytosis of Ficoll is likely to have directly affected cellular 
transparency by causing a change in the refractive index within the cell. Similarly, the uptake 
of Ficoll may also impact the expression of corneal crystallins. Although not investigated in 
this study, as the expression is typically reduced in corneal fibroblasts, corneal crystallins 
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help to maintain cellular transparency by creating short-range order within the cell thus 
reducing any fluctuations in the refractive index, reviewed in (Jester, 2008). It is possible that 
intracellular Ficoll may reduce the expression of corneal crystallins and further affect cell 
transparency. Furthermore, the fibrils seen in the TEM images of hCFs crowded with Ficoll 
do not seem to be as homogeneous in diameter as those in the control. This may be an 
artefact of sample sectioning and not a true phenotype of MMC with Ficoll – serial sectioning 
of the sample, along with an increase in the number of replicates may help to confirm this. 
If, however, this is a true phenotype and crowding with the Ficoll cocktail results in 
misshapen and irregular collagen fibrils, this will further affect the transparency of the 
culture (Chakravarti et al., 2000).  
 
4.6.2.2.3 The effect of crowding with a Ficoll cocktail on cell viability 
Surprisingly, despite the ultrastructural appearance of the hCFs when cultured in FC, there 
were no differences in either cell number or metabolic activity of the cells compared to those 
cultured in A2PM. This data supports previous findings which report that the metabolic 
activity of cells cultured in the presence of a Ficoll cocktail does not change after 6 days 
(Satyam et al., 2014; Kumar et al., 2015a). These results imply that the abundance of vesicles 
within the hCFs does not have a detrimental effect on cell proliferation, metabolic activity or 
collagen synthesis. Nevertheless, the vesicles may be having an effect on a variable that was 
not measured in this study.  
 
4.7 Conclusions 
In this study two macromolecular crowders were assessed for their potential to accelerate 
collagen deposition within the in vitro model of the corneal stroma. Both carrageenan and 
the Ficoll cocktail appeared to increase the deposition of collagen but the qualitative nature 
of ICC meant that this could not be quantified. Ultrastructural analysis of collagen revealed 
that lamellar-like structures were formed when hCFs were cultured on Transwell membranes 
in uncrowded media, as previously described, suggesting that this substrate is best suited to 
the creation of an in vitro stroma model (Guo et al., 2007). Ultrastructural analysis also 
revealed that crowding with carrageenan resulted in large collagen aggregates, whilst 
crowding with a Ficoll cocktail resulted in the uptake of Ficoll within vesicles that slightly 
reduced transparency.  
The data presented in this chapter suggest that carrageenan is not a suitable crowder 
for corneal stroma tissue engineering. Uniform collagen, with a small fibril diameter and 
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regular intrafibrillar spacing, is a key component in maintaining stroma transparency and this 
is disrupted by large aggregates when crowding with carrageenan. Although transparency 
was disrupted, the Ficoll cocktail may suitably accelerate collagen deposition. The possible 
deleterious effects of intracellular Ficoll uptake requires further investigation prior to its use 
in tissue engineering. Alternatively, the use of a cocktail containing other neutrally charged 
macromolecular crowders could be considered. Polyethylene glycol (PEG) is a neutral 
polymer that has previously been used to accelerate the conversion of procollagen to 
collagen in dermal fibroblast cultures (Bateman et al., 1986). More recently, PEG with a 
molecular weight of 600 kDa has been shown to increase collagen deposition in an 
adenocarcinoma cell line (Gonzalez-Molina et al., 2019). The calculated (supraphysiologic) 
FVO (300%) achieved through crowding with PEG also induced cell alignment. Given that cell 
and matrix alignment is essential when trying to recapitulate the corneal stroma, PEG may 
prove to be a useful macromolecular crowder.  
MMC with both dextran sulphate and a Ficoll cocktail has been used with TGF-β1 to 
create in vitro models of lung and skin fibrosis (C. Chen et al., 2009; Juhl et al., 2020). These 
models have been used as screening tools for anti-fibrotic therapies by companies such as 
GlaxoSmithKline and Nordic Bioscience (Juhl et al., 2020; Rønnow et al., 2020). The approach 
described here can be adapted to create a model of a corneal scar by stimulating the cells 
with TGF-β1, inducing myofibroblast differentiation and further stimulating collagen 
deposition. The stromal scar model would be useful to test anti-fibrotic therapies, targeting 
corneal haze, such as human recombinant decorin (Hill et al., 2018). 
 
4.8 Limitations and Future work 
The limitations of this study include the low number of biological replicates, particularly with 
the TEM analysis. TEM has its own limitations such as the small field of view which can 
provide a challenge when trying to draw conclusions about the gross effect of crowding, cell 
viability and collagen deposition. However, as the described phenotypes were observed in 
constructs cultured on both PTFE-nf and on Transwell membranes, it is likely that these 
observations are representative of each culture condition.  
Future work would include the fluorescent labelling of Ficoll prior to cell culture and 
subsequent live cell imaging. This would allow for the tracking of Ficoll particles after they 
are endocytosed to see how long they remain within the cell, if they are eventually released 
or accumulate indefinitely, using a pulse-chase protocol. Equally, if a specific antibody 
becomes available, the labelling of constructs with an anti-carrageenan antibody may help 
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to determine whether residual carrageenan remains after processing or if carrageenan is 
incorporated into the ECM. The live cell imaging of collagen deposition using CNA35 and CTR, 
as described in Chapter 3, in carrageenan-crowded media would enable the visualisation of 
aggregate formation which could help to understand their formation. Similarly, the use of 
correlative light-electron microscopy, can be used to identify the time point at which 
aggregation occurs. This, combined with immuno-EM, may reveal whether or not the 
aggregates do coat type I collagen fibrils and confirm if the aggregates are, at least in some 
part, formed of type VI collagen.  
 
 
Chapter 5. General discussion
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5.1 General discussion 
The corneal stroma is composed of heterotypic type I/V collagen fibrils which are small in 
diameter to maintain corneal transparency. These fibrils form lamellae which are arranged 
roughly orthogonally throughout and provide the cornea with its mechanical strength. An in 
vitro model of the stroma could be used to investigate stroma wound healing and collagen 
fibrillogenesis whilst also reducing the number of animal models used in research. An ideal 
model would be composed of an ECM that resembles the microarchitecture of the corneal 
stroma. The main aim of this thesis was to identify a suitable cell source and substrate for 
the development of an in vitro corneal stroma model, as well as employing macromolecular 
crowding to increase the deposition of collagen.  
 A suitable cell source is one that is easily obtained, readily expanded and can deposit 
an ECM with a similar composition as the native stroma. Substrates can modulate cell 
behaviour and the provision of topographical cues can induce cell alignment which can lead 
to the deposition of an organised matrix. However, cells cultured in vitro are removed from 
their typical microenvironments that are crowded with macromolecules. Here, the 
conversion of procollagen to collagen can be slow. The addition of inert macromolecules to 
aqueous culture media can increase the rate of collagen deposition, thus reducing the 
culture time necessary to create a stroma model.  
 Human corneal stromal stem cells (hCSSCs) have been shown to differentiate into 
keratocytes and deposit an organised ECM, suggesting these cells have great potential for 
use in a stroma model (Wu et al., 2012, 2013). In this study, however, the isolated population 
of hCSSCs was heterogeneous resulting in both inter- and intra-donor variability in the 
expression of stem cell markers. The isolated populations also transitioned into cells with a 
fibroblast-like morphology by passage 2, indicative of a phenotype change. These cells were 
difficult to culture and, as a result, hMSCs were considered as an alternative cell type. Despite 
also displaying inter-donor variability, hMSCs were capable of trilineage differentiation and, 
when cultured in keratocyte differentiating medium (KDM), expressed two proteoglycans 
commonly associated with keratocytes – keratocan and lumican (Carlson et al., 2005). A cell 
sphere was formed when the medium was switched to KDM and so substrates with 
topographical cues were used to encourage cell alignment. Human corneal fibroblasts (hCFs) 
were easily isolated and readily expanded, which may explain their widespread use in corneal 
tissue engineering (Guo et al., 2007; Proulx et al., 2010; Priyadarsini et al., 2016b). For these 
reasons, hCFs and hMSCs were incorporated into in vitro stroma models. 
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 The ideal model of the stroma would consist of an organised ECM, which can be 
achieved by aligning cells – a compromise between the natural morphology of keratocytes 
and the deposition of an organised ECM. In vivo keratocytes are dendritic-like cells with 
interconnecting lamellipodia. Providing cells with aligned, topographical cues can result in 
the cells becoming polarised and their processes unable to extend perpendicular to the 
topographical features. This would prevent keratocytes from exhibiting their characteristic 
dendritic morphology but would allow for the deposition of an aligned matrix. However, this 
is less of an issue with hCFs, which are inherently spindle-shaped. Two substrates with 
aligned, linear nanotopographical features were investigated in this study: PTFE nanofibres 
(PTFE-nf) and polycarbonate Transwell membranes. The high seeding density used in the 
Transwell model meant that there was an apparent increase in collagen deposition when 
compared to those cultured on PTFE-nf. However, the topographical cues provided by the 
PTFE-nf resulted in a significant increase in hCF alignment which translates to the alignment 
of the deposited ECM. Furthermore, hCFs cultured on PTFE-nf formed an angle shift between 
30° – 55°, relative to the first layer. hCFs on Transwell membranes did also shift in angle 
between the first and top layers but the distribution of angles was still broad, likely a result 
of the non-uniform distribution of grooves found on the Transwell membranes. Whilst both 
substrates appeared to support the growth of hMSCs in KDM, neither were successful in 
supporting keratocyte differentiation. The addition of topographical cues did not prevent the 
formation of cell spheres and α-SMA expression was observed in cultures on Transwell 
membranes, indicative of a myofibroblast phenotype. Both substrates were further 
investigated, as each had its own benefits, with PTFE-nf increasing cell alignment and the 
Transwell membrane, with the large cell number, appearing to deposit more collagen. 
 To increase collagen deposition, macromolecular crowding was incorporated into 
the corneal stroma models. The polydispersity and charge of crowders is known to affect 
collagen deposition. Two commonly used crowders were trialled – carrageenan, a negatively 
charged polysaccharide, and a Ficoll cocktail of neutral charge. At an early timepoint, 
carrageenan appeared to increase type I collagen deposition however, labelling with CNA35 
suggested that the collagen formed aggregates. Longer time points confirmed this, with ICC 
analysis showing aggregates of collagen at day 30, whereas the Ficoll cocktail resulted in an 
apparent increase of fibrillar collagen. The ultrastructural analysis of collagens in a crowded 
system is under-investigated, with few studies investigating the ultrastructure of the 
deposited ECM (Lareu et al., 2007b). TEM of the deposited collagen revealed that crowding 
with carrageen resulted in the formation of large banded structures, possibly the aggregated 
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form of type VI collagen, typically seen in pathological tissues. TEM also revealed the 
apparent uptake of Ficoll by the hCFs, evidenced by the presence of large vesicles. This 
supports the previous finding by Zeiger et al. who observed the uptake of Ficoll by bone 
marrow-derived MSCs (Zeiger et al., 2012). Despite this, no cytotoxic effects were observed 
when crowding with the Ficoll cocktail and its use in the stroma model may suitably 
accelerate collagen deposition. Alternatively, other neutrally charged crowders could be 
investigated to avoid the cellular uptake of the macromolecules.  
 
5.2 Summary of main findings 
This study demonstrated:  
1. hCFs are readily available cells that can be easily incorporated into an in vitro model 
2. PTFE nanofibres provide topographical cues which result in the alignment of hCFs 
and deposited collagens (more so than cultures on Transwell membranes) 
3. Long-term culture (up to 30 days) of hCFs on PTFE-nf can result in cell stratification 
and a shift in alignment between 30 – 55°  
4. Ultrastructural analysis of hCFs cultured on Transwell membranes showed the 
formation of loose lamellar-like collagen 
5. Crowding with carrageenan resulted in the formation of collagen aggregates with an 
ultrastructure resembling that of fibrous long-spacing collagen and type VI collagen 
aggregates 
6. Macromolecular crowding with Ficoll appeared to increase collagen deposition by 
hCFs on PTFE-nf, although ultrastructural analysis revealed cellular uptake  
 
5.3 Suggestions for future work 
To further optimise the hCF stroma model, the culture media could be switched to a low-
glucose, serum-free medium which may rescue the keratocyte phenotype. Other cell sources 
could be investigated, such as iPSCs or early-passage MSCs, and differentiated into 
keratocytes. The alternative compositions of KDM could also be investigated, as described 
by Bray et al. (Bray et al., 2012). Alternatively, corneal stromal cells could be expanded in a 
low-serum medium, as described by Yam et al., and then serum-starved to induce an 
activated keratocyte phenotype prior to incorporation into the model (Yam et al., 2015). 
Identifying and comparing other macromolecular crowders, such as polyethylene glycol 
(PEG), to the Ficoll cocktail used in this study may also improve the model. It is possible that 
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other neutrally charged crowder (e.g. PEG) may increase the rate of collagen deposition 
without the potentially deleterious effects of intracellular Ficoll uptake  
 To further understand the effect that crowding with carrageenan has on collagens 
ultrastructural analysis of collagen deposited after a shorter timeframe (e.g. 7 days) could be 
undertaken. Immunocytochemistry suggested that type I collagen was not as aggregated at 
day 7 when compared to day 30. Performing TEM at an earlier timepoint may show the 
formation of the protein aggregates and could show the early stages of type VI collagen 
aggregates covering type I collagen fibrils. Additionally, using immuno-EM to label the 
aggregates would reveal if type I collagen fibrils are present or if the aggregates are formed 
purely of type VI collagen. Finally, ultrastructural analysis of collagens deposited when 
crowded with other negatively charged crowders can be used to see if the results observed 
in this study are specific to carrageenan or are an attribute of the negative charge. 
 If an ideal cell line were to be produced it would be one where the ECM deposited 
could be fine-tuned with ease. For example, the addition of a certain combination of growth 
factors (e.g. TGF-β3, FGF-2 etc.) would result in the deposition of heterotypic type I/V 
collagen fibrils with a diameter of around 30 nm, similar to that produced by keratoblasts. 
By being able to perfectly control the components of the matrix that is deposited, one could 
use the collagen probe to investigate mammalian stromal development. To speculate 
further, if the cell line could be manipulated so that it suddenly resembled a myofibroblast 
(perhaps by changing the growth factors), the deposition of collagens during wound healing 
could also be explored. 
 
5.4 Applications of a corneal stroma model 
An in vitro model of the corneal stroma has many applications. To date, stroma models are 
used to model different disease states, from keratoconus to diabetic neuropathy and fibrosis 
(Karamichos et al., 2010, 2012). Adapting the model to include the co-culture of other 
corneal cells, such as the endothelium, epithelium and nerve cells, would allow for the 
modelling of more complex diseases. Modelling these diseases, such as keratoconus and 
diabetic neuropathy, will enable the exploration of treatments and therapies. For example, 
mutations in CHST6 are responsible for some cases of the genetic condition macular corneal 
dystrophy (Klintworth, 2009). A stroma model could be created using corneal cells isolated 
from donors with this condition. This disease model can then be used to test treatments such 
as the application of small activating RNAs to upregulate the expression CHST6 (Kwok et al., 
2019).  




5.4.1 Understanding mechanisms of tissue development  
How the stroma forms during development is still being investigated, with most research 
focusing on chick models (Funderburgh et al., 1986; Koudouna et al., 2018; Young et al., 
2019). However, it is known that avian corneas first form a primary stroma, an event not 
seen in mammalian corneas (Espana and Birk, 2020). The stroma model could be used to 
further understand the mechanisms behind tissue development. In particular, the model 
could be used to study collagen fibril alignment and cell stratification. Live cell imaging of 
cells cultured on substrates with aligned nanotopography, and labelling collagen with CNA35, 
may reveal how collagen is aligned. Future research could focus on how collagen fibrils 
maintain alignment once cells stratify and they are no longer in contact with the cues 
provided by the substrate. Imaging cells as they stratify and as their orientation rotates may 
reveal key events, necessary for the formation of lamellar tissues. Understanding tissue 
development can assist in understanding disease. 
 
5.4.2 Understanding wound healing  
Corneal stroma models are currently being used to investigate matrix metalloproteinase 
expression during wound healing (Couture et al., 2016). During wound healing, growth 
factors and cytokines such as IL-1 and TNFα are released by epithelial cells and enter the 
stroma to recruit myofibroblasts. The addition of epithelial cells to the model may allow for 
the modelling of wound healing. By further understanding would healing, research into 
treatments for corneal scars can take place, perhaps by identifying signalling pathways to 
target. 
 
5.5 Applications of a lamellar collagen model 
The stroma model could be adapted to research other lamellar collagen tissues. One example 
is the annulus fibrosus (AF) of the intervertebral disc. With adaptation, such as changing the 
cell type, the in vitro model used in the present study may also be used to model the lamellar 
collagen of the AF. Here, the tissue is composed of aligned collagen fibrils, lamellae, which 
are oriented at 30° to adjacent layers (Shamsah et al., 2019). The stratification and rotation 
observed as hCFs were cultured on PTFE-nf may also be useful in tissue engineering the AF, 
assuming AF cells behave similarly. The alignment of cells is also a design requirement in 
other areas of regenerative medicine, such as tendon healing and the generation of nerve 
guides. In fact, a recent study by Foolen et al. suggests that tendon-derived cells cultured in 
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an aligned, organised matrix possessed a greater ability to remodel the ECM than cells in a 
disorganised (scar) matrix (Foolen et al., 2018). The stroma model could be adapted to create 
both a 2D model of both healthy and scarred tendons, using PTFE-nf and glass substrates 
respectively.  
 
5.6 Modelling other diseases 
Incorporating macromolecular crowding with carrageenan into the model used in the 
present study resulted in the formation of collagen aggregates which resembled aggregates 
observed in pathological tissues (Kobayasi et al., 1985; Knupp et al., 2006). Crowding with 
carrageenan may, therefore, offer a disease model for conditions such as Sorsby’s fundus 
dystrophy (condition affecting the Bruch’s membrane) and morphea (condition affecting the 
skin) (Kobayasi et al., 1985; Knupp et al., 2002). Being able to model these diseases in vitro 
may lead to the development of drug treatments and possibly reduce the use of animal 
models. 
 
5.7 Concluding remarks 
The original hypothesis of this study was that cells residing in the limbal stroma can be 
influenced by nanotopography to deposit an organised matrix that resembled the 
microarchitecture of the corneal stroma. Further, it was hypothesised that macromolecular 
crowding would increase matrix deposition without disrupting the organisation of the 
matrix. This study has shown that that corneal fibroblasts can deposit oriented collagen 
when cultured on PTFE-nf. It was also shown that hCFs and, consequently, the ECM also 
remained oriented as the cells stratified, most likely through cell-cell contact guidance. 
Macromolecular crowding appeared to increase the deposition of collagen, with Ficoll 
maintaining matrix alignment. The stroma model presented here meets the minimum design 
requirements for studying collagen fibrillogenesis and this is the proposed use of this model. 
It is expected that the stroma model can be easily adapted with the addition of a stratified 
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6.1 Appendix A  
6.1.1 Positive control for primary antibodies used to characterise keratocytes 
A human corneal stroma was collagenase-digested and subjected to cytospinning as a way 
of isolating keratocytes prior to them transitioning into fibroblasts. The cytospin 
preparations were then used as a positive control for the primary antibodies specific to 
corneal keratocytes: collagens type I, V and VI, CD34, ALDH1A1, ALDH3A1, keratocan and 
lumican. Fibroblast marker, CD90, and myofibroblast marker, α-SMA were also used as a 
control.  
 Collagens type V and VI were expressed in cytospin preparations; collagen type I 
staining was relatively diffuse but this may be as a result of the low cell number (Figure 6.1). 
All keratocyte markers, with the exception of ALDH1A1 were expressed in cytospin 
preparations and so this antibody was not used in further experiments (Figure 6.2). As 
expected, both CD90 and α-SMA were not expressed. 
 
 
Figure 6.1 Max. z-projection from ICC of collagens in human corneal stroma cytospin 
preparations. Cytospin preparations displayed positive expression of collagens type V and VI 
(magenta) but staining of collagen type I was diffuse and may be non-specific. Preparations 
were also stained with Phalloidin to visualise F-actin (yellow) and DAPI (blue). Merge images 
are also shown. n = 1 biological replicate. Scale bar represents 50 µm. 




Figure 6.2 ICC of keratocyte-, fibroblast- and myofibroblast-markers in human corneal 
stroma cytospin preparations. Cytospin preparations displayed positive expression of CD34, 
keratocan and lumican (magenta) but not ALDH1A1. Positive expression of ALDH3A1 (green) 
was also shown. Fibroblast marker CD90 was not expressed, neither was myofibroblast 
marker α-SMA (green). One preparation was also stained with Phalloidin to visualise F-actin 
(yellow). All preparations were co-stained with DAPI (blue). Merged images are also shown. 
IgG negative controls are shown for comparison. n = 1 biological replicate. Scale bar 
represents 50 µm. 
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6.2 Appendix B  
6.2.1 Selection of housekeeping gene using GeNorm 
Analysis of housekeeping genes for both hCSSCs compared with hCFs (Table 6.1) and hMSCs 
compared with differentiated hMSCs (Table 6.2) using geNorm analysis revealed that GAPDH 
and ACTB were equally stable. GAPDH was chosen as the housekeeping gene for all future 
experiments.  
 
Table 6.1 Stepwise elimination of least stable housekeeping genes for hCSSCs and hCFs. 
 GAPDH 18S RNA ACTB B2M 
hCFs 1.00E+00 1.00E+00 1.00E+00 8.50E-01 
hCSSCs 7.39E-03 2.07E-01 1.87E-03 1.00E+00 
1) M < 1.51 3.325 3.325 4.260 4.508 
2) M < 1.51 2.401 4.099 3.103 - 
3) M < 1.51 1.404 - 1.404 - 
1 At each step, the gene expression stability measure (M) is calculated and the gene with the highest 
M value (magenta) is excluded until just two genes remain (green).  
 
 
Figure 6.3 Graphical representation of the average expression stability value of the 































<:::::  Least stable genes             Most stable genes ::::>
Average expression stability values of remaining control 
genes
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Table 6.2 Stepwise elimination of least stable housekeeping genes for hMSCs. 
 
GAPDH 18S RNA ACTB B2M 
hMSC (SCM) 1.37E-01 3.41E-02 1.18E-01 3.33E-01 
hMSC (KDM) 1.00E+00 1.00E+00 1.00E+00 1.00E+00 
1) M < 1.51 0.827 1.671 0.827 1.431 
2) M < 1.51 0.530 - 0.608 0.983 
3) M < 1.51 0.156 - 0.156 - 
1 At each step, the gene expression stability measure (M) is calculated and the gene with the 
highest M value (magenta) is excluded until just two genes remain (green). 
 
 
Figure 6.4 Graphical representation of the average expression stability value of the 
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6.3 Appendix C  
6.3.1 Program for paraffin embedding chondrocyte pellets 
Chondrocyte pellets were embedded in paraffin using the program outlined in Table 6.3. 
 
Table 6.3 Paraffin embedding program used to embed chondrocyte pellets. 
Reagent Duration (min) 
70% ethanol 30 
90% ethanol 30 
100% ethanol 5 
100% ethanol 10 
100% ethanol 10 




Paraffin wax 30 
Paraffin wax 60 
Paraffin wax 150 
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6.4 Appendix D  
6.4.1 Details for hCSSC isolation attempts 
The length of time between donor death and CSSC isolation may have had an effect on the 
success of cell isolation. The average length of time between donor death and cell isolation 
was 41.6 ± 16.3 days (Table 6.4). However, for donors isolated using Method 1, this assumes 
that the tissue was stored in organ culture medium for no more than 3 weeks prior to 
supplementing the medium with dextran (Pels, 1997).  
 
Table 6.4 Length of time between date of death and cell isolation from donor tissue. 
Donor number Age (sex) ‡ 
Number of days between 
date of death* and cell 
isolation 
Method 1 
Donor A (HCR025) Unknown 6* 
Donor B (HCR043) 74 16* 
Method 2 
Donor 1 (IEB012) 61 49 
Donor 2 (IEB015) 65 43 
Donor 3 (IEB024_025) 49 (M) 67 
Donor 4 (NHS021) Unknown 33 
Donor 5 (NHS025_026) Unknown 25 and 34† 
*Where date of death was not provided, date corneas were placed into dextran was used; †two donors 
were combined to improve cell numbers; ‡where the sex of the donor was known it is included in 
parentheses – M, male; F, female.  
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6.5 Appendix C 
6.5.1 pQE-30 vector for CNA35  
For the expression of CNA35, a microbial surface component recognising adhesive matrix 
molecules, a pQE30CNA35 plasmid (Figure 6.5) was transformed into single competent cells 
(Chapter 3, 3.4.2). 
 
 
Figure 6.5 Vector pQE-30 coding for the collagen binding part of the A domain of S. aureus. 
The plasmid was kindly gifted to Dr. Elizabeth Canty-Laird (supervisor) by Magnus Höök. 
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6.6 Appendix E 
6.6.1 Confirming OrientationJ Distribution  
To confirm that the OrientationJ Distribution plugin performed as expected, an image was 
digitally rotated within FIJI prior to running the plugin. The distribution shifted 20°, as 
expected, however the frequency at the dominant orientation decreased (Figure 6.6). This 
can be explained by the loss of image corners that occurred when rotating the image and 
can be seen in Figure 6.7. Surprisingly, a new peak was also formed at 75° and so the 
OrientationJ Analysis plugin was used to create a colour survey where Hue represents the 
angle of orientation; Saturation represents coherency; and Brightness is the same as the 
input image. The colour survey revealed an artefact at the edge of the rotated images where 
a band of a singular colour could be seen which was absent from the original images. This 
has been magnified in the boxed region of the third image and the circular colour map 
confirms that this colour is at 75°. 
 
 
Figure 6.6 OrientationJ analysis of the cumulative distribution of one donor which has been 
digitally rotated by 20 degrees. When the image is digitally rotated by 20° using FIJI, the 
peak of the distribution shifts to the left by 20°. The peak isn’t as large as the original 
distribution and a new peak has been formed at 75°, caused by image artefacts shown below. 
 






















Figure 6.7 OrientationJ Colour Survey of both the original and the rotated images. When 
the original image was digitally rotated by 20°, the corners of the image are lost. There is also 
an edge artefact in the rotated images showing a magenta streak (magnified in the bottom 
right image) which corresponds to 75° as shown in the circular colour map (bottom left). 
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6.7 Appendix F 
6.7.1 P values for growth curves, resazurin assay and RFU/cell for hCFs  
Cell number and metabolic activity were assessed to compare media treatments (growth, 
A2PM and FC) of hCFs , with the same data being reported in both Chapter 3 (3.5.2) and 
Chapter 4 (4.5.4). A two-way ANOVA was performed on cell number (Table 6.5), metabolic 
activity (Table 6.6) and relative fluorescence per cell (Table 6.8), and a Tukey’s post hoc test 
for multiple comparisons was performed (Table 6.7).  
 
Table 6.5 Results from two-way ANOVA performed on hCF cell number data with growth, 
A2PM and FC. 
Source of variation SS (Type III) DF MS F (DFn, DFd) p value 
Time 173534 5 34707 F (5, 35) = 104.8 p < 0.0001 
Media 493.5 2 246.7 F (2, 35) = 0.7449 p = 0.4822 
Interaction 2874 10 287.4 F (10, 35) = 0.8678 p = 0.5705 
Residual 11593 35 331.2 
  
 
Table 6.6 Results from one-way ANOVA performed on metabolic activity data with growth, 
A2PM and FC where media and time variables were concatenated.  
Source of variation SS (Type III) DF MS F (DFn, DFd) p value 
Between groups 290774336406 17 17104372730 F (17, 36) = 107.3 p < 0.0001 
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Table 6.7 Tukey’s pairwise multiple comparisons. Comparisons of interest are shown. 
Comparison Diff. of means q p value 
Growth1 vs. A2PM1 9374 1.286 >0.9999 
Growth1 vs. FC1 7115 0.9759 >0.9999 
A2PM1 vs. FC1 -2260 0.3099 >0.9999 
Growth3 vs. A2PM3 32639 4.477 0.1839 
Growth3 vs. FC3 17805 2.442 0.948 
A2PM3 vs. FC3 -14834 2.035 0.9901 
Growth5 vs. A2PM5 19128 2.624 0.9101 
Growth5 vs. FC5 15633 2.144 0.9834 
A2PM5 vs. FC5 -3496 0.4795 >0.9999 
Growth7 vs. A2PM7 4684 0.6425 >0.9999 
Growth7 vs. FC7 5912 0.8109 >0.9999 
A2PM7 vs. FC7 1228 0.1684 >0.9999 
Growth14 vs. A2PM14 -4978 0.6827 >0.9999 
Growth14 vs. FC14 1114 0.1528 >0.9999 
A2PM14 vs. FC14 6092 0.8356 >0.9999 
Growth21 vs. A2PM21 -1760 0.2414 >0.9999 
Growth21 vs. FC21 7032 0.9646 >0.9999 
A2PM21 vs. FC21 8792 1.206 >0.9999 
 
Table 6.8 Results from two-way ANOVA performed on hCF fluorescence per cell (RFU/cell) 
data with growth, A2PM and FC. 
Source of variation SS (Type III) DF MS F (DFn, DFd) P value 
Time 0.2992 5 0.05985 F (5, 35) = 7.772 p < 0.0001 
Media 0.03494 2 0.01747 F (2, 35) = 2.269 p = 0.1184 
Interaction 0.06133 10 0.006133 F (10, 35) = 0.7965 p = 0.6326 
Residual 0.2695 35 0.007700 
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6.8 Appendix G  
6.8.1 hCFs imaged over time show the secretion of collagen  
The in vitro model of the corneal stroma was used to visualise collagen deposition over time. 
hCFs were seeded onto PTFE-nf in a chamber slide and allowed to rest for 24 hours. The cells 
were then labelled with CellTracker Red (CTR) and collagen was labelled with the collagen 
probe (CNA35) before imaging hourly over 64 hours on a Zeiss LSM 700 (Figure 6.8). The 
images show the migration of cells over time as they move adjacent to the PTFE-nf and the 
increased secretion of collagen. Magnified images at time points: 0, 16, 32, 48 and 64 hours 
















Figure 6.8 Live cell imaging of hCFs cultured in magnetic chamber slide on PTFE-nf were imaged every hour for 64 hours. Images at 1-hour intervals are 
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